Amedeo Smart

Free Medical Literature Service


 

Amedeo

Bacterial Infections and Mycoses

  Free Subscription

Articles published in
Antimicrob Agents Chemother
    July 2021
  1. CLARKE RS, Ha KP, Edwards AM
    RexAB promotes the survival of Staphylococcus aureus exposed to multiple classes of antibiotics.
    Antimicrob Agents Chemother. 2021 Jul 26:AAC0059421. doi: 10.1128/AAC.00594.
    >> Share

  2. CHIREHWA MT, Court R, de Kock M, Wiesner L, et al
    The effect of isoniazid intake on ethionamide pharmacokinetics and target attainment in multidrug-resistant tuberculosis patients.
    Antimicrob Agents Chemother. 2021 Jul 26:AAC0027821. doi: 10.1128/AAC.00278.
    >> Share

  3. SHAHEEN SK, Juvvadi PR, Allen Iv J, Shwab EK, et al
    In vitro activity of APX2041, a new GWT1-inhibitor and in vivo efficacy of the prodrug APX2104 against Aspergillus fumigatus.
    Antimicrob Agents Chemother. 2021 Jul 26:AAC0068221. doi: 10.1128/AAC.00682.
    >> Share

  4. YU W, Buhari Y, Wang S, Tian X, et al
    Sterilizing Effects of Novel Regimens Containing TB47, Clofazimine and Linezolid in a Murine Model of Tuberculosis.
    Antimicrob Agents Chemother. 2021 Jul 19:AAC0070621. doi: 10.1128/AAC.00706.
    >> Share

  5. VAN SCHIE L, Borgers K, Michielsen G, Plets E, et al
    Exploration of synergistic action of cell wall-degrading enzymes against Mycobacterium tuberculosis.
    Antimicrob Agents Chemother. 2021 Jul 19:AAC0065921. doi: 10.1128/AAC.00659.
    >> Share

  6. HANDELMAN M, Morogovsky A, Liu W, Ben-Ami R, et al
    Triazole resistant Aspergillus fumigatus in an Israeli patient with Chronic Cavitary Pulmonary Aspergillosis due to a novel E306K Substitution in Hmg1.
    Antimicrob Agents Chemother. 2021 Jul 19:AAC0108921. doi: 10.1128/AAC.01089.
    >> Share

  7. GOMIS-FONT MA, Pitart C, Del Barrio-Tofino E, Zboromyrska Y, et al
    Emergence of Resistance to Novel Cephalosporin-beta-Lactamase Inhibitor Combinations through the Modification of the Pseudomonas aeruginosa MexCD-OprJ Efflux Pump.
    Antimicrob Agents Chemother. 2021;65:e0008921.
    >> Share

  8. SERRANO-LOBO J, Gomez A, Rodriguez-Sanchez B, Munoz P, et al
    Azole resistant Aspergillus fumigatus clinical isolate screening in azole-containing agar plates (EUCAST E.Def 10.1): low impact of plastic trays used and poor performance in cryptic species.
    Antimicrob Agents Chemother. 2021 Jul 12:AAC0048221. doi: 10.1128/AAC.00482.
    >> Share

  9. ERNEST JP, Sarathy J, Wang N, Kaya F, et al
    Lesion penetration and activity limit the utility of second-line injectable agents in pulmonary tuberculosis.
    Antimicrob Agents Chemother. 2021 Jul 12:AAC0050621. doi: 10.1128/AAC.00506.
    >> Share

  10. CANAS MA, Tellez A, de la Maria CG, Dahl A, et al
    Development of high level daptomycin resistance (HLDR) in Abiotrophia and Granulicatella spp isolates from patients with infective endocarditis (IE).
    Antimicrob Agents Chemother. 2021 Jul 12:AAC0252220. doi: 10.1128/AAC.02522.
    >> Share

  11. GEWITZ AD, Solans BP, Mac Kenzie WR, Heilig C, et al
    A Longitudinal Model-Based Biomarker Analysis of Exposure Response in Adults with Pulmonary Tuberculosis.
    Antimicrob Agents Chemother. 2021 Jul 12:AAC0179420. doi: 10.1128/AAC.01794.
    >> Share

  12. POUVARET A, Dureault A, Garcia-Hermoso D, Serris A, et al
    Combined high dose caspofungin and liposomal amphotericin B for the treatment of azole-resistant cerebral aspergillosis.
    Antimicrob Agents Chemother. 2021 Jul 12:AAC0047421. doi: 10.1128/AAC.00474.
    >> Share

  13. BIGGEL M, Nuesch-Inderbinen M, Jans C, Stevens MJA, et al
    Genetic context of optrA and poxtA in florfenicol-resistant enterococci isolated from flowing surface water in Switzerland.
    Antimicrob Agents Chemother. 2021 Jul 12:AAC0108321. doi: 10.1128/AAC.01083.
    >> Share

  14. BRENNAN-KROHN T, Friar L, Ditelberg S, Kirby JE, et al
    Evaluation of the Synergistic Activity of Antibacterial and Antifungal Drugs against Candida auris using an Inkjet Printer-Assisted Method.
    Antimicrob Agents Chemother. 2021 Jul 12:AAC0026821. doi: 10.1128/AAC.00268.
    >> Share

  15. WESTGEEST AC, Schippers EF, Delfos NM, Ellerbroek LJ, et al
    Complicated carriage with methicillin-resistant Staphylococcus aureus (MRSA): evaluation of the effectiveness of decolonization regimens advised in the Dutch national guideline.
    Antimicrob Agents Chemother. 2021 Jul 6:AAC0025721. doi: 10.1128/AAC.00257.
    >> Share

  16. GAMAL A, Long L, Herrada J, Aram J, et al
    Efficacy of Voriconazole, Isavuconazole, Fluconazole, and Anidulafungin in the treatment of emerging Candida auris using an immunocompromised murine model of disseminated candidiasis.
    Antimicrob Agents Chemother. 2021 Jul 6:AAC0054921. doi: 10.1128/AAC.00549.
    >> Share

  17. EGBELOWO O, Sarathy JP, Gausi K, Zimmerman MD, et al
    Pharmacokinetics and target attainment of SQ109 in plasma and human-like tuberculosis lesions in rabbits.
    Antimicrob Agents Chemother. 2021 Jul 6:AAC0002421. doi: 10.1128/AAC.00024.
    >> Share

  18. SWIFT SM, Sauve K, Cassino C, Schuch R, et al
    Exebacase is Active In Vitro in Pulmonary Surfactant and is Efficacious Alone and Synergistic with Daptomycin in a Mouse Model of Lethal Staphylococcus aureus Lung Infection.
    Antimicrob Agents Chemother. 2021 Jul 6:AAC0272320. doi: 10.1128/AAC.02723.
    >> Share

  19. MAPHANGA TG, Naicker SD, Kwenda S, Munoz JF, et al
    In-vitro antifungal resistance of Candida auris isolates from bloodstream infections, South Africa.
    Antimicrob Agents Chemother. 2021 Jul 6:AAC0051721. doi: 10.1128/AAC.00517.
    >> Share

    June 2021
  20. WERNGREN J, Mansjo M, Glader M, Hoffner S, et al
    Detection of pyrazinamide heteroresistance in Mycobacterium tuberculosis.
    Antimicrob Agents Chemother. 2021 Jun 28:AAC0072021. doi: 10.1128/AAC.00720.
    >> Share

  21. GONZALEZ-JIMENEZ I, Garcia-Rubio R, Monzon S, Lucio J, et al
    Multi-resistance to non-azole fungicides in Aspergillus fumigatus TR34/L98H azole resistant isolates.
    Antimicrob Agents Chemother. 2021 Jun 21:AAC0064221. doi: 10.1128/AAC.00642.
    >> Share

  22. KOHLHOFF S, Hammerschlag MR
    In Vitro Activity of Nafithromycin (WCK 4873) against Chlamydia pneumoniae.
    Antimicrob Agents Chemother. 2021 Jun 21:AAC0058521. doi: 10.1128/AAC.00585.
    >> Share

  23. ZENG S, Zhang J, Sun M, Zhang X, et al
    Nitric oxide-dependent electron transport chain inhibition by the cytochrome bc1 inhibitor and pretomanid combination kills Mycobacterium tuberculosis.
    Antimicrob Agents Chemother. 2021 Jun 21:AAC0095621. doi: 10.1128/AAC.00956.
    >> Share

  24. CAMERON A, Mangat R, Mostafa HH, Taffner S, et al
    Detection of CTX-M-27 beta-Lactamase Genes on Two Distinct Plasmid Types in ST38 Escherichia coli from Three U.S. States.
    Antimicrob Agents Chemother. 2021;65:e0082521.
    >> Share

  25. PLAUNT AJ, Rose SJ, Kang JY, Chen KJ, et al
    Development and Preclinical Evaluation of New Inhaled Lipoglycopeptides for the Treatment of Persistent Pulmonary Methicillin-Resistant Staphylococcus aureus Infections.
    Antimicrob Agents Chemother. 2021;65:e0031621.
    >> Share

  26. RHODES NJ, Jozefczyk CC, Moore WJ, Yarnold PR, et al
    Characterizing Risk Factors for Clostridioides difficile Infection among Hospitalized Patients with Community-Acquired Pneumonia.
    Antimicrob Agents Chemother. 2021;65:e0041721.
    >> Share

  27. GUPTILL JT, Raja SM, Juel VC, Walter EB, et al
    Safety, Tolerability, and Pharmacokinetics of NTM-1632, a Novel Mixture of Three Monoclonal Antibodies against Botulinum Toxin B.
    Antimicrob Agents Chemother. 2021;65:e0232920.
    >> Share

  28. LIZZA BD, Betthauser KD, Ritchie DJ, Micek ST, et al
    New Perspectives on Antimicrobial Agents: Ceftolozane-Tazobactam.
    Antimicrob Agents Chemother. 2021;65:e0231820.
    >> Share

  29. BROWN ELLIOTT BA, Wallace RJ Jr
    Comparison of In Vitro Susceptibility of Delafloxacin with Ciprofloxacin, Moxifloxacin, and Other Comparator Antimicrobials against Isolates of Nontuberculous Mycobacteria.
    Antimicrob Agents Chemother. 2021;65:e0007921.
    >> Share

  30. SINGH KV, Arias CA, Murray BE
    Efficacy of Omadacycline Against Multiresistant Enterococcus faecium Strains in a Mouse Peritonitis Model.
    Antimicrob Agents Chemother. 2021 Jun 14:AAC0070921. doi: 10.1128/AAC.00709.
    >> Share

  31. CHIN D, Goncheva MI, Flannagan RS, Heinrichs DE, et al
    Mutations in a membrane permease or hpt lead to 6-thioguanine resistance in Staphylococcus aureus.
    Antimicrob Agents Chemother. 2021 Jun 14:AAC0076021. doi: 10.1128/AAC.00760.
    >> Share

  32. GUTHRIDGE I, Smith S, Law M, Binotto E, et al
    The efficacy and safety of intravenous lincosamide therapy in methicillin-resistant Staphylococcus aureus bacteremia.
    Antimicrob Agents Chemother. 2021 Jun 14:AAC0034321. doi: 10.1128/AAC.00343.
    >> Share

  33. TOYOTOME T, Onishi K, Sato M, Kusuya Y, et al
    Identification of novel mutations contributing to azole tolerance of Aspergillus fumigatus through in vitro exposure to tebuconazole.
    Antimicrob Agents Chemother. 2021 Jun 14:AAC0265720. doi: 10.1128/AAC.02657.
    >> Share

  34. SHETYE GS, Choi KB, Kim CY, Franzblau SG, et al
    In Vitro Profiling of Anti-tubercular Compounds by Rapid, Efficient, and Non-Destructive Assays Using Auto-luminescent Mycobacterium tuberculosis.
    Antimicrob Agents Chemother. 2021 Jun 7:AAC0028221. doi: 10.1128/AAC.00282.
    >> Share

  35. HUANG DB, Gaukel E, Kerzee N, Borroto-Esoda K, et al
    Efficacy of Anti-Staphylococcal Lysin, LSVT-1701, in Combination with Daptomycin in Experimental Left-Sided Infective Endocarditis Due to Methicillin-Resistant Staphylococcus aureus (MRSA).
    Antimicrob Agents Chemother. 2021 Jun 7:AAC0050821. doi: 10.1128/AAC.00508.
    >> Share

  36. SHIBATA M, Masuda M, Sasahara K, Sasabe H, et al
    Prediction of Human Pharmacokinetic Profiles of the Anti-tuberculosis Drug Delamanid from Nonclinical Data: Potential Therapeutic Value Against Extrapulmonary Tuberculosis.
    Antimicrob Agents Chemother. 2021 Jun 7:AAC0257120. doi: 10.1128/AAC.02571.
    >> Share

  37. BACCANI I, Antonelli A, Di Pilato V, Coppi M, et al
    Detection of poxtA2, a presumptive poxtA ancestor, in a plasmid from a linezolid-resistant Enterococcus gallinarum.
    Antimicrob Agents Chemother. 2021 Jun 7:AAC0069521. doi: 10.1128/AAC.00695.
    >> Share

  38. LEW C, Mishra NN, Bayer AS, Rose WE, et al
    beta-lactam-induced cell envelope adaptations, not solely enhanced daptomycin binding, underlies daptomycin-beta-lactam synergy in methicillin-resistant Staphylococcus aureus.
    Antimicrob Agents Chemother. 2021 Jun 7:AAC0035621. doi: 10.1128/AAC.00356.
    >> Share

  39. ZAINABADI K, Walsh KF, Vilbrun SC, Mathurin LD, et al
    Characterization of differentially detectable Mycobacterium tuberculosis in the sputum of subjects with drug sensitive or drug resistant tuberculosis before and after two months of therapy.
    Antimicrob Agents Chemother. 2021 Jun 1:AAC0060821. doi: 10.1128/AAC.00608.
    >> Share

    May 2021
  40. MIRANDA-CADENA K, Dias M, Costa-Barbosa A, Collins T, et al
    Erratum for Miranda-Cadena et al., "Development and Characterization of Monoolein-Based Liposomes of Carvacrol, Cinnamaldehyde, Citral, or Thymol with Anti-Candida Activities".
    Antimicrob Agents Chemother. 2021;65.
    >> Share

  41. HERRERA-HIDALGO L, de Alarcon A, Lopez-Cortes LE, Luque-Marquez R, et al
    Erratum for Herrera-Hidalgo et al., "Is Once-Daily High-Dose Ceftriaxone plus Ampicillin an Alternative for Enterococcus faecalis Infective Endocarditis in Outpatient Parenteral Antibiotic Therapy Programs?"
    Antimicrob Agents Chemother. 2021;65.
    >> Share

  42. VAN DAELE R, Debaveye Y, Lagrou K, Spriet I, et al
    Fluconazole Underexposure in Critically Ill Patients: a Matter of Using the Right Targets?
    Antimicrob Agents Chemother. 2021;65.
    >> Share

  43. MARTSON AG, Boonstra JM, Sandaradura I, Kosterink JGW, et al
    Reply to Van Daele et al., "Fluconazole Underexposure in Critically Ill Patients: a Matter of Using the Right Targets?"
    Antimicrob Agents Chemother. 2021;65.
    >> Share

  44. QIN S, Peng J, Deng R, Peng K, et al
    Identification of Two Plasmids Coharboring Carbapenemase Genes and tmexCD1-toprJ1 in Clinical Klebsiella pneumoniae ST2667.
    Antimicrob Agents Chemother. 2021;65.
    >> Share

  45. RUBIO AM, Kline EG, Jones CE, Chen L, et al
    In Vitro Susceptibility of Multidrug-Resistant Pseudomonas aeruginosa following Treatment-Emergent Resistance to Ceftolozane-Tazobactam.
    Antimicrob Agents Chemother. 2021;65.
    >> Share

  46. LIU L, Zhou X, Li B, Cheng F, et al
    In Vitro and In Vivo Activities, Absorption, Tissue Distribution, and Excretion of OBP-4, a Potential Anti-Clostridioides difficile Agent.
    Antimicrob Agents Chemother. 2021;65.
    >> Share

  47. SOLIMAN AM, Ramadan H, Zarad H, Sugawara Y, et al
    Coproduction of Tet(X7) Conferring High-Level Tigecycline Resistance, Fosfomycin FosA4, and Colistin Mcr-1.1 in Escherichia coli Strains from Chickens in Egypt.
    Antimicrob Agents Chemother. 2021;65.
    >> Share

  48. FAHEEM M, Zhang CJ, Morris MN, Pleiss J, et al
    Role of Synonymous Mutations in the Evolution of TEM beta-Lactamase Genes.
    Antimicrob Agents Chemother. 2021;65.
    >> Share

  49. LOMOVSKAYA O, Rubio-Aparicio D, Nelson K, Sun D, et al
    In Vitro Activity of the Ultrabroad-Spectrum Beta-Lactamase Inhibitor QPX7728 in Combination with Multiple Beta-Lactam Antibiotics against Pseudomonas aeruginosa.
    Antimicrob Agents Chemother. 2021;65.
    >> Share

  50. KOVANDA LL, Sass G, Martinez M, Clemons KV, et al
    Efficacy and Associated Drug Exposures of Isavuconazole and Fluconazole in an Experimental Model of Coccidioidomycosis.
    Antimicrob Agents Chemother. 2021;65.
    >> Share

  51. HUANG HY, Wang CF, Lu PL, Tseng SP, et al
    Clinical Impact of the Revised 2019 CLSI Levofloxacin Breakpoints in Patients with Enterobacterales Bacteremia.
    Antimicrob Agents Chemother. 2021;65.
    >> Share

  52. BARNES KB, Richards MI, Laws TR, Nunez A, et al
    Finafloxacin Is an Effective Treatment for Inhalational Tularemia and Plague in Mouse Models of Infection.
    Antimicrob Agents Chemother. 2021;65.
    >> Share

  53. BABOWICZ F, LaPlante R, Mitchell C, O'Donnell JN, et al
    Impact of Accelerate Pheno and BacT/Alert Virtuo on Clinical Processes and Outcomes in Patients with Sepsis and Concurrent Gram-Negative Bacteremia.
    Antimicrob Agents Chemother. 2021;65.
    >> Share

  54. JIN L, Wang R, Gao H, Wang Q, et al
    Identification of a Novel Hybrid Plasmid Encoding KPC-2 and Virulence Factors in Klebsiella pneumoniae Sequence Type 11.
    Antimicrob Agents Chemother. 2021;65.
    >> Share

  55. LOS-ARCOS I, Berastegui C, Martin-Gomez MT, Grau S, et al
    Nebulized Micafungin Treatment for Scopulariopsis/Microascus Tracheobronchitis in Lung Transplant Recipients.
    Antimicrob Agents Chemother. 2021;65.
    >> Share

  56. MADRID-MORALES J, Sharma A, Reveles K, Velez-Mejia C, et al
    Validation of Available Extended-Spectrum-Beta-Lactamase Clinical Scoring Models in Predicting Drug Resistance in Patients with Enteric Gram-Negative Bacteremia Treated at South Texas Veterans Health Care System.
    Antimicrob Agents Chemother. 2021;65.
    >> Share

  57. SOBEL JD, Borroto-Esoda K, Azie N, Angulo D, et al
    In Vitro pH Activity of Ibrexafungerp Against Fluconazole-susceptible and -resistant Candida Isolates from Women with Vulvovaginal Candidiasis.
    Antimicrob Agents Chemother. 2021 May 17. pii: AAC.00562.
    >> Share

  58. JOHANSEN MD, Shalini, Kumar S, Raynaud C, et al
    Biological and biochemical evaluation of isatin-isoniazid hybrids as bactericidal candidates against Mycobacterium tuberculosis.
    Antimicrob Agents Chemother. 2021 May 10. pii: AAC.00011.
    >> Share

  59. WASSERMAN S, Davis A, Stek C, Chirehwa M, et al
    Plasma pharmacokinetics of high dose oral versus intravenous rifampicin in patients with tuberculous meningitis: a randomized controlled trial.
    Antimicrob Agents Chemother. 2021 May 10. pii: AAC.00140.
    >> Share

  60. FREDERICKS LR, Lee MD, Eckert HR, Li S, et al
    Vaginal Isolates of Candida glabrata are Uniquely Susceptible to Ionophoric Killer Toxins Produced by Saccharomyces cerevisiae.
    Antimicrob Agents Chemother. 2021 May 10. pii: AAC.02450.
    >> Share

  61. MOK S, Roycroft E, Flanagan PR, Montgomery L, et al
    Overcoming the Challenges of Pyrazinamide Susceptibility Testing in Clinical Mycobacterium tuberculosis isolates.
    Antimicrob Agents Chemother. 2021 May 10. pii: AAC.02617.
    >> Share

  62. LAWAL OU, Fraqueza MJ, Worning P, Bouchami O, et al
    Staphylococcus saprophyticus causing infections in humans are associated with high resistance to heavy metals.
    Antimicrob Agents Chemother. 2021 May 3. pii: AAC.02685.
    >> Share

  63. LIANG T, Yang X, Li R, Yang E, et al
    Emergence of W272C Substitution in Hmg1 in a Triazole-Resistant Isolate of Aspergillus fumigatus from a Chinese Patient with Chronic Cavitary Pulmonary Aspergillosis.
    Antimicrob Agents Chemother. 2021 May 3. pii: AAC.00263.
    >> Share

  64. JANICE J, Agyepong N, Owusu-Ofori A, Govinden U, et al
    Carbapenem-resistance determinants acquired through novel chromosomal integrations in XDR Pseudomonas aeruginosa.
    Antimicrob Agents Chemother. 2021 May 3. pii: AAC.00289.
    >> Share

    April 2021
  65. MAO Y, Valour F, Nguyen NTQ, Doan TMN, et al
    Multi-mechanistic Monoclonal Antibody Combination Targeting Key Staphylococcus aureus Virulence Determinants in a Rabbit Model of Prosthetic Joint Infection.
    Antimicrob Agents Chemother. 2021 Apr 26. pii: AAC.01832.
    >> Share

  66. SONNENKALB L, Strohe G, Dreyer V, Andres S, et al
    Microevolution of Mycobacterium tuberculosis hetero-resistance subpopulations in a patient receiving 27 years of tuberculosis treatment in Germany.
    Antimicrob Agents Chemother. 2021 Apr 26. pii: AAC.02520.
    >> Share

  67. TASNEEN R, Mortensen DS, Converse PJ, Urbanowski ME, et al
    Dual mTORC1/mTORC2 inhibition as a Host-Directed Therapeutic Target in Pathologically Distinct Mouse Models of Tuberculosis.
    Antimicrob Agents Chemother. 2021 Apr 26. pii: AAC.00253.
    >> Share

  68. LEY SD, Pillay S, Streicher EM, van der Heijden YF, et al
    Melting the Eis: non-detection of kanamycin resistance markers by routine diagnostic tests and identification of new eis-promoter variants.
    Antimicrob Agents Chemother. 2021 Apr 26. pii: AAC.02502.
    >> Share

  69. KIM DH, Kim SY, Koh WJ, Jhun BW, et al
    In Vitro Activity of Oxazolidinone against Nontuberculous Mycobacteria, Including Macrolide-Resistant Clinical Isolates.
    Antimicrob Agents Chemother. 2021 Apr 26. pii: AAC.02306.
    >> Share

  70. YAO D, Zhang G, Chen W, Chen J, et al
    Pyrogallol and Fluconazole Interact Synergistically In Vitro Against Candida glabrata Through an Efflux-Associated Mechanism.
    Antimicrob Agents Chemother. 2021 Apr 19. pii: AAC.00100.
    >> Share

  71. ABDELWAHAB MT, Court R, Everitt D, Diacon AH, et al
    The effect of Clofazimine Concentration on QT prolongation in patients treated for tuberculosis.
    Antimicrob Agents Chemother. 2021 Apr 19. pii: AAC.02687.
    >> Share

  72. LIN WH, Lee WT, Tsai HY, Jou R, et al
    Disputed rpoB mutations in Mycobacterium tuberculosis and tuberculosis treatment outcomes.
    Antimicrob Agents Chemother. 2021 Apr 12. pii: AAC.01573.
    >> Share

  73. HERRADA J, Gamal A, Long L, Sanchez SP, et al
    In Vitro and In Vivo Antifungal Activity of AmBisome Compared to Conventional Amphotericin B and Fluconazole against Candida auris.
    Antimicrob Agents Chemother. 2021 Apr 12. pii: AAC.00306.
    >> Share

  74. POULSEN JS, Madsen AM, White JK, Nielsen JL, et al
    Physiological responses of Aspergillus niger challenged with itraconazole.
    Antimicrob Agents Chemother. 2021 Apr 5. pii: AAC.02549.
    >> Share

  75. OKOLIEGBE IN, Hijazi K, Cooper K, Ironside C, et al
    Trends of antimicrobial resistance and combination susceptibility testing of cystic fibrosis multidrug-resistant Pseudomonas aeruginosa: A ten-year update.
    Antimicrob Agents Chemother. 2021 Apr 5. pii: AAC.02483.
    >> Share

    March 2021
  76. STEWART AG, Price EP, Schabacker K, Birikmen M, et al
    Molecular epidemiology of third-generation cephalosporin-resistant Enterobacteriaceae in Southeast Queensland, Australia.
    Antimicrob Agents Chemother. 2021 Mar 29. pii: AAC.00130.
    >> Share

  77. WIEDERHOLD NP, Najvar LK, Olivo M, Morris KN, et al
    Ibrexafungerp Demonstrates in vitro Activity against Fluconazole-Resistant Candida auris and in vivo Efficacy with Delayed Initiation of Therapy in an Experimental Model of Invasive Candidiasis.
    Antimicrob Agents Chemother. 2021 Mar 22. pii: AAC.02694.
    >> Share

  78. ORTIZ DE LA ROSA JM, Nordmann P, Poirel L
    Antioxidant molecules as a source of mitigation of antibiotic resistance genes dissemination.
    Antimicrob Agents Chemother. 2021 Mar 22. pii: AAC.02658.
    >> Share

  79. MAY M, Chang M, Dietz D, Shoucri S, et al
    Limited Utility of Procalcitonin in Identifying Community-Associated Bacterial Infections in Patients Presenting with Coronavirus Disease 2019.
    Antimicrob Agents Chemother. 2021;65.
    >> Share

  80. AURITI C, Goffredo BM, Ronchetti MP, Piersigilli F, et al
    High-Dose Micafungin in Neonates and Young Infants with Invasive Candidiasis: Results of a Phase 2 Study.
    Antimicrob Agents Chemother. 2021;65.
    >> Share

  81. MASUKO A, Takata I, Fujita K, Okumura H, et al
    In Vitro and In Vivo Activities of TP0480066, a Novel Topoisomerase Inhibitor, against Neisseria gonorrhoeae.
    Antimicrob Agents Chemother. 2021;65.
    >> Share

  82. BOOT W, Schmid T, D'Este M, Guillaume O, et al
    A Hyaluronic Acid Hydrogel Loaded with Gentamicin and Vancomycin Successfully Eradicates Chronic Methicillin-Resistant Staphylococcus aureus Orthopedic Infection in a Sheep Model.
    Antimicrob Agents Chemother. 2021;65.
    >> Share

  83. NAKAMURA R, Oota M, Matsumoto S, Sato T, et al
    In Vitro Activity and In Vivo Efficacy of Cefiderocol against Stenotrophomonas maltophilia.
    Antimicrob Agents Chemother. 2021;65.
    >> Share

  84. URBANOWICZ P, Bitar I, Izdebski R, Baraniak A, et al
    Epidemic Territorial Spread of IncP-2-Type VIM-2 Carbapenemase-Encoding Megaplasmids in Nosocomial Pseudomonas aeruginosa Populations.
    Antimicrob Agents Chemother. 2021;65.
    >> Share

  85. OKA D, Yamaya N, Kuno T, Asakawa Y, et al
    In Vitro and In Vivo Antibacterial Activities of a Novel Quinolone Compound, OPS-2071, against Clostridioides difficile.
    Antimicrob Agents Chemother. 2021;65.
    >> Share

  86. ABUTALEB NS, Elkashif A, Flaherty DP, Seleem MN, et al
    In Vivo Antibacterial Activity of Acetazolamide.
    Antimicrob Agents Chemother. 2021;65.
    >> Share

  87. OUESLATI S, Emeraud C, Grosperrin V, Levy M, et al
    Polyclonal Dissemination of NDM-1- and NDM-9-Producing Escherichia coli and Klebsiella pneumoniae in French Polynesia.
    Antimicrob Agents Chemother. 2021;65.
    >> Share

  88. DIAZ-GARCIA J, Mesquida A, Sanchez-Carrillo C, Reigadas E, et al
    Monitoring the Epidemiology and Antifungal Resistance of Yeasts Causing Fungemia in a Tertiary Care Hospital in Madrid, Spain: Any Relevant Changes in the Last 13 Years?
    Antimicrob Agents Chemother. 2021;65.
    >> Share

  89. POILVACHE H, Ruiz-Sorribas A, Cornu O, Van Bambeke F, et al
    In Vitro Study of the Synergistic Effect of an Enzyme Cocktail and Antibiotics against Biofilms in a Prosthetic Joint Infection Model.
    Antimicrob Agents Chemother. 2021;65.
    >> Share

  90. PENNINGS LJ, Ruth MM, Wertheim HFL, van Ingen J, et al
    The Benzimidazole SPR719 Shows Promising Concentration-Dependent Activity and Synergy against Nontuberculous Mycobacteria.
    Antimicrob Agents Chemother. 2021;65.
    >> Share

  91. LEE A, Wang N, Carter CL, Zimmerman M, et al
    Therapeutic Potential of Fosmanogepix (APX001) for Intra-abdominal Candidiasis: from Lesion Penetration to Efficacy in a Mouse Model.
    Antimicrob Agents Chemother. 2021;65.
    >> Share

  92. CHENG J, Yan J, Reyna Z, Slarve M, et al
    Synergistic Rifabutin and Colistin Reduce Emergence of Resistance When Treating Acinetobacter baumannii.
    Antimicrob Agents Chemother. 2021;65.
    >> Share

  93. XIANG R, Li M
    Identification of Tn6835 and a Novel Genomic Island, MMGI-1, in a Pan-Resistant Morganella morganii Strain.
    Antimicrob Agents Chemother. 2021;65.
    >> Share

  94. MAZZANTINI D, Celandroni F, Calvigioni M, Lupetti A, et al
    In Vitro Resistance and Evolution of Resistance to Tavaborole in Trichophyton rubrum.
    Antimicrob Agents Chemother. 2021;65.
    >> Share

  95. ARDIZZONI E, Ariza E, Mulengwa D, Mpala Q, et al
    Thin layer agar-based direct phenotypic drug-susceptibility testing on sputum in Eswatini rapidly detects Mycobacterium tuberculosis growth and rifampicin resistance, otherwise missed by WHO endorsed diagnostic tests.
    Antimicrob Agents Chemother. 2021 Mar 15. pii: AAC.02263.
    >> Share

  96. MODLIN SJ, Marbach T, Werngren J, Mansjo M, et al
    Atypical Genetic Basis of Pyrazinamide Resistance in Mono-resistant Mycobacterium tuberculosis.
    Antimicrob Agents Chemother. 2021 Mar 15. pii: AAC.01916.
    >> Share

  97. KARAU MJ, Schmidt-Malan SM, Mandrekar J, Lehoux D, et al
    Activity of Lysin CF-296 Alone and in Addition to Daptomycin in a Rat Model of Experimental Methicillin-Resistant Staphylococcus aureus Osteomyelitis.
    Antimicrob Agents Chemother. 2021 Mar 15. pii: AAC.00117.
    >> Share

  98. SU H, Zhu M, Tsui CK, van der Lee H, et al
    Potency of olorofim (F901318) compared to contemporary antifungal agents against clinical Aspergillus fumigatus isolates, and review of azole resistance phenotype and genotype epidemiology in China.
    Antimicrob Agents Chemother. 2021 Mar 8. pii: AAC.02546.
    >> Share

  99. CHO HK, Karau MJ, Greenwood-Quaintance KE, Hansford KA, et al
    In Vitro Activity of Vancapticin MCC5145 against Methicillin-Resistant Staphylococcus aureus from Periprosthetic Joint Infection.
    Antimicrob Agents Chemother. 2021 Mar 8. pii: AAC.02443.
    >> Share

  100. PEREZ-CANTERO A, Martin-Vicente A, Guarro J, Fortwendel JR, et al
    Analysis of the cyp51 genes contribution to azole resistance in Aspergillus section Nigri with the CRISPR-Cas9 technique.
    Antimicrob Agents Chemother. 2021 Mar 8. pii: AAC.01996.
    >> Share

  101. ERSOY SC, Chambers HF, Proctor RA, Rosato AE, et al
    Impact of Bicarbonate on PBP2a Production, Maturation, and Functionality in Methicillin-Resistant Staphylococcus aureus (MRSA).
    Antimicrob Agents Chemother. 2021 Mar 1. pii: AAC.02621.
    >> Share

  102. CANFIELD GS, Chatterjee A, Espinosa J, Mangalea MR, et al
    Lytic bacteriophages facilitate antibiotic sensitization of Enterococcus faecium.
    Antimicrob Agents Chemother. 2021 Mar 1. pii: AAC.00143.
    >> Share

  103. COJUTTI PG, Rinaldi M, Zamparini E, Rossi N, et al
    Population pharmacokinetics of dalbavancin and dosing consideration for optimal treatment of adult patients with staphylococcal osteoarticular infections.
    Antimicrob Agents Chemother. 2021 Mar 1. pii: AAC.02260.
    >> Share

    February 2021
  104. OMOLLO C, Singh V, Kigondu E, Wasuna A, et al
    Developing synergistic drug combinations to restore antibiotic sensitivity in drug-resistant Mycobacterium tuberculosis.
    Antimicrob Agents Chemother. 2021 Feb 22. pii: AAC.02554.
    >> Share

  105. SHELTON CD, McNeil MB, Early JV, Ioerger TR, et al
    Deletion of Rv2571c confers resistance to arylamide compounds in Mycobacterium tuberculosis.
    Antimicrob Agents Chemother. 2021 Feb 22. pii: AAC.02334.
    >> Share

  106. SCHULTHESS B, Schafle D, Kalin N, Widmer T, et al
    Drug susceptibility distributions of Mycobacterium chimaera and other non-tuberculous mycobacteria.
    Antimicrob Agents Chemother. 2021 Feb 22. pii: AAC.02131.
    >> Share

  107. VILCHEZE C, Jacobs WR Jr
    The promises and limitations of N-acetylcysteine as a potentiator of first-line and second-line tuberculosis drugs.
    Antimicrob Agents Chemother. 2021 Feb 22. pii: AAC.01703.
    >> Share

  108. LI J, Coste AT, Liechti M, Bachmann D, et al
    Novel ERG11 and TAC1b mutations associated with azole resistance in Candida auris.
    Antimicrob Agents Chemother. 2021 Feb 22. pii: AAC.02663.
    >> Share

  109. ARIAS LS, Butcher MC, Short B, McKloud E, et al
    Correction for Arias et al., "Chitosan Ameliorates Candida auris Virulence in a Galleria mellonella Infection Model".
    Antimicrob Agents Chemother. 2021;65.
    >> Share

  110. SANDARADURA I, Wojciechowski J, Marriott DJE, Day RO, et al
    Model-Optimized Fluconazole Dose Selection for Critically Ill Patients Improves Early Pharmacodynamic Target Attainment without the Need for Therapeutic Drug Monitoring.
    Antimicrob Agents Chemother. 2021;65.
    >> Share

  111. AEDO SJ, Tang J, Brynildsen MP
    Metabolites Potentiate Nitrofurans in Nongrowing Escherichia coli.
    Antimicrob Agents Chemother. 2021;65.
    >> Share

  112. WAN M, Gao X, Lv L, Cai Z, et al
    IS26 Mediates the Acquisition of Tigecycline Resistance Gene Cluster tmexCD1-toprJ1 by IncHI1B-FIB Plasmids in Klebsiella pneumoniae and Klebsiella quasipneumoniae from Food Market Sewage.
    Antimicrob Agents Chemother. 2021;65.
    >> Share

  113. BOONSTRA JM, Martson AG, Sandaradura I, Kosterink JGW, et al
    Optimization of Fluconazole Dosing for the Prevention and Treatment of Invasive Candidiasis Based on the Pharmacokinetics of Fluconazole in Critically Ill Patients.
    Antimicrob Agents Chemother. 2021;65.
    >> Share

  114. POT M, Guyomard-Rabenirina S, Couvin D, Ducat C, et al
    Dissemination of Extended-Spectrum-beta-Lactamase-Producing Enterobacter cloacae Complex from a Hospital to the Nearby Environment in Guadeloupe (French West Indies): ST114 Lineage Coding for a Successful IncHI2/ST1 Plasmid.
    Antimicrob Agents Chemother. 2021;65.
    >> Share

  115. PAPP-WALLACE KM, Shapiro AB, Becka SA, Zeiser ET, et al
    In Vitro Antibacterial Activity and In Vivo Efficacy of Sulbactam-Durlobactam against Pathogenic Burkholderia Species.
    Antimicrob Agents Chemother. 2021;65.
    >> Share

  116. FRANCISCO EC, de Almeida Junior JN, Queiroz-Telles F, Aquino VR, et al
    Correlation of Trichosporon asahii Genotypes with Anatomical Sites and Antifungal Susceptibility Profiles: Data Analyses from 284 Isolates Collected in the Last 22 Years across 24 Medical Centers.
    Antimicrob Agents Chemother. 2021;65.
    >> Share

  117. LE W, Su X, Lou X, Li X, et al
    Susceptibility Trends of Zoliflodacin against Multidrug-Resistant Neisseria gonorrhoeae Clinical Isolates in Nanjing, China, 2014 to 2018.
    Antimicrob Agents Chemother. 2021;65.
    >> Share

  118. SCHAFLE D, Selchow P, Borer B, Meuli M, et al
    Rifabutin Is Inactivated by Mycobacterium abscessus Arr.
    Antimicrob Agents Chemother. 2021;65.
    >> Share

  119. KEATING CL, Zuckerman JB, Singh PK, McKevitt M, et al
    Pseudomonas aeruginosa Susceptibility Patterns and Associated Clinical Outcomes in People with Cystic Fibrosis following Approval of Aztreonam Lysine for Inhalation.
    Antimicrob Agents Chemother. 2021;65.
    >> Share

  120. BEGANOVIC M, Daffinee KE, Luther MK, LaPlante KL, et al
    Minocycline Alone and in Combination with Polymyxin B, Meropenem, and Sulbactam against Carbapenem-Susceptible and -Resistant Acinetobacter baumannii in an In Vitro Pharmacodynamic Model.
    Antimicrob Agents Chemother. 2021;65.
    >> Share

  121. LUO P, Huang Y, Hang X, Tong Q, et al
    Dihydrotanshinone I Is Effective against Drug-Resistant Helicobacter pylori In Vitro and In Vivo.
    Antimicrob Agents Chemother. 2021;65.
    >> Share

  122. FANG Y, Kirsch JR, Li L, Brooks SA, et al
    Deimmunized Lysostaphin Synergizes with Small-Molecule Chemotherapies and Resensitizes Methicillin-Resistant Staphylococcus aureus to beta-Lactam Antibiotics.
    Antimicrob Agents Chemother. 2021;65.
    >> Share

  123. BROWN-ELLIOTT BA, Wallace RJ Jr
    In Vitro Susceptibility Testing of Omadacycline against Nontuberculous Mycobacteria.
    Antimicrob Agents Chemother. 2021;65.
    >> Share

  124. FEKKAR A, Blaize M, Bougle A, Normand AC, et al
    Hospital outbreak of fluconazole-resistant Candida parapsilosis: arguments for clonal transmission and long-term persistence.
    Antimicrob Agents Chemother. 2021 Feb 16. pii: AAC.02036.
    >> Share

  125. NUNEZ-OTERO C, Bahnan W, Vielfort K, Silver J, et al
    A 2-pyridone amide inhibitor of transcriptional activity in Chlamydia trachomatis.
    Antimicrob Agents Chemother. 2021 Feb 16. pii: AAC.01826.
    >> Share

  126. NONG Y, Taiaroa G, Pasricha S, Guerillot R, et al
    Clinical relevance of topical antibiotic use in co-selecting for multidrug-resistant Staphylococcus aureus: Insights from in vitro and ex vivo models.
    Antimicrob Agents Chemother. 2021 Feb 16. pii: AAC.02048.
    >> Share

  127. GHANNOUM M, Herrada J, McCormick TS, Long L, et al
    A Novel Transdermal Application for Clearing Skin Colonization by Candida auris.
    Antimicrob Agents Chemother. 2021 Feb 8. pii: AAC.02303.
    >> Share

  128. LUN S, Xiao S, Zhang W, Wang S, et al
    Therapeutic potential of coumestan Pks13 inhibitors for tuberculosis.
    Antimicrob Agents Chemother. 2021 Feb 8. pii: AAC.02190.
    >> Share

  129. PIETERMAN ED, van den Berg S, van der Meijden A, Svensson EM, et al
    Higher dosing of rifamycins does not increase activity against M. tuberculosis in the hollow fibre infection model.
    Antimicrob Agents Chemother. 2021 Feb 8. pii: AAC.02255.
    >> Share

  130. XU J, Converse PJ, Upton AM, Mdluli K, et al
    Comparative efficacy of the novel diarylquinoline TBAJ-587 and bedaquiline against a resistant Rv0678 mutant in a mouse model of tuberculosis.
    Antimicrob Agents Chemother. 2021 Feb 1. pii: AAC.02418.
    >> Share

    January 2021
  131. HO VQT, Verboom T, Rong MK, Habjan E, et al
    Heterologous expression of ethA and katG in Mycobacterium marinum enables the rapid identification of new prodrugs active against Mycobacterium tuberculosis.
    Antimicrob Agents Chemother. 2021 Jan 25. pii: AAC.01445.
    >> Share

  132. SIOPI M, Perlin DS, Arendrup MC, Pournaras S, et al
    Comparative pharmacodynamics of echinocandins against Aspergillus fumigatus using an in vitro pharmacokinetic/pharmacodynamic model that correlates with clinical response to caspofungin therapy: Is there a place for dose optimization?
    Antimicrob Agents Chemother. 2021 Jan 25. pii: AAC.01618.
    >> Share

  133. SMITH NM, Ang A, Tan F, Macias K, et al
    Interaction of Staphylococcus aureus and Acinetobacter baumannii during in vitro beta-lactam exposure.
    Antimicrob Agents Chemother. 2021 Jan 25. pii: AAC.02414.
    >> Share

  134. ASEMPA TE, Abdelraouf K, Nicolau DP
    The Ongoing Challenge with NDM-Harboring Enterobacteriaceae in Murine Infection Models.
    Antimicrob Agents Chemother. 2021;65.
    >> Share

  135. DAS S, Everett M, Zalacain M, Hope W, et al
    Reply to Asempa et al., "The Ongoing Challenge with NDM-Harboring Enterobacteriaceae in Murine Infection Models".
    Antimicrob Agents Chemother. 2021;65.
    >> Share

  136. MOTA FERNANDES C, Dasilva D, Haranahalli K, McCarthy JB, et al
    The Future of Antifungal Drug Therapy: Novel Compounds and Targets.
    Antimicrob Agents Chemother. 2021;65.
    >> Share

  137. FOURNIER D, Carriere R, Bour M, Grisot E, et al
    Mechanisms of Resistance to Ceftolozane/Tazobactam in Pseudomonas aeruginosa: Results of the GERPA Multicenter Study.
    Antimicrob Agents Chemother. 2021;65.
    >> Share

  138. HE R, Yang Y, Wu Y, Zhong LL, et al
    Characterization of a Plasmid-Encoded Resistance-Nodulation-Division Efflux Pump in Klebsiella pneumoniae and Klebsiella quasipneumoniae from Patients in China.
    Antimicrob Agents Chemother. 2021;65.
    >> Share

  139. DRUSANO GL, Kim S, Almoslem M, Schmidt S, et al
    The Funnel: a Screening Technique for Identifying Optimal Two-Drug Combination Chemotherapy Regimens.
    Antimicrob Agents Chemother. 2021;65.
    >> Share

  140. PYBUS CA, Felder-Scott C, Obuekwe V, Greenberg DE, et al
    Cefiderocol Retains Antibiofilm Activity in Multidrug-Resistant Gram-Negative Pathogens.
    Antimicrob Agents Chemother. 2021;65.
    >> Share

  141. LEE J, Ammerman N, Agarwal A, Naji M, et al
    Differential In Vitro Activities of Individual Drugs and Bedaquiline-Rifabutin Combinations against Actively Multiplying and Nutrient-Starved Mycobacterium abscessus.
    Antimicrob Agents Chemother. 2021;65.
    >> Share

  142. BERNET E, Lebughe M, Vincent AT, Haghdoost MM, et al
    Sodium Tetraphenylborate Displays Selective Bactericidal Activity against Neisseria meningitidis and N. gonorrhoeae and Is Effective at Reducing Bacterial Infection Load.
    Antimicrob Agents Chemother. 2021;65.
    >> Share

  143. MOTOS A, Li Bassi G, Pagliara F, Fernandez-Barat L, et al
    Short-Term Effects of Appropriate Empirical Antimicrobial Treatment with Ceftolozane/Tazobactam in a Swine Model of Nosocomial Pneumonia.
    Antimicrob Agents Chemother. 2021;65.
    >> Share

  144. CAVENEY NA, Serapio-Palacios A, Woodward SE, Bozorgmehr T, et al
    Structural and Cellular Insights into the l,d-Transpeptidase YcbB as a Therapeutic Target in Citrobacter rodentium, Salmonella Typhimurium, and Salmonella Typhi Infections.
    Antimicrob Agents Chemother. 2021;65.
    >> Share

  145. BEREDAKI MI, Arendrup MC, Andes D, Mouton JW, et al
    The Role of New Posaconazole Formulations in the Treatment of Candida albicans Infections:Data from an in Vitro Pharmacokinetic-Pharmacodynamic Model.
    Antimicrob Agents Chemother. 2021 Jan 19. pii: AAC.01292.
    >> Share

  146. CHENG YS, Roma JS, Shen M, Fernandes CM, et al
    Identification of Antifungal Compounds against Multidrug Resistant Candida auris Utilizing a High Throughput Drug Repurposing Screen.
    Antimicrob Agents Chemother. 2021 Jan 19. pii: AAC.01305.
    >> Share

  147. KHAN MZ, Nandicoori VK
    Deletion of PknG abates reactivation of latent Mycobacterium tuberculosis in mice.
    Antimicrob Agents Chemother. 2021 Jan 19. pii: AAC.02095.
    >> Share

  148. PRATER AG, Mehta HH, Beabout K, Supandy A, et al
    Daptomycin resistance in Enterococcus faecium can be delayed by disruption of the LiaFSR stress response pathway.
    Antimicrob Agents Chemother. 2021 Jan 19. pii: AAC.01317.
    >> Share

  149. DRUSANO GL, Rogers S, Brown D, Peloquin CA, et al
    Dose-fractionation of moxifloxacin for the treatment of tuberculosis: impact of dosing interval and elimination half-life on microbial kill and resistance suppression.
    Antimicrob Agents Chemother. 2021 Jan 19. pii: AAC.02533.
    >> Share

  150. MIRANDA-CADENA K, Dias M, Costa-Barbosa A, Collins T, et al
    Development and Characterization of Monoolein-Based Liposomes of Carvacrol, Cinnamaldehyde, Citral or Thymol with anti-Candida Activities.
    Antimicrob Agents Chemother. 2021 Jan 19. pii: AAC.01628.
    >> Share

  151. YANG X, Ye L, Chan EW, Zhang R, et al
    Characterization of an IncFIB/IncHI1B plasmid encoding efflux pump TMexCD1-TOprJ1 in a clinical tigecycline and carbapenem-resistant Klebsiella pneumoniae strain.
    Antimicrob Agents Chemother. 2021 Jan 19. pii: AAC.02340.
    >> Share

  152. CHALKER VJ, Sharratt MG, Rees C, Bell OH, et al
    Tetracycline resistance mediated by tet(M) has variable Integrative Conjugative Element composition in Mycoplasma hominis isolated in the United Kingdom from 2005-2015.
    Antimicrob Agents Chemother. 2021 Jan 19. pii: AAC.02513.
    >> Share

  153. ZHU H, Fu L, Wang B, Chen X, et al
    Activity of Clofazimine and TBI-166 against Mycobacterium tuberculosis, in different administration intervals in mouse tuberculosis models.
    Antimicrob Agents Chemother. 2021 Jan 11. pii: AAC.02164.
    >> Share

  154. PFALLER MA, Messer SA, Deshpande LM, Rhomberg PR, et al
    Evaluation of Synergistic Activity of Isavuconazole or Voriconazole plus Anidulafungin and the Occurrence and Genetic Characterisation of Candida auris Detected in a Surveillance Program.
    Antimicrob Agents Chemother. 2021 Jan 11. pii: AAC.02031.
    >> Share

  155. CAZER CL, Westblade LF, Simon MS, Magleby R, et al
    Analysis of multidrug resistance in Staphylococcus aureus with a machine learning generated antibiogram.
    Antimicrob Agents Chemother. 2021 Jan 11. pii: AAC.02132.
    >> Share

  156. DU W, Zhai P, Wang T, Bromley MJ, et al
    The C2H2 Transcription Factor SltA Contributes to Azole Resistance by Coregulating the Expression of the Drug Target Erg11A and the Drug Efflux Pump Mdr1 in Aspergillus fumigatus.
    Antimicrob Agents Chemother. 2021 Jan 11. pii: AAC.01839.
    >> Share

    December 2020
  157. PETRAITIENE R, Petraitis V, Maung BBW, Mansbach RS, et al
    Efficacy and Pharmacokinetics of Fosmanogepix (APX001) in the Treatment of Candida Endophthalmitis and Hematogenous Meningoencephalitis in Non-neutropenic Rabbits.
    Antimicrob Agents Chemother. 2020 Dec 23. pii: AAC.01795.
    >> Share

  158. VALAFAR SJ
    A Systematic Review of Mutations Associated with Isoniazid Resistance Points to Continuing Evolution and Subsequent Evasion of Molecular Detection, and Potential for Emergence of Multidrug Resistance in Clinical Strains of Mycobacterium tuberculosis.
    Antimicrob Agents Chemother. 2020 Dec 23. pii: AAC.02091.
    >> Share

  159. LIN SY, Feng JY, Lee CY, Lin YC, et al
    Completion and adverse drug events of latent tuberculosis infection treatment in patients receiving dialysis: predictors and impacts of different regimens in a prospective cohort study.
    Antimicrob Agents Chemother. 2020 Dec 23. pii: AAC.02184.
    >> Share

  160. CAMPIONE E, Gaziano R, Doldo E, Marino D, et al
    Antifungal effect of all-trans retinoic acid against Aspergillus fumigatus in vitro and in a pulmonary aspergillosis in vivo model.
    Antimicrob Agents Chemother. 2020 Dec 23. pii: AAC.01874.
    >> Share

  161. MIESEL L, Cushion MT, Ashbaugh A, Lopez SR, et al
    Efficacy of Rezafungin in Prophylactic Mouse Models of Invasive Candidiasis, Aspergillosis, and Pneumocystis Pneumonia.
    Antimicrob Agents Chemother. 2020 Dec 14. pii: AAC.01992.
    >> Share

  162. CHU S, Long L, McCormick TS, Borroto-Esoda K, et al
    A second generation fungerp analog SCY-247, shows potent in vivo activity in a murine model of hematogenously disseminated Candida albicans.
    Antimicrob Agents Chemother. 2020 Dec 14. pii: AAC.01989.
    >> Share

  163. CHU S, Long L, Sherif R, McCormick TS, et al
    A second generation fungerp analog SCY-247, shows potent in vitro activity against Candida auris and other clinically relevant fungal isolates.
    Antimicrob Agents Chemother. 2020 Dec 14. pii: AAC.01988.
    >> Share

    November 2020
  164. VIJAY S, Nhung HN, Bao NLH, Thu DDA, et al
    Most-probable number based minimum duration of killing assay for determining the spectrum of rifampicin susceptibility in clinical M. tuberculosis isolates.
    Antimicrob Agents Chemother. 2020 Nov 30. pii: AAC.01439.
    >> Share

  165. ASADZADEH M, Dashti M, Ahmad S, Alfouzan W, et al
    Whole genome and targeted-amplicon sequencing of fluconazole-susceptible and -resistant Candida parapsilosis isolates from Kuwait reveals a previously undescribed N1132D polymorphism in CDR1.
    Antimicrob Agents Chemother. 2020 Nov 30. pii: AAC.01633.
    >> Share

  166. KAWAGUCHI N, Katsube T, Echols R, Wajima T, et al
    Population Pharmacokinetic and Pharmacokinetic/Pharmacodynamic Analyses of Cefiderocol, a Parenteral Siderophore Cephalosporin, in Patients with Pneumonia, Bloodstream Infection/Sepsis, or Complicated Urinary Tract Infection.
    Antimicrob Agents Chemother. 2020 Nov 30. pii: AAC.01437.
    >> Share

  167. SAITO S, Hayakawa K, Tsuzuki S, Ishikane M, et al
    The Impact of the Clinical Outcomes and Risk Factors of Patients with IMP-Type Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae in Japan: A Matched Case-Case-Control Study.
    Antimicrob Agents Chemother. 2020 Nov 30. pii: AAC.01483.
    >> Share

  168. IGNATIUS EH, Abdelwahab MT, Hendricks B, Gupte N, et al
    Pretomanid Pharmacokinetics in the Presence of Rifamycins: interim Results from a Randomized Trial among Patients with Tuberculosis.
    Antimicrob Agents Chemother. 2020 Nov 23. pii: AAC.01196.
    >> Share

  169. FISHER C, Patel R
    Rifampin, Rifapentine, and Rifabutin are Active Against Intracellular Periprosthetic Joint Infection-Associated Staphylococcus epidermidis.
    Antimicrob Agents Chemother. 2020 Nov 16. pii: AAC.01275.
    >> Share

  170. XIONG K, Su C, Sun Q, Lu Y, et al
    Efg1 and Cas5 Orchestrate Cell Wall Damage Response to Caspofungin in Candida albicans.
    Antimicrob Agents Chemother. 2020 Nov 9. pii: AAC.01584.
    >> Share

  171. GASTINE S, Hope W, Hempel G, Petraitiene R, et al
    Pharmacodynamics of Posaconazole in Experimental Invasive Pulmonary Aspergillosis: Utility of Serum Galactomannan as a Dynamic Endpoint of Antifungal Efficacy.
    Antimicrob Agents Chemother. 2020 Nov 9. pii: AAC.01574.
    >> Share

  172. PANJASAWATWONG N, Wattanakul T, Hoglund RM, Bang ND, et al
    Population pharmacokinetic properties of anti-tuberculosis drugs in Vietnamese children with tuberculous meningitis.
    Antimicrob Agents Chemother. 2020 Nov 2. pii: AAC.00487.
    >> Share

  173. GRZEGORZEWICZ AE, Lelievre J, Esquivias J, Angala B, et al
    Lack of Specificity of Phenotypic Screens for Inhibitors of the Mycobacterium tuberculosis FAS-II System.
    Antimicrob Agents Chemother. 2020 Nov 2. pii: AAC.01914.
    >> Share

  174. KANE A, Campbell L, Ky D, Hibbs D, et al
    The antifungal and synergistic effect of bisphosphonates in Cryptococcus.
    Antimicrob Agents Chemother. 2020 Nov 2. pii: AAC.01753.
    >> Share

  175. PHAM CD, Nash E, Liu H, Schmerer MW, et al
    Atypical Mutation in Neisseria gonorrhoeae 23S rRNA Associated with High-Level Azithromycin Resistance.
    Antimicrob Agents Chemother. 2020 Nov 2. pii: AAC.00885.
    >> Share

    October 2020
  176. KRAUSS S, Zipperer A, Wirtz S, Saur J, et al
    Secretion of and self-resistance to the novel fibupeptide antimicrobial lugdunin by distinct ABC transporters in Staphylococcus lugdunensis.
    Antimicrob Agents Chemother. 2020 Oct 26. pii: AAC.01734.
    >> Share

  177. ARUN KB, Madhavan A, Abraham B, Balaji M, et al
    Acetylation of isoniazid - a novel mechanism of isoniazid resistance in Mycobacterium tuberculosis.
    Antimicrob Agents Chemother. 2020 Oct 26. pii: AAC.00456.
    >> Share

  178. WILLBY M, Chopra P, Lemmer D, Klein K, et al
    Molecular evaluation of fluoroquinolone resistance in serial Mycobacterium tuberculosis isolates from individuals diagnosed with multidrug-resistant tuberculosis.
    Antimicrob Agents Chemother. 2020 Oct 26. pii: AAC.01663.
    >> Share

  179. MALLIKAARJUN S, Chapagain ML, Sasaki T, Hariguchi N, et al
    Cumulative Fraction of Response for Once- and Twice-Daily Delamanid in Pulmonary Multidrug-Resistant Tuberculosis Patients.
    Antimicrob Agents Chemother. 2020 Oct 26. pii: AAC.01207.
    >> Share

  180. WANG X, Mallikaarjun S, Gibiansky E
    Population Pharmacokinetic Analysis of Delamanid in Patients with Pulmonary Multi-Drug Resistant Tuberculosis.
    Antimicrob Agents Chemother. 2020 Oct 26. pii: AAC.01202.
    >> Share

  181. JAKOBSEN L, Vingsbro Lundberg C, Frimodt-Moller N
    Ciprofloxacin pharmacokinetics/pharmacodynamics (PKPD) against susceptible and low level resistant Escherichia coli in an experimental ascending urinary tract infection model in mice.
    Antimicrob Agents Chemother. 2020 Oct 26. pii: AAC.01804.
    >> Share

  182. BING J, Hu T, Zheng Q, Munoz JF, et al
    Experimental evolution identifies adaptive aneuploidy as a mechanism of fluconazole resistance in Candida auris.
    Antimicrob Agents Chemother. 2020 Oct 19. pii: AAC.01466.
    >> Share

  183. NAVARRO-RODRIGUEZ P, Lopez-Fernandez L, Martin-Vicente A, Guarro J, et al
    ERG11 polymorphism in voriconazole-resistant Candida tropicalis. Weak role of ERG11 expression, ergosterol content and membrane permeability.
    Antimicrob Agents Chemother. 2020 Oct 19. pii: AAC.00325.
    >> Share

  184. KOSMIDIS C, Otu A, Moore CB, Richardson MD, et al
    Isavuconazole therapeutic drug monitoring during long-term treatment for chronic pulmonary aspergillosis.
    Antimicrob Agents Chemother. 2020 Oct 19. pii: AAC.01511.
    >> Share

  185. RIFAT D, Li SY, Ioerger T, Shah K, et al
    Mutations in fbiD (Rv2983) as a novel determinant of resistance to pretomanid and delamanid in Mycobacterium tuberculosis.
    Antimicrob Agents Chemother. 2020 Oct 19. pii: AAC.01948.
    >> Share

  186. BARBEE LA, Soge OO, Ocbamichael N, LeClair A, et al
    A Single-arm Open-label Clinical Trial of 2g Aztreonam for the treatment of N. gonorrhoeae.
    Antimicrob Agents Chemother. 2020 Oct 19. pii: AAC.01739.
    >> Share

  187. BATTAGLINI D, Motos A, Bassi GL, Yang H, et al
    Efficacy of telavancin in comparison to linezolid in a porcine model of severe methicillin-resistant Staphylococcus aureus (MRSA) pneumonia.
    Antimicrob Agents Chemother. 2020 Oct 12. pii: AAC.01009.
    >> Share

  188. SATHKUMARA HD, Hansen K, Miranda-Hernandez S, Govan B, et al
    Disparate effects of metformin on Mycobacterium tuberculosis infection in diabetic and non-diabetic mice.
    Antimicrob Agents Chemother. 2020 Oct 12. pii: AAC.01422.
    >> Share

  189. VAN DER WALT ML, Shean K, Becker P, Keddy KH, et al
    Treatment outcomes and adverse drug effects of ethambutol, cycloserine and terizidone for treatment of multi-drug resistant tuberculosis in South Africa.
    Antimicrob Agents Chemother. 2020 Oct 12. pii: AAC.00744.
    >> Share

  190. HERRERA-HIDALGO L, de Alarcon A, Lopez-Cortes LE, Luque-Marquez R, et al
    Is once-daily high-dose ceftriaxone plus ampicillin an alternative for Enterococcus faecalis infective endocarditis in OPAT?
    Antimicrob Agents Chemother. 2020 Oct 12. pii: AAC.02099.
    >> Share

  191. ELDESOUKY HE, Salama EA, Lanman NA, Hazbun TR, et al
    Potent synergistic interactions between lopinavir and azole antifungal drugs against emerging multidrug-resistant Candida auris.
    Antimicrob Agents Chemother. 2020 Oct 12. pii: AAC.00684.
    >> Share

  192. SERRANO-LOBO J, Gomez A, Sanchez-Yebra W, Fajardo M, et al
    Azole and amphotericin B minimum inhibitory concentrations against Aspergillus fumigatus: high agreement between spectrophotometric and visual readings using the EUCAST 9.3.2 procedure.
    Antimicrob Agents Chemother. 2020 Oct 5. pii: AAC.01693.
    >> Share

  193. SAKOULAS G
    Imipenem/Cilistatin and Fosfomycin for Refractory Methicillin-Resistant Staphylococcus aureus Infection: a Novel Combination Therapy.
    Antimicrob Agents Chemother. 2020 Oct 5. pii: AAC.02039.
    >> Share

  194. NESPOROVA K, Wyrsch ER, Valcek A, Bitar I, et al
    Escherichia coli ST457: an emerging extended-spectrum beta-lactam resistant lineage with reservoirs in wildlife and food-producing animals.
    Antimicrob Agents Chemother. 2020 Oct 5. pii: AAC.01118.
    >> Share

    September 2020
  195. CACACI M, Menchinelli G, Torelli R, Sanglard D, et al
    Fenticonazole against Fluconazole-Resistant Candida Species: New In Vitro Activity Data.
    Antimicrob Agents Chemother. 2020 Sep 28. pii: AAC.01459.
    >> Share

  196. COURJON J, Garzaro M, Roger PM, Ruimy R, et al
    Continuous infusion of cloxacillin during Staphylococcus aureus bone and joint infections: a population pharmacokinetic analysis.
    Antimicrob Agents Chemother. 2020 Sep 28. pii: AAC.01562.
    >> Share

  197. ZHUCHENKO G, Schmidt-Malan S, Patel R
    Planktonic and Biofilm Activity of Eravacycline against Staphylococci Isolated From Periprosthetic Joint Infections.
    Antimicrob Agents Chemother. 2020 Sep 28. pii: AAC.01304.
    >> Share

  198. DRUSANO GL, Duncanson B, Scanga CA, Kim S, et al
    Developing new drugs for the therapy of Mycobacterium tuberculosis: What information do we get from pre-clinical animal models?
    Antimicrob Agents Chemother. 2020 Sep 21. pii: AAC.01376.
    >> Share

  199. LI M, Nyantakyi SA, Go ML, Dick T, et al
    Resistance against membrane-inserting MmpL3 inhibitor through upregulation of MmpL5 in M. tuberculosis.
    Antimicrob Agents Chemother. 2020 Sep 21. pii: AAC.01100.
    >> Share

  200. LUO D, Huang L, Gondil VS, Zhou W, et al
    A choline-recognizing monomeric lysin ClyJ-3m showing elevated activity against Streptococcus pneumoniae.
    Antimicrob Agents Chemother. 2020 Sep 21. pii: AAC.00311.
    >> Share

  201. ZHOU YF, Liu P, Dai SH, Sun J, et al
    In Vivo Pharmacodynamic Target Assessment of Antofloxacin against Streptococcus pneumoniae and Staphylococcus aureus in a Neutropenic Murine Pneumonia Model.
    Antimicrob Agents Chemother. 2020 Sep 14. pii: AAC.01354.
    >> Share

  202. IMBERT S, Normand AC, Cassaing S, Gabriel F, et al
    Multicentric analysis of the species distribution and antifungal susceptibility of cryptic isolates from Aspergillus section Fumigati.
    Antimicrob Agents Chemother. 2020 Sep 8. pii: AAC.01374.
    >> Share

  203. LIM HJ, Shin JH, Kim MN, Yong D, et al
    Evaluation of Two Commercial Broth Microdilution Methods Using Different Interpretive Criteria for the Detection of Molecular Mechanisms of Acquired Azole and Echinocandin Resistance in Four Common Candida Species.
    Antimicrob Agents Chemother. 2020 Sep 8. pii: AAC.00740.
    >> Share

    August 2020
  204. REICHMUTH ML, Homke R, Zurcher K, Sander P, et al
    Natural Polymorphisms in Mycobacterium tuberculosis Conferring Resistance to Delamanid in Drug-naive Patients.
    Antimicrob Agents Chemother. 2020 Aug 31. pii: AAC.00513.
    >> Share

  205. MADUNA LD, Kock MM, van der Veer BMJW, Radebe O, et al
    Antimicrobial resistance of Neisseria gonorrhoeae isolates from high risk men in Johannesburg, South Africa.
    Antimicrob Agents Chemother. 2020 Aug 31. pii: AAC.00906.
    >> Share

  206. ARENSMAN K, Shields M, Beganovic M, Miller JL, et al
    Fluoroquinolone versus beta-lactam oral step-down therapy for uncomplicated streptococcal bloodstream infections.
    Antimicrob Agents Chemother. 2020 Aug 24. pii: AAC.01515.
    >> Share

  207. ZHU Y, Kilburn S, Kapoor M, Chaturvedi S, et al
    Evaluation of in vitro activity of manogepix against multidrug-resistant and pan-resistant Candida auris from the New York Outbreak.
    Antimicrob Agents Chemother. 2020 Aug 24. pii: AAC.01124.
    >> Share

  208. WANG C, Ye C, Liao L, Wang Z, et al
    Adjuvant beta-lactam therapy combined with vancomycin or daptomycin for methicillin-resistant Staphylococcus aureus bacteraemia: a systematic review and meta-analysis.
    Antimicrob Agents Chemother. 2020 Aug 24. pii: AAC.01377.
    >> Share

  209. CHIREHWA MT, Court R, De Kock M, Wiesner L, et al
    Population pharmacokinetics of cycloserine, and pharmacokinetic/pharmacodynamic target attainment, in MDR-tuberculosis patients dosed with terizidone.
    Antimicrob Agents Chemother. 2020 Aug 17. pii: AAC.01381.
    >> Share

  210. GUO Y, Yang Y, Zheng Y, Wu S, et al
    Comparative in Vitro Activities of Ceftaroline and Tedizolid against Clinical Strains of Staphylococcus aureus and Enterococcus: Results from the China Antimicrobial Surveillance Network (CHINET) in 2018.
    Antimicrob Agents Chemother. 2020 Aug 17. pii: AAC.01461.
    >> Share

  211. DAO TH, Alsallaq R, Parsons J, Ferrolino J, et al
    Vancomycin Heteroresistance and Clinical Outcomes in Coagulase-Negative Staphylococcal Bloodstream Infections.
    Antimicrob Agents Chemother. 2020 Aug 17. pii: AAC.00944.
    >> Share

  212. HAGMANN SHF, Angelo KM, Huits R, Plewes K, et al
    Epidemiological, and Clinical Characteristics of International Travelers with Enteric Fever and Antibiotic Resistance Profiles of their Isolates: A GeoSentinel Analysis.
    Antimicrob Agents Chemother. 2020 Aug 17. pii: AAC.01084.
    >> Share

  213. ISNARD C, Hernandez SB, Guerin F, Joalland F, et al
    Unexpected cell wall alteration-mediated bactericidal activity of the antifungal caspofungin against vancomycin-resistant Enterococcus faecium.
    Antimicrob Agents Chemother. 2020 Aug 10. pii: AAC.01261.
    >> Share

  214. ALGHAMDI WA, Al-Shaer MH, An G, Alsultan A, et al
    Population Pharmacokinetics of Linezolid in Tuberculosis Patients: Dosing Regimens Simulation and Target Attainment Analysis.
    Antimicrob Agents Chemother. 2020 Aug 10. pii: AAC.01174.
    >> Share

  215. ADAMOWICZ EM, Harcombe WR
    Weakest link dynamics predict apparent antibiotic interactions in a model cross-feeding community.
    Antimicrob Agents Chemother. 2020 Aug 10. pii: AAC.00465.
    >> Share

  216. WITTKE F, Vincent C, Chen J, Heller B, et al
    Afabicin, a first-in-class anti-staphylococcal antibiotic, in the treatment of acute bacterial skin and skin structure infections: clinical non-inferiority to vancomycin/linezolid.
    Antimicrob Agents Chemother. 2020 Aug 3. pii: AAC.00250.
    >> Share

  217. KIM H, Kim ES, Lee SC, Yang E, et al
    Decreased incidence of methicillin-resistant Staphylococcus aureus bacteremia in intensive care units: a 10-year clinical, microbiological, and genotypic analysis in a tertiary hospital.
    Antimicrob Agents Chemother. 2020 Aug 3. pii: AAC.01082.
    >> Share

  218. PEIRANO G, Chen L, Kreiswirth BN, Pitout JDD, et al
    Emerging Antimicrobial Resistant High-Risk clones among Klebsiella pneumoniae: ST307 and ST147.
    Antimicrob Agents Chemother. 2020 Aug 3. pii: AAC.01148.
    >> Share

  219. SKIPPER C, Atukunda M, Stadelman A, Engen N, et al
    Safety and tolerability of a novel oral formulation of amphotericin B: Phase I EnACT Trial.
    Antimicrob Agents Chemother. 2020 Aug 3. pii: AAC.00838.
    >> Share

  220. STAPLETON AE, Wagenlehner FME, Mulgirigama A, Twynholm M, et al
    E. coli Resistance to Fluoroquinolones in Community-Acquired Uncomplicated Urinary Tract Infection In Women: A Systematic Review.
    Antimicrob Agents Chemother. 2020 Aug 3. pii: AAC.00862.
    >> Share

    July 2020
  221. HERNANDO-ORTIZ A, Mateo E, Ortega-Riveros M, De-la-Pinta I, et al
    Caenorhabditis elegans as a model system to assess Candida glabrata, Candida nivariensis and Candida bracarensis virulence and antifungal efficacy.
    Antimicrob Agents Chemother. 2020 Jul 27. pii: AAC.00824.
    >> Share

  222. LOISEAU C, Brites D, Reinhard M, Zurcher K, et al
    HIV coinfection is associated with low fitness rpoB variants in rifampicin-resistant Mycobacterium tuberculosis.
    Antimicrob Agents Chemother. 2020 Jul 27. pii: AAC.00782.
    >> Share

  223. BAYER AS, Tong SYC
    DAPTOMYCIN RESISTANCE IN STAPHYLOCOCCUS ARGENTEUS: FROM NORTHERN AUSTRALIA TO SAN FRANCISCO.
    Antimicrob Agents Chemother. 2020 Jul 27. pii: AAC.01502.
    >> Share

  224. CAO D, Wu R, Dong S, Wang F, et al
    Azole resistance in environmental Aspergillus fumigatus isolates from China: A five-year survey from 2014 to 2018.
    Antimicrob Agents Chemother. 2020 Jul 27. pii: AAC.00904.
    >> Share

  225. GHANNOUM M, Isham N, Angulo D, Borroto-Esoda K, et al
    Efficacy of Ibrexafungerp (SCY-078) Against Candida auris in an In Vivo Guinea Pig Cutaneous Infection Model.
    Antimicrob Agents Chemother. 2020 Jul 27. pii: AAC.00854.
    >> Share

  226. KLOTZ SA, Gaur NK, Rauceo J, Lake DF, et al
    Correction for Klotz et al., "Inhibition of Adherence and Killing of Candida albicans with a 23-Mer Peptide (Fn/23) with Dual Antifungal Properties".
    Antimicrob Agents Chemother. 2020;64.
    >> Share

  227. SINGH M, Matsuo M, Sasaki T, Hishinuma T, et al
    RNA sequencing identifies a common physiology in vancomycin- and ciprofloxacin-tolerant Staphylococcus aureus induced by ileS mutations.
    Antimicrob Agents Chemother. 2020 Jul 20. pii: AAC.00827.
    >> Share

  228. TITS J, Cools F, De Cremer K, De Brucker K, et al
    Combination of miconazole and domiphen bromide is fungicidal against biofilms of resistant Candida spp.
    Antimicrob Agents Chemother. 2020 Jul 20. pii: AAC.01296.
    >> Share

  229. ARASTEHFAR A, Daneshnia F, Hilmioglu-Polat S, Fang W, et al
    First report of candidemia clonal outbreak caused by emerging fluconazole-resistant Candida parapsilosis isolates harboring Y132F and/or Y132F+K143R in Turkey.
    Antimicrob Agents Chemother. 2020 Jul 20. pii: AAC.01001.
    >> Share

  230. MARIOTTI S, Teloni R, de Turris V, Pardini M, et al
    Amphotericin B inhibits Mycobacterium tuberculosis infection of human alveolar type II epithelial A549 cells.
    Antimicrob Agents Chemother. 2020 Jul 13. pii: AAC.01164.
    >> Share

  231. ARENDRUP MC, Chowdhary A, Jorgensen KM, Meletiadis J, et al
    Manogepix (APX001A) in vitro activity against Candida auris. A head to head comparison of EUCAST and CLSI MICs.
    Antimicrob Agents Chemother. 2020 Jul 13. pii: AAC.00656.
    >> Share

  232. ROUNDTREE MT, Juvvadi PR, Shwab EK, Cole DC, et al
    Aspergillus fumigatus Cyp51A and Cyp51B Proteins are Compensatory in Function and Localize Differentially in Response to Antifungals and Cell Wall Inhibitors.
    Antimicrob Agents Chemother. 2020 Jul 13. pii: AAC.00735.
    >> Share

  233. MCNEIL JC, Sommer LM, Boyle M, Hogan P, et al
    The Cefazolin Inoculum Effect and Methicillin-Susceptible Staphylococcus aureus Osteoarticular Infections in Children: Does it Matter?
    Antimicrob Agents Chemother. 2020 Jul 13. pii: AAC.00703.
    >> Share

  234. AL-SHAER MH, Martson AG, Alghamdi WA, Alsultan A, et al
    Ethionamide population pharmacokinetic model and target attainment in multidrug-resistant tuberculosis.
    Antimicrob Agents Chemother. 2020 Jul 6. pii: AAC.00713.
    >> Share

  235. VILCHEZE C, Saranathan R, Weinrick B, Jacobs WR Jr, et al
    Characterization of large deletion mutants of Mycobacterium tuberculosis selected for isoniazid resistance.
    Antimicrob Agents Chemother. 2020 Jul 6. pii: AAC.00792.
    >> Share

  236. HAO M, He Y, Zhang H, Liao XP, et al
    CRISPR/Cas9-mediated carbapenemase genes and plasmids curing in carbapenem-resistant Enterobacteriaceae.
    Antimicrob Agents Chemother. 2020 Jul 6. pii: AAC.00843.
    >> Share

    June 2020
  237. JENSON RE, Baines SL, Howden BP, Mishra NN, et al
    Prolonged exposure to beta-lactam antibiotics reestablishes susceptibility of daptomycin-nonsusceptible Staphylococcus aureus to daptomycin.
    Antimicrob Agents Chemother. 2020 Jun 29. pii: AAC.00890.
    >> Share

  238. HAO S, Abdelghany M, Lyden A, Sit R, et al
    Genomic Profiling of Evolving Daptomycin Resistance in a Patient with Recurrent Staphylococcus argenteus Sepsis.
    Antimicrob Agents Chemother. 2020 Jun 29. pii: AAC.00961.
    >> Share

  239. REITZEL RA, Rosenblatt J, Gerges BZ, Vargas-Cruz N, et al
    Erratum for Reitzel et al., "Minocycline-EDTA-Ethanol Antimicrobial Catheter Lock Solution Is Highly Effective In Vitro for Eradication of Candida auris Biofilms".
    Antimicrob Agents Chemother. 2020;64.
    >> Share

  240. RODRIGUEZ LOPEZ AL, Lee MR, Wang NB, Dunn KK, et al
    Correction for Rodriguez Lopez et al., "Small-Molecule Morphogenesis Modulators Enhance the Ability of 14-Helical beta-Peptides To Prevent Candida albicans Biofilm Formation".
    Antimicrob Agents Chemother. 2020;64.
    >> Share

  241. LEPELLETIER D, Maillard JY, Pozzetto B, Simon A, et al
    Povidone Iodine: Properties, Mechanisms of Action and Role in Infection Control and Staphylococcus aureus Decolonization.
    Antimicrob Agents Chemother. 2020 Jun 22. pii: AAC.00682.
    >> Share

  242. SAFI H, Lingaraju S, Ma S, Husain S, et al
    Rapidly-correcting Frameshift Mutations in the Mycobacterium tuberculosis orn Gene Produce Reversible Ethambutol Resistance and Small Colony Variant Morphology.
    Antimicrob Agents Chemother. 2020 Jun 22. pii: AAC.00213.
    >> Share

  243. KHALIFA HO, Arai T, Majima H, Watanabe A, et al
    Genetic Basis of Azole and Echinocandin Resistance in Clinical Candida glabrata in Japan.
    Antimicrob Agents Chemother. 2020 Jun 22. pii: AAC.00783.
    >> Share

  244. PAIS P, California R, Galocha M, Viana R, et al
    Candida glabrata Transcription Factor Rpn4 Mediates Fluconazole Resistance Through Regulation of Ergosterol Biosynthesis and Plasma Membrane Permeability.
    Antimicrob Agents Chemother. 2020 Jun 22. pii: AAC.00554.
    >> Share

  245. MORRISETTE T, Lev KL, Kebriaei R, Abdul-Mutakabbir J, et al
    Bacteriophage-Antibiotic Combinations for Enterococcus faecium with Varying Bacteriophage and Daptomycin Susceptibilities.
    Antimicrob Agents Chemother. 2020 Jun 22. pii: AAC.00993.
    >> Share

  246. PARMAR NR, Singh R, Martin I, Perera SR, et al
    Genomic Analysis Reveals Antibiotic Susceptible Clones and Emerging Resistance in Neisseria gonorrhoeae (Saskatchewan, Canada).
    Antimicrob Agents Chemother. 2020 Jun 22. pii: AAC.02514.
    >> Share

  247. NGUYEN CT, Bethel C, Pettit NN, Charnot-Katsikas A, et al
    From Etest to Vitek 2: Impact of Enterococcal Linezolid Susceptibility Testing Methodology on Time to Active Therapy.
    Antimicrob Agents Chemother. 2020 Jun 15. pii: AAC.00302.
    >> Share

  248. NIU Y, Wang K, Zheng S, Wang Y, et al
    The antibacterial effect of caffeic acid phenethyl ester on cariogenic bacteria and Streptococcus mutans biofilms.
    Antimicrob Agents Chemother. 2020 Jun 15. pii: AAC.00251.
    >> Share

  249. COHEN KA, Stott KE, Munsamy V, Manson AL, et al
    Evidence for expanding the role of streptomycin in the management of drug-resistant M. tuberculosis.
    Antimicrob Agents Chemother. 2020 Jun 15. pii: AAC.00860.
    >> Share

  250. ARIAS LS, Butcher MC, Short B, McKloud E, et al
    Chitosan ameliorates Candida auris virulence in a Galleria mellonella infection model.
    Antimicrob Agents Chemother. 2020 Jun 1. pii: AAC.00476.
    >> Share

    May 2020
  251. HUANG HN, Pan CY, Chan YL, Chen JY, et al
    Retraction for Huang et al., "Use of the Antimicrobial Peptide Pardaxin (GE33) To Protect against Methicillin-Resistant Staphylococcus aureus Infection in Mice with Skin Injuries".
    Antimicrob Agents Chemother. 2020;64.
    >> Share

  252. MACEDO D, Brito Devoto T, Pola S, Finquelievich JL, et al
    A novel combination of CYP51A mutations confers pan-azole resistance in Aspergillus fumigatus.
    Antimicrob Agents Chemother. 2020 May 18. pii: AAC.02501.
    >> Share

  253. HOLLAND TL
    Early Oral Antibiotic Switch for Staphylococcus aureus Bacteremia: Many are Called, but Few are Chosen.
    Antimicrob Agents Chemother. 2020 May 11. pii: AAC.00317.
    >> Share

  254. KEBRIAEI R, Lev K, Morrisette T, Stamper K, et al
    Bacteriophage-Antibiotic Combination Strategy: An Alternative against Methicillin-resistant Phenotypes of Staphylococcus aureus.
    Antimicrob Agents Chemother. 2020 May 11. pii: AAC.00461.
    >> Share

  255. SFEIR MM
    Methicillin-resistant Staphylococcus aureus (MRSA) nasal screening: Clinical use for excluding diabetic foot infection with MRSA.
    Antimicrob Agents Chemother. 2020 May 11. pii: AAC.00635.
    >> Share

  256. MERGENHAGEN KA, Croix M, Starr KE, Sellick JA, et al
    Reply to Sfeir, "Methicillin-Resistant Staphylococcus aureus (MRSA) Nasal Screening: Clinical Use for Excluding Diabetic Foot Infection with MRSA".
    Antimicrob Agents Chemother. 2020 May 11. pii: AAC.00803.
    >> Share

  257. LI Y, Dong W, Lan T, Fan J, et al
    Distribution of linezolid in tuberculosis lesions in patients with spinal multidrug-resistant tuberculosis.
    Antimicrob Agents Chemother. 2020 May 4. pii: AAC.00450.
    >> Share

  258. KIM HY, Srivastava S, Kumar Ak H, Marais BJ, et al
    Optimal dose or optimal exposure? Consideration for linezolid in tuberculosis treatment.
    Antimicrob Agents Chemother. 2020 May 4. pii: AAC.00287.
    >> Share

  259. DIACON AH, De Jager VR, Dawson R, Narunsky K, et al
    Reply to Kim et al., "Optimal Dose or Optimal Exposure? Consideration for Linezolid in Tuberculosis Treatment".
    Antimicrob Agents Chemother. 2020 May 4. pii: AAC.00709.
    >> Share

  260. WILSEY HA, Burgess DR, Burgess DS
    Focusing the lens on the CAMERA concepts: Early combination beta-lactam and vancomycin therapy in methicillin-resistant Staphylococcus aureus bacteremia.
    Antimicrob Agents Chemother. 2020 May 4. pii: AAC.00360.
    >> Share

  261. SHIRAKAWA T, Sekizuka T, Kuroda M, Suzuki S, et al
    Comparative Genomic Analysis of Third Generation Cephalosporin-Resistant Escherichia coli Harboring bla CMY-2-Positive IncI1 group, IncB/O/K/Z, and IncC Plasmids Isolated from Healthy Broilers in Japan.
    Antimicrob Agents Chemother. 2020 May 4. pii: AAC.02385.
    >> Share

    April 2020
  262. PIETERMAN ED, Sarink MJ, Sala C, Cole ST, et al
    Advanced quantification methods to improve the 18b dormancy model for assessing the activity of tuberculosis drugs in vitro.
    Antimicrob Agents Chemother. 2020 Apr 27. pii: AAC.00280.
    >> Share

  263. SPOONMORE TJ, Ford CA, Curry JM, Guelcher SA, et al
    Concurrent local delivery of diflunisal limits bone destruction but fails to improve systemic vancomycin efficacy during Staphylococcus aureus osteomyelitis.
    Antimicrob Agents Chemother. 2020 Apr 27. pii: AAC.00182.
    >> Share

  264. KIM D, Yoon EJ, Hong JS, Lee H, et al
    Impact of vanA-positive Enterococcus faecium exhibiting diverse susceptibility phenotypes to glycopeptides on 30-day mortality of patients with a bloodstream infection.
    Antimicrob Agents Chemother. 2020 Apr 27. pii: AAC.02180.
    >> Share

  265. SHAH SU, Xiong YQ, Abdelhady W, Iwaz J, et al
    Effect of the Lysin, Exebacase, on Cardiac Vegetation Progression in a Rabbit Model of Methicillin-Resistant Staphylococcus aureus (MRSA) Endocarditis as Determined by Echocardiography.
    Antimicrob Agents Chemother. 2020 Apr 27. pii: AAC.00482.
    >> Share

  266. GAGLIARDI A, Selchow P, Luthra S, Schafle D, et al
    KatG as Counterselection Marker for Nontuberculous Mycobacteria.
    Antimicrob Agents Chemother. 2020;64.
    >> Share

  267. VAN MATRE ET, Teitelbaum I, Kiser TH
    Intravenous and Intraperitoneal Pharmacokinetics of Dalbavancin in Peritoneal Dialysis Patients.
    Antimicrob Agents Chemother. 2020;64.
    >> Share

  268. FARAJ A, Svensson RJ, Diacon AH, Simonsson USH, et al
    Drug Effect of Clofazimine on Persisters Explains an Unexpected Increase in Bacterial Load in Patients.
    Antimicrob Agents Chemother. 2020;64.
    >> Share

  269. DUBOIS J, Dubois M, Martel JF
    In Vitro and Intracellular Activities of Omadacycline against Legionella pneumophila.
    Antimicrob Agents Chemother. 2020;64.
    >> Share

  270. COLQUE CA, Albarracin Orio AG, Feliziani S, Marvig RL, et al
    Hypermutator Pseudomonas aeruginosa Exploits Multiple Genetic Pathways To Develop Multidrug Resistance during Long-Term Infections in the Airways of Cystic Fibrosis Patients.
    Antimicrob Agents Chemother. 2020;64.
    >> Share

  271. DI J, Zhang J, Cao L, Huang TT, et al
    Hydrogen Peroxide-Mediated Oxygen Enrichment Eradicates Helicobacter pylori In Vitro and In Vivo.
    Antimicrob Agents Chemother. 2020;64.
    >> Share

  272. ARECHIGA-ALVARADO NA, Medellin-Garibay SE, Milan-Segovia RDC, Ortiz-Alvarez A, et al
    Population Pharmacokinetics of Amikacin Administered Once Daily in Patients with Different Renal Functions.
    Antimicrob Agents Chemother. 2020;64.
    >> Share

  273. SAK B, Brdickova K, Holubova N, Kvetonova D, et al
    Encephalitozoon cuniculi Genotype III Evinces a Resistance to Albendazole Treatment in both Immunodeficient and Immunocompetent Mice.
    Antimicrob Agents Chemother. 2020;64.
    >> Share

  274. MATSUO N, Nonogaki R, Hayashi M, Wachino JI, et al
    Characterization of bla CTX-M-27/F1:A2:B20 Plasmids Harbored by Escherichia coli Sequence Type 131 Sublineage C1/H30R Isolates Spreading among Elderly Japanese in Nonacute-Care Settings.
    Antimicrob Agents Chemother. 2020;64.
    >> Share

  275. HAYASHI M, Nishiyama A, Kitamoto R, Tateishi Y, et al
    Adduct Formation of Delamanid with NAD in Mycobacteria.
    Antimicrob Agents Chemother. 2020;64.
    >> Share

  276. LIN YT, Cheng YH, Chuang C, Chou SH, et al
    Molecular and Clinical Characterization of Multidrug-Resistant and Hypervirulent Klebsiella pneumoniae Strains from Liver Abscess in Taiwan.
    Antimicrob Agents Chemother. 2020;64.
    >> Share

  277. PALWE S, Veeraraghavan B, Periasamy H, Khobragade K, et al
    Unorthodox Parenteral beta-Lactam and beta-Lactamase Inhibitor Combinations: Flouting Antimicrobial Stewardship and Compromising Patient Care.
    Antimicrob Agents Chemother. 2020;64.
    >> Share

  278. ESHAGHI A, Zittermann S, Bharat A, Mulvey MR, et al
    Importation of Extensively Drug-Resistant Salmonella enterica Serovar Typhi Cases in Ontario, Canada.
    Antimicrob Agents Chemother. 2020;64.
    >> Share

  279. WAACK U, Weinstein EA, Farley JJ
    Assessing Animal Models of Bacterial Pneumonia Used in Investigational New Drug Applications for the Treatment of Bacterial Pneumonia.
    Antimicrob Agents Chemother. 2020;64.
    >> Share

  280. ADAMS MD, Pasteran F, Traglia GM, Martinez J, et al
    Distinct Mechanisms of Dissemination of NDM-1 Metallo-beta-Lactamase in Acinetobacter Species in Argentina.
    Antimicrob Agents Chemother. 2020;64.
    >> Share

  281. STOESSER N, Phan HTT, Seale AC, Aiken Z, et al
    Genomic Epidemiology of Complex, Multispecies, Plasmid-Borne bla KPC Carbapenemase in Enterobacterales in the United Kingdom from 2009 to 2014.
    Antimicrob Agents Chemother. 2020;64.
    >> Share

  282. CASTANHEIRA M, Sader HS, Mendes RE, Jones RN, et al
    Activity of Plazomicin Tested against Enterobacterales Isolates Collected from U.S. Hospitals in 2016-2017: Effect of Different Breakpoint Criteria on Susceptibility Rates among Aminoglycosides.
    Antimicrob Agents Chemother. 2020;64.
    >> Share

  283. SADER HS, Carvalhaes CG, Duncan LR, Shortridge D, et al
    Antimicrobial Activity of Ceftolozane-Tazobactam and Comparators against Clinical Isolates of Haemophilus influenzae from the United States and Europe.
    Antimicrob Agents Chemother. 2020;64.
    >> Share

  284. YUAN WL, Xu JL, Guo L, Deng QF, et al
    Predominant Distribution of OXA-48-Like Carbapenemase in Fecal Colonization.
    Antimicrob Agents Chemother. 2020;64.
    >> Share

  285. KAYE KS, Boucher HW, Brown ML, Aggrey A, et al
    Comparison of Treatment Outcomes between Analysis Populations in the RESTORE-IMI 1 Phase 3 Trial of Imipenem-Cilastatin-Relebactam versus Colistin plus Imipenem-Cilastatin in Patients with Imipenem-Nonsusceptible Bacterial Infections.
    Antimicrob Agents Chemother. 2020;64.
    >> Share

  286. SCHMERER MW, Abrams AJ, Seby S, Thomas JC 4th, et al
    Genomic Characterization of Neisseria gonorrhoeae Strains from 2016 U.S. Sentinel Surveillance Displaying Reduced Susceptibility to Azithromycin.
    Antimicrob Agents Chemother. 2020;64.
    >> Share

  287. STONE GG, Bradford PA, Tawadrous M, Taylor D, et al
    In Vitro Activity of Ceftazidime-Avibactam against Isolates from Respiratory and Blood Specimens from Patients with Nosocomial Pneumonia, Including Ventilator-Associated Pneumonia, in a Phase 3 Clinical Trial.
    Antimicrob Agents Chemother. 2020;64.
    >> Share

  288. LANOIX JP, Joseph C, Peltier F, Castelain S, et al
    Synergistic Activity of Clofazimine and Clarithromycin in an Aerosol Mouse Model of Mycobacterium avium Infection.
    Antimicrob Agents Chemother. 2020;64.
    >> Share

  289. PFALLER MA, Huband MD, Shortridge D, Flamm RK, et al
    Surveillance of Omadacycline Activity Tested against Clinical Isolates from the United States and Europe: Report from the SENTRY Antimicrobial Surveillance Program, 2016 to 2018.
    Antimicrob Agents Chemother. 2020;64.
    >> Share

  290. RAYNAUD C, Daher W, Roquet-Baneres F, Johansen MD, et al
    Synergistic Interactions of Indole-2-Carboxamides and beta-Lactam Antibiotics against Mycobacterium abscessus.
    Antimicrob Agents Chemother. 2020;64.
    >> Share

  291. NARMANDAKH E, Tumenbayar O, Borolzoi T, Erkhembayar B, et al
    Genetic Mutations Associated with Isoniazid Resistance in Mycobacterium tuberculosis in Mongolia.
    Antimicrob Agents Chemother. 2020 Apr 20. pii: AAC.00537.
    >> Share

  292. CARRARA B, Richards R, Imbert S, Morio F, et al
    Species Distribution and Comparison between EUCAST and Gradient Concentration Strips Methods for Antifungal Susceptibility Testing of 112 Aspergillus Section Nigri Isolates.
    Antimicrob Agents Chemother. 2020 Apr 20. pii: AAC.02510.
    >> Share

  293. MOLINA KC, Morrisette T, Miller MA, Huang V, et al
    The Emerging Role of beta-lactams in the Treatment of Methicillin-Resistant Staphylococcus aureus Bloodstream Infections.
    Antimicrob Agents Chemother. 2020 Apr 20. pii: AAC.00468.
    >> Share

  294. KANCHUGAL P S, Selmer M
    Structural recognition of spectinomycin by resistance enzyme ANT(9) from Enterococcus faecalis.
    Antimicrob Agents Chemother. 2020 Apr 6. pii: AAC.00371.
    >> Share

  295. ALMEIDA LM, Lebreton F, Gaca A, Bispo PM, et al
    Transferable Resistance Gene optrA in Enterococcus faecalis from Swine in Brazil.
    Antimicrob Agents Chemother. 2020 Apr 6. pii: AAC.00142.
    >> Share

  296. ABBOTT IJ, van Gorp E, van der Meijden A, Wijma RA, et al
    Oral Fosfomycin Treatment for Enterococcal Urinary Tract Infections in a Dynamic In Vitro Model.
    Antimicrob Agents Chemother. 2020 Apr 6. pii: AAC.00342.
    >> Share

  297. BROWN MM, Kwiecinski JM, Mejia Cruz L, Shahbandi A, et al
    Novel peptide from commensal Staphylococcus simulans blocks MRSA quorum sensing and protects host skin from damage.
    Antimicrob Agents Chemother. 2020 Apr 6. pii: AAC.00172.
    >> Share

    March 2020
  298. HARIGUCHI N, Chen X, Hayashi Y, Kawano Y, et al
    OPC-167832, a novel carbostyril derivative with potent anti-tuberculosis activity as a DprE1 inhibitor.
    Antimicrob Agents Chemother. 2020 Mar 30. pii: AAC.02020.
    >> Share

  299. BEREDAKI MI, Georgiou PC, Siopi M, Kanioura L, et al
    Towards harmonization of voriconazole CLSI and EUCAST breakpoints for Candida albicans using a validated in vitro pharmacokinetic/pharmacodynamic model.
    Antimicrob Agents Chemother. 2020 Mar 30. pii: AAC.00170.
    >> Share

  300. YANG T, Pan L, Wu N, Wang L, et al
    Antimicrobial resistance in clinical Ureaplasma spp. and Mycoplasma hominis and structural mechanisms underlying the quinolone resistance.
    Antimicrob Agents Chemother. 2020 Mar 30. pii: AAC.02560.
    >> Share

  301. CABRERA NL, Malek AE, Aitken SL, Arias CA, et al
    Outcomes of Patients with Bloodstream Infections Caused by Ampicillin-Susceptible but Penicillin-Resistant Enterococcus faecalis: Caution in Interpreting the Results.
    Antimicrob Agents Chemother. 2020;64.
    >> Share

  302. SEKAGGYA-WILTSHIRE C, Chirehwa M, Musaazi J, von Braun A, et al
    Erratum for Sekaggya-Wiltshire et al., "Low Antituberculosis Drug Concentrations in HIV-Tuberculosis-Coinfected Adults with Low Body Weight: Is It Time To Update Dosing Guidelines?"
    Antimicrob Agents Chemother. 2020;64.
    >> Share

  303. KIM D, Lee H, Yoon EJ, Hong JS, et al
    Reply to Cabrera et al., "Outcomes of Patients with Bloodstream Infections Caused by Ampicillin-Susceptible but Penicillin-Resistant Enterococcus faecalis: Caution in Interpreting the Results".
    Antimicrob Agents Chemother. 2020;64.
    >> Share

  304. SHIELDS RK
    Case Commentary: the Need for Cefiderocol Is Clear, but Are the Supporting Clinical Data?
    Antimicrob Agents Chemother. 2020;64.
    >> Share

  305. TSIVKOVSKI R, Lomovskaya O
    Potency of Vaborbactam Is Less Affected than That of Avibactam in Strains Producing KPC-2 Mutations That Confer Resistance to Ceftazidime-Avibactam.
    Antimicrob Agents Chemother. 2020;64.
    >> Share

  306. WILLIX JL, Stockton JL, Olson RM, Anderson PE, et al
    Activation of Heme Oxygenase Expression by Cobalt Protoporphyrin Treatment Prevents Pneumonic Plague Caused by Inhalation of Yersinia pestis.
    Antimicrob Agents Chemother. 2020;64.
    >> Share

  307. KESTER JC, Brubaker DK, Velazquez J, Wright C, et al
    Clostridioides difficile-Associated Antibiotics Alter Human Mucosal Barrier Functions by Microbiome-Independent Mechanisms.
    Antimicrob Agents Chemother. 2020;64.
    >> Share

  308. COPPI M, Di Pilato V, Monaco F, Giani T, et al
    Ceftazidime-Avibactam Resistance Associated with Increased bla KPC-3 Gene Copy Number Mediated by pKpQIL Plasmid Derivatives in Sequence Type 258 Klebsiella pneumoniae.
    Antimicrob Agents Chemother. 2020;64.
    >> Share

  309. CONTRERAS DA, Fitzwater SP, Nanayakkara DD, Schaenman J, et al
    Coinfections of Two Strains of NDM-1- and OXA-232-Coproducing Klebsiella pneumoniae in a Kidney Transplant Patient.
    Antimicrob Agents Chemother. 2020;64.
    >> Share

  310. PETRAITIENE R, Petraitis V, Kavaliauskas P, Maung BBW, et al
    Pharmacokinetics and Efficacy of Ceftazidime-Avibactam in the Treatment of Experimental Pneumonia Caused by Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae in Persistently Neutropenic Rabbits.
    Antimicrob Agents Chemother. 2020;64.
    >> Share

  311. SHAW D, Singh S, Dogra S, Jayaraman J, et al
    MIC and Upper Limit of Wild-Type Distribution for 13 Antifungal Agents against a Trichophyton mentagrophytes-Trichophyton interdigitale Complex of Indian Origin.
    Antimicrob Agents Chemother. 2020;64.
    >> Share

  312. RICHARD G, MacKenzie CR, Henry KA, Vinogradov E, et al
    Antibody Binding to the O-Specific Antigen of Pseudomonas aeruginosa O6 Inhibits Cell Growth.
    Antimicrob Agents Chemother. 2020;64.
    >> Share

  313. MOON SH, Kaufmann Y, Huang E
    Paenipeptin Analogues Potentiate Clarithromycin and Rifampin against mcr-1-Mediated Polymyxin-Resistant Escherichia coli In Vivo.
    Antimicrob Agents Chemother. 2020;64.
    >> Share

  314. MUHLEN S, Ramming I, Pils MC, Koeppel M, et al
    Identification of Antibiotics That Diminish Disease in a Murine Model of Enterohemorrhagic Escherichia coli Infection.
    Antimicrob Agents Chemother. 2020;64.
    >> Share

  315. WEBB BJ, Subramanian A, Lopansri B, Goodman B, et al
    Antibiotic Exposure and Risk for Hospital-Associated Clostridioides difficile Infection.
    Antimicrob Agents Chemother. 2020;64.
    >> Share

  316. SIMONETTI O, Lucarini G, Morroni G, Orlando F, et al
    New Evidence and Insights on Dalbavancin and Wound Healing in a Mouse Model of Skin Infection.
    Antimicrob Agents Chemother. 2020;64.
    >> Share

  317. KONTOU A, Sarafidis K, Begou O, Gika HG, et al
    Population Pharmacokinetics of Teicoplanin in Preterm and Term Neonates: Is It Time for a New Dosing Regimen?
    Antimicrob Agents Chemother. 2020;64.
    >> Share

  318. MONTERO M, Domene Ochoa S, Lopez-Causape C, VanScoy B, et al
    Efficacy of Ceftolozane-Tazobactam in Combination with Colistin against Extensively Drug-Resistant Pseudomonas aeruginosa, Including High-Risk Clones, in an In Vitro Pharmacodynamic Model.
    Antimicrob Agents Chemother. 2020;64.
    >> Share

  319. DIAZ IGLESIAS Y, Van Bambeke F
    Activity of Antibiotics against Pseudomonas aeruginosa in an In Vitro Model of Biofilms in the Context of Cystic Fibrosis: Influence of the Culture Medium.
    Antimicrob Agents Chemother. 2020;64.
    >> Share

  320. ARCARI G, Di Lella FM, Bibbolino G, Mengoni F, et al
    A Multispecies Cluster of VIM-1 Carbapenemase-Producing Enterobacterales Linked by a Novel, Highly Conjugative, and Broad-Host-Range IncA Plasmid Forebodes the Reemergence of VIM-1.
    Antimicrob Agents Chemother. 2020;64.
    >> Share

  321. LOGAN LK, Zhang L, Green SJ, Dorevitch S, et al
    A Pilot Study of Chicago Waterways as Reservoirs of Multidrug-Resistant Enterobacteriaceae (MDR-Ent) in a High-Risk Region for Community-Acquired MDR-Ent Infection in Children.
    Antimicrob Agents Chemother. 2020;64.
    >> Share

  322. GUDIOL C, Albasanz-Puig A, Laporte-Amargos J, Pallares N, et al
    Clinical Predictive Model of Multidrug Resistance in Neutropenic Cancer Patients with Bloodstream Infection Due to Pseudomonas aeruginosa.
    Antimicrob Agents Chemother. 2020;64.
    >> Share

  323. DELMA FZ, Al-Hatmi AMS, Buil JB, van der Lee H, et al
    Comparison of MIC Test Strip and Sensititre YeastOne with the CLSI and EUCAST Broth Microdilution Reference Methods for In Vitro Antifungal Susceptibility Testing of Cryptococcus neoformans.
    Antimicrob Agents Chemother. 2020;64.
    >> Share

  324. SABET M, Tarazi Z, Griffith DC
    Pharmacodynamics of Meropenem against Acinetobacter baumannii in a Neutropenic Mouse Thigh Infection Model.
    Antimicrob Agents Chemother. 2020;64.
    >> Share

  325. MCLEOD SM, Moussa SH, Hackel MA, Miller AA, et al
    In Vitro Activity of Sulbactam-Durlobactam against Acinetobacter baumannii-calcoaceticus Complex Isolates Collected Globally in 2016 and 2017.
    Antimicrob Agents Chemother. 2020;64.
    >> Share

  326. BRILHANTE M, Menezes J, Belas A, Feudi C, et al
    OXA-181-Producing Extraintestinal Pathogenic Escherichia coli Sequence Type 410 Isolated from a Dog in Portugal.
    Antimicrob Agents Chemother. 2020;64.
    >> Share

  327. SARATHY JP, Ganapathy US, Zimmerman MD, Dartois V, et al
    TBAJ-876, a 3,5-Dialkoxypyridine Analogue of Bedaquiline, Is Active against Mycobacterium abscessus.
    Antimicrob Agents Chemother. 2020;64.
    >> Share

  328. JORGENSEN SCJ, Trinh TD, Zasowski EJ, Lagnf AM, et al
    Real-World Experience with Ceftolozane-Tazobactam for Multidrug-Resistant Gram-Negative Bacterial Infections.
    Antimicrob Agents Chemother. 2020;64.
    >> Share

  329. GONG J, Bing J, Guan G, Nobile CJ, et al
    The Als3 cell wall adhesin plays a critical role in human Serum amyloid A1 (SAA1)-induced cell death and aggregation in Candida albicans.
    Antimicrob Agents Chemother. 2020 Mar 23. pii: AAC.00024.
    >> Share

  330. LISTON SD, Whitesell L, Kapoor M, Shaw KJ, et al
    Enhanced efflux pump expression in Candida mutants results in decreased manogepix susceptibility.
    Antimicrob Agents Chemother. 2020 Mar 16. pii: AAC.00261.
    >> Share

  331. PETRAITIS V, Petraitiene R, Katragkou A, Maung BBW, et al
    Combination Therapy with Ibrexafungerp (formerly SCY-078), a First-in-Class Triterpenoid Inhibitor of (1-->3)-beta-D-Glucan Synthesis, and Isavuconazole for Treatment of Experimental Invasive Pulmonary Aspergillosis.
    Antimicrob Agents Chemother. 2020 Mar 16. pii: AAC.02429.
    >> Share

  332. CHATTERJEE A, Poon R, Chatterjee SS
    Stp1 loss of function promotes beta-lactam resistance in S. aureus that is independent of classical genes.
    Antimicrob Agents Chemother. 2020 Mar 16. pii: AAC.02222.
    >> Share

  333. MACFADDEN DR, Coburn B, Brinda K, Corbeil A, et al
    Using Genetic Distance from Archived Samples for the Prediction of Antibiotic Resistance in Escherichia coli.
    Antimicrob Agents Chemother. 2020 Mar 9. pii: AAC.02417.
    >> Share

  334. JOHNSTON BD, Thuras P, Porter SB, Anacker M, et al
    Activity of imipenem/relebactam against carbapenem-resistant Escherichia coli isolates from the United States in relation to clonal background, resistance genes, co-resistance, and region.
    Antimicrob Agents Chemother. 2020 Mar 9. pii: AAC.02408.
    >> Share

  335. SCHWENDENER S, Dona V, Perreten V
    The novel macrolide resistance genes mef(D), msr(F) and msr(H) are present on resistance islands in Macrococcus canis, Macrococcus caseolyticus and Staphylococcus aureus.
    Antimicrob Agents Chemother. 2020 Mar 2. pii: AAC.00160.
    >> Share

  336. FRAPWELL CJ, Skipp PJ, Howlin RP, Angus EM, et al
    Antimicrobial activity of the quinoline derivative HT61 against Staphylococcus aureus biofilms.
    Antimicrob Agents Chemother. 2020 Mar 2. pii: AAC.02073.
    >> Share

  337. ENKIRCH T, Werngren J, Groenheit R, Alm E, et al
    Systematic review of whole genome sequencing data to predict phenotypic drug resistance and susceptibility in Swedish Mycobacterium tuberculosis isolates 2016-2018.
    Antimicrob Agents Chemother. 2020 Mar 2. pii: AAC.02550.
    >> Share

  338. SINGH KV, Arias CA, Murray BE
    Tedizolid as step-down therapy following daptomycin versus continuation of daptomycin against enterococci and Staphylococcus aureus (MRSA/VRSA) in a rat endocarditis model.
    Antimicrob Agents Chemother. 2020 Mar 2. pii: AAC.02303.
    >> Share

  339. CUI CY, Chen C, Liu BT, He Q, et al
    Co-occurrence of plasmid-mediated tigecycline and carbapenem resistance in Acinetobacter spp. from waterfowls and their neighboring environment.
    Antimicrob Agents Chemother. 2020 Mar 2. pii: AAC.02502.
    >> Share

    February 2020
  340. JAHANBAKHSH S, Singh NB, Yim J, Kebriaei R, et al
    Impact of Daptomycin Dose Exposure Alone or in Combination with beta- lactams or Rifampin against Vancomycin-Resistant Enterococci (VRE) in an In vitro Biofilm Model.
    Antimicrob Agents Chemother. 2020 Feb 24. pii: AAC.02074.
    >> Share

  341. ACKLEY R, Roshdy D, Meredith J, Minor S, et al
    Meropenem/Vaborbactam versus Ceftazidime/Avibactam for Treatment of Carbapenem-Resistant Enterobacteriaceae Infections.
    Antimicrob Agents Chemother. 2020 Feb 24. pii: AAC.02313.
    >> Share

  342. SIOPI M, Tarpatzi A, Kalogeropoulou E, Damianidou S, et al
    Epidemiological Trends of Fungemia in Greece with a Focus on Candidemia during the Recent Financial Crisis: a 10-Year Survey in a Tertiary Care Academic Hospital and Review of Literature.
    Antimicrob Agents Chemother. 2020;64.
    >> Share

  343. DECEMBRINO N, Perruccio K, Zecca M, Colombini A, et al
    A Case Series and Literature Review of Isavuconazole Use in Pediatric Patients with Hemato-oncologic Diseases and Hematopoietic Stem Cell Transplantation.
    Antimicrob Agents Chemother. 2020;64.
    >> Share

  344. TIMBROOK TT, McKay L, Sutton JD, Spivak ES, et al
    Disproportionality Analysis of Safety with Nafcillin and Oxacillin with the FDA Adverse Event Reporting System (FAERS).
    Antimicrob Agents Chemother. 2020;64.
    >> Share

  345. JI XW, Xue F, Kang ZS, Zhong W, et al
    Model-Informed Drug Development, Pharmacokinetic/Pharmacodynamic Cutoff Value Determination, and Antibacterial Efficacy of Benapenem against Enterobacteriaceae.
    Antimicrob Agents Chemother. 2020;64.
    >> Share

  346. MORRISSEY I, Hawser S, Lob SH, Karlowsky JA, et al
    In Vitro Activity of Eravacycline against Gram-Positive Bacteria Isolated in Clinical Laboratories Worldwide from 2013 to 2017.
    Antimicrob Agents Chemother. 2020;64.
    >> Share

  347. LIU Y, Tan Y, Islam MM, Cao Y, et al
    Assessment of Clofazimine and TB47 Combination Activity against Mycobacterium abscessus Using a Bioluminescent Approach.
    Antimicrob Agents Chemother. 2020;64.
    >> Share

  348. SONNABEND MS, Klein K, Beier S, Angelov A, et al
    Identification of Drug Resistance Determinants in a Clinical Isolate of Pseudomonas aeruginosa by High-Density Transposon Mutagenesis.
    Antimicrob Agents Chemother. 2020;64.
    >> Share

  349. HAMDI AM, Fida M, Deml SM, Abu Saleh OM, et al
    Retrospective Analysis of Antimicrobial Susceptibility Profiles of Nocardia Species from a Tertiary Hospital and Reference Laboratory, 2011 to 2017.
    Antimicrob Agents Chemother. 2020;64.
    >> Share

  350. ALKHAZRAJI S, Gebremariam T, Alqarihi A, Gu Y, et al
    Fosmanogepix (APX001) Is Effective in the Treatment of Immunocompromised Mice Infected with Invasive Pulmonary Scedosporiosis or Disseminated Fusariosis.
    Antimicrob Agents Chemother. 2020;64.
    >> Share

  351. ABBOTT IJ, van Gorp E, Wijma RA, Meletiadis J, et al
    Oral Fosfomycin Efficacy with Variable Urinary Exposures following Single and Multiple Doses against Enterobacterales: the Importance of Heteroresistance for Growth Outcome.
    Antimicrob Agents Chemother. 2020;64.
    >> Share

  352. LEE A, Prideaux B, Zimmerman M, Carter C, et al
    Penetration of Ibrexafungerp (Formerly SCY-078) at the Site of Infection in an Intra-abdominal Candidiasis Mouse Model.
    Antimicrob Agents Chemother. 2020;64.
    >> Share

  353. MCCURDY S, Keedy K, Lawrence L, Nenninger A, et al
    Efficacy of Delafloxacin versus Moxifloxacin against Bacterial Respiratory Pathogens in Adults with Community-Acquired Bacterial Pneumonia (CABP): Microbiology Results from the Delafloxacin Phase 3 CABP Trial.
    Antimicrob Agents Chemother. 2020;64.
    >> Share

  354. ARENDRUP MC, Jorgensen KM, Hare RK, Chowdhary A, et al
    In Vitro Activity of Ibrexafungerp (SCY-078) against Candida auris Isolates as Determined by EUCAST Methodology and Comparison with Activity against C. albicans and C. glabrata and with the Activities of Six Comparator Agents.
    Antimicrob Agents Chemother. 2020;64.
    >> Share

  355. LAI JCY, Svedin P, Ek CJ, Mottahedin A, et al
    Vancomycin Is Protective in a Neonatal Mouse Model of Staphylococcus epidermidis-Potentiated Hypoxic-Ischemic Brain Injury.
    Antimicrob Agents Chemother. 2020;64.
    >> Share

  356. RABIE H, Tikiso T, Lee J, Fairlie L, et al
    Abacavir exposure in children co-treated for tuberculosis with rifampicin and super-boosted lopinavir-ritonavir.
    Antimicrob Agents Chemother. 2020 Feb 18. pii: AAC.01923.
    >> Share

  357. WALSH KF, McAulay K, Lee MH, Vilbrun SC, et al
    Early bactericidal activity trial of nitazoxanide for pulmonary tuberculosis.
    Antimicrob Agents Chemother. 2020 Feb 18. pii: AAC.01956.
    >> Share

  358. CARVAJAL LP, Rincon S, Echeverri AM, Porras J, et al
    Novel Insights Into The Classification of Staphylococcal beta-Lactamases In Relation To The Cefazolin Inoculum Effect.
    Antimicrob Agents Chemother. 2020 Feb 18. pii: AAC.02511.
    >> Share

  359. ERSOY SC, Otmishi M, Milan VT, Li L, et al
    Scope and Predictive Genetic/Phenotypic Signatures of 'Bicarbonate [NaHCO3]-Responsiveness' and beta-Lactam Sensitization Among Methicillin-Resistant Staphylococcus aureus (MRSA).
    Antimicrob Agents Chemother. 2020 Feb 10. pii: AAC.02445.
    >> Share

  360. GENGENBACHER M, Zimmerman MD, Sarathy JP, Kaya F, et al
    Tissue distribution of doxycycline in animal models of tuberculosis.
    Antimicrob Agents Chemother. 2020 Feb 10. pii: AAC.02479.
    >> Share

  361. DJORIC D, Little JL, Kristich CJ
    Multiple low-reactivity class B penicillin-binding proteins are required for cephalosporin resistance in enterococci.
    Antimicrob Agents Chemother. 2020 Feb 10. pii: AAC.02273.
    >> Share

  362. CHOI S, Moon SM, Park SJ, Lee SC, et al
    Antagonistic effect of colistin on vancomycin activity against methicillin-resistant Staphylococcus aureus in in vitro and in vivo studies.
    Antimicrob Agents Chemother. 2020 Feb 10. pii: AAC.01925.
    >> Share

  363. ARAI T, Majima H, Watanabe A, Kamei K, et al
    A simple method to detect point mutations in Aspergillus fumigatus cyp51A gene using a Surveyor Nuclease assay.
    Antimicrob Agents Chemother. 2020 Feb 3. pii: AAC.02271.
    >> Share

  364. HELLEBERG M, Jorgensen KM, Hare RK, Datcu R, et al
    Rezafungin In Vitro Activity against Contemporary Clinical Nordic Candida Isolates and Candida auris Determined by the EUCAST Reference Method.
    Antimicrob Agents Chemother. 2020 Feb 3. pii: AAC.02438.
    >> Share

  365. BUPHA-INTR O, Blackmore T, Bloomfield M
    Efficacy of early oral switch with beta-lactams for low-risk Staphylococcus aureus bacteremia.
    Antimicrob Agents Chemother. 2020 Feb 3. pii: AAC.02345.
    >> Share

  366. CARVALHAES CG, Sader HS, Flamm RK, Streit JM, et al
    Assessment of Tedizolid In Vitro Activity and Resistance Mechanisms against a Collection of Enterococcus spp. Causing Invasive Infections Including Isolates Requiring an Optimized Dosing Strategy for Daptomycin from United States and European Medical
    Antimicrob Agents Chemother. 2020 Feb 3. pii: AAC.00175.
    >> Share

    January 2020
  367. KEMPKER RR, Alghamdi WA, Al-Shaer MH, Burch G, et al
    Correction for Kempker et al., "A Pharmacology Perspective on Simultaneous Tuberculosis and Hepatitis C Treatment".
    Antimicrob Agents Chemother. 2020;64.
    >> Share

  368. DIACON AH, De Jager VR, Dawson R, Narunsky K, et al
    Fourteen-Day Bactericidal Activity, Safety, and Pharmacokinetics of Linezolid in Adults with Drug-Sensitive Pulmonary Tuberculosis.
    Antimicrob Agents Chemother. 2020 Jan 27. pii: AAC.02012.
    >> Share

  369. ROSSI SA, de Oliveira HC, Agreda-Mellon D, Lucio J, et al
    Identification of off-patent drugs that show synergism with Amphotericin B or that present antifungal action against Cryptococcus neoformans and Candida spp.
    Antimicrob Agents Chemother. 2020 Jan 27. pii: AAC.01921.
    >> Share

  370. MERGENHAGEN KA, Croix M, Starr KE, Sellick JA, et al
    The utility of methicillin-resistant Staphylococcus aureus nares screening for patients with a diabetic foot infection.
    Antimicrob Agents Chemother. 2020 Jan 27. pii: AAC.02213.
    >> Share

  371. EKKELENKAMP MB, Canton R, Diez-Aguilar M, Tunney MM, et al
    Susceptibility of Pseudomonas aeruginosa Recovered from Cystic Fibrosis Patients to Murepavadin and 13 Comparator Antibiotics.
    Antimicrob Agents Chemother. 2020;64.
    >> Share

  372. BROUTIN A, Bigot J, Senghor Y, Moreno-Sabater A, et al
    In Vitro Susceptibility of Fusarium to Isavuconazole.
    Antimicrob Agents Chemother. 2020;64.
    >> Share

  373. WU X, Venkataramanan R, Rivosecchi RM, Tang C, et al
    Population Pharmacokinetics of Intravenous Isavuconazole in Solid-Organ Transplant Recipients.
    Antimicrob Agents Chemother. 2020;64.
    >> Share

  374. YANG H, Luo D, Etobayeva I, Li X, et al
    Linker Editing of Pneumococcal Lysin ClyJ Conveys Improved Bactericidal Activity.
    Antimicrob Agents Chemother. 2020;64.
    >> Share

  375. KOLPEN M, Jensen PO, Qvist T, Kragh KN, et al
    Biofilms of Mycobacterium abscessus Complex Can Be Sensitized to Antibiotics by Disaggregation and Oxygenation.
    Antimicrob Agents Chemother. 2020;64.
    >> Share

  376. ROSOWSKI EE, He J, Huisken J, Keller NP, et al
    Efficacy of Voriconazole against Aspergillus fumigatus Infection Depends on Host Immune Function.
    Antimicrob Agents Chemother. 2020;64.
    >> Share

  377. DONG W, Li S, Wen S, Jing W, et al
    In Vitro Susceptibility Testing of GSK656 against Mycobacterium Species.
    Antimicrob Agents Chemother. 2020;64.
    >> Share

  378. LU RY, Ni TJ, Wu J, Yan L, et al
    New Triazole NT-a9 Has Potent Antifungal Efficacy against Cryptococcus neoformans In Vitro and In Vivo.
    Antimicrob Agents Chemother. 2020;64.
    >> Share

  379. SONG H, Liu D, Li R, Fu Y, et al
    Polymorphism Existence of Mobile Tigecycline Resistance Gene tet(X4) in Escherichia coli.
    Antimicrob Agents Chemother. 2020;64.
    >> Share

  380. RICHARD M, Gutierrez AV, Kremer L
    Dissecting erm(41)-Mediated Macrolide-Inducible Resistance in Mycobacterium abscessus.
    Antimicrob Agents Chemother. 2020;64.
    >> Share

  381. CHI X, Zhang J, Xu H, Yu X, et al
    Emergence of KPC-2-Producing Raoultella ornithinolytica Isolated from a Hospital Wastewater Treatment Plant.
    Antimicrob Agents Chemother. 2020;64.
    >> Share

  382. SUN Q, Xiong K, Yuan Y, Yu J, et al
    Inhibiting Fungal Echinocandin Resistance by Small-Molecule Disruption of Geranylgeranyltransferase Type I Activity.
    Antimicrob Agents Chemother. 2020;64.
    >> Share

  383. REINGEWERTZ TH, Meyer T, McIntosh F, Sullivan J, et al
    Differential Sensitivity of Mycobacteria to Isoniazid Is Related to Differences in KatG-Mediated Enzymatic Activation of the Drug.
    Antimicrob Agents Chemother. 2020;64.
    >> Share

  384. DICK T, Shin SJ, Koh WJ, Dartois V, et al
    Rifabutin Is Active against Mycobacterium abscessus in Mice.
    Antimicrob Agents Chemother. 2020;64.
    >> Share

  385. SABET M, Griffith DC
    Activity of Aerosolized Levofloxacin against Burkholderia cepacia in a Mouse Model of Chronic Lung Infection.
    Antimicrob Agents Chemother. 2020;64.
    >> Share

  386. ALBAC S, Medina M, Labrousse D, Hayez D, et al
    Efficacy of Bacteriophages in a Staphylococcus aureus Nondiabetic or Diabetic Foot Infection Murine Model.
    Antimicrob Agents Chemother. 2020;64.
    >> Share

  387. FANG LX, Jiang Q, Deng GH, He B, et al
    Diverse and Flexible Transmission of fosA3 Associated with Heterogeneous Multidrug Resistance Regions in Salmonella enterica Serovar Typhimurium and Indiana Isolates.
    Antimicrob Agents Chemother. 2020;64.
    >> Share

  388. WATERER G, Lord J, Hofmann T, Jouhikainen T, et al
    A Phase I, dose-escalating study of safety and pharmacokinetics of inhaled dry powder vancomycin (AeroVanc) in volunteers and patients with cystic fibrosis: a new approach to therapy for methicillin-resistant Staphylococcus aureus.
    Antimicrob Agents Chemother. 2020 Jan 21. pii: AAC.01776.
    >> Share

  389. MTHIYANE T, Millard J, Adamson J, Balakrishna Y, et al
    N-acetyltransferase 2 genotypes amongst Zulu Speaking South Africans and isoniazid/N-acetyl-isoniazid pharmacokinetics during anti-tuberculosis treatment.
    Antimicrob Agents Chemother. 2020 Jan 21. pii: AAC.02376.
    >> Share

  390. REITZEL RA, Rosenblatt J, Gerges BZ, Vargas-Cruz N, et al
    Minocycline-EDTA-Ethanol Antimicrobial Catheter Lock Solution is highly effective in vitro for Eradication of Candida auris Biofilms.
    Antimicrob Agents Chemother. 2020 Jan 13. pii: AAC.02146.
    >> Share

  391. JIN Y, Guo Y, Zhan Q, Shang Y, et al
    Sub-Inhibitory Concentrations of Mupirocin Stimulate Staphylococcus aureus Biofilm Formation by Up-regulating cidA.
    Antimicrob Agents Chemother. 2020 Jan 13. pii: AAC.01912.
    >> Share

  392. MILLER CR, Dey S, Smolenski PD, Kulkarni PS, et al
    Distinct Subpopulations of Intravalvular Methicillin-Resistant Staphylococcus aureus With Variable Susceptibility to Daptomycin in Tricuspid Valve Endocarditis.
    Antimicrob Agents Chemother. 2020 Jan 13. pii: AAC.01593.
    >> Share

  393. ROTONDO CM, Sychantha D, Koteva K, Wright GD, et al
    Suppression of beta-Lactam Resistance by Aspergillomarasmine A is Influenced by Both the Metallo-beta-Lactamase Target and the Antibiotic Partner.
    Antimicrob Agents Chemother. 2020 Jan 13. pii: AAC.01386.
    >> Share

  394. RICARDO E, Grenouillet F, Miranda IM, Silva RM, et al
    Mechanisms of acquired in vivo and in vitro resistance to voriconazole by Candida krusei following exposure to suboptimal drug concentration.
    Antimicrob Agents Chemother. 2020 Jan 13. pii: AAC.01651.
    >> Share

  395. O'BRIEN B, Chaturvedi S, Chaturvedi V
    In vitro Evaluation of Antifungal Drug Combinations against Multidrug-resistant Candida auris isolates from New York Outbreak.
    Antimicrob Agents Chemother. 2020 Jan 13. pii: AAC.02195.
    >> Share

  396. WASSERMAN S, Huo S, Ky K, Malig YN, et al
    CORRELATION OF LINEZOLID HAIR CONCENTRATIONS WITH PLASMA EXPOSURE IN PATIENTS WITH DRUG-RESISTANT TB.
    Antimicrob Agents Chemother. 2020 Jan 13. pii: AAC.02145.
    >> Share

  397. BIAGI M, Shajee A, Vialichka A, Jurkovic M, et al
    Activity of imipenem-relebactam and meropenem-vaborbactam against carbapenem-resistant SME-producing Serratia marcescens.
    Antimicrob Agents Chemother. 2020 Jan 13. pii: AAC.02255.
    >> Share

  398. ALLAN DS, Del Carmen Parquet M, Savage KA, Holbein BE, et al
    Iron sequestrant DIBI, potential alternative for nares decolonization of MRSA Staphylococcus aureus, is anti-infective and inhibitory for mupirocin resistant isolates.
    Antimicrob Agents Chemother. 2020 Jan 6. pii: AAC.02353.
    >> Share

  399. HASBUN R
    Delayed cerebral vasculitis associated with the development of ceftriaxone resistant pneumococcal meningitis.
    Antimicrob Agents Chemother. 2020 Jan 6. pii: AAC.02251.
    >> Share

  400. ZHANG N, Strydom N, Tyagi S, Soni H, et al
    Mechanistic Modeling of Mycobacterium tuberculosis Infection in Murine Models for Drug and Vaccine Efficacy Studies.
    Antimicrob Agents Chemother. 2020 Jan 6. pii: AAC.01727.
    >> Share

  401. PERICAS JM, Cervera C, Garcia-de-la-Maria C, Sharma-Kuinkel BK, et al
    Relationship between Vancomycin Minimum Inhibitory Concentration with Virulence Genes Expression and Clonal Complexes of Methicillin-Susceptible Staphylococcus aureus (MSSA) Strains Isolated from Left-sided Endocarditis.
    Antimicrob Agents Chemother. 2020 Jan 6. pii: AAC.01579.
    >> Share

  402. JING W, Zong Z, Tang B, Wang J, et al
    Population Pharmacokinetic Analysis of Isoniazid among Pulmonary Tuberculosis Patients from China.
    Antimicrob Agents Chemother. 2020 Jan 6. pii: AAC.01736.
    >> Share

    December 2019
  403. BJUGARD NYBERG H, Draper HR, Garcia-Prats AJ, Thee S, et al
    Population pharmacokinetics and dosing of ethionamide in children with tuberculosis.
    Antimicrob Agents Chemother. 2019 Dec 23. pii: AAC.01984.
    >> Share

  404. PONTES L, Beraquet CAG, Arai T, Pigolli GL, et al
    Aspergillus fumigatus clinical isolates carrying CYP51A TR34/L98H/S297T/F495I mutation detected after 4 years retrospective azole resistance screening test in Brazil.
    Antimicrob Agents Chemother. 2019 Dec 23. pii: AAC.02059.
    >> Share

  405. ELINGS W, Gaur A, Blok AJ, Timmer M, et al
    beta-Lactamase of Mycobacterium tuberculosis shows dynamics in the active site that increase upon inhibitor binding.
    Antimicrob Agents Chemother. 2019 Dec 23. pii: AAC.02025.
    >> Share

  406. LIN Z, Pu Z, Xu G, Bai B, et al
    Omadacycline efficacy against Enterococcus faecalis isolated in China: in vitro activity, heteroresistance, and resistance mechanisms.
    Antimicrob Agents Chemother. 2019 Dec 23. pii: AAC.02097.
    >> Share

  407. KOLENDA C, Josse J, Medina M, Fevre C, et al
    Evaluation of the activity of a combination of three bacteriophages alone or in association with antibiotics on Staphylococcus aureus embedded in biofilm or internalised in osteoblasts.
    Antimicrob Agents Chemother. 2019 Dec 23. pii: AAC.02231.
    >> Share

  408. BRYSON D, Hettle AG, Boraston AB, Hobbs JK, et al
    Clinical Mutations that Partially Activate the Stringent Response Confer Multi-Drug Tolerance in Staphylococcus aureus.
    Antimicrob Agents Chemother. 2019 Dec 23. pii: AAC.02103.
    >> Share

  409. EDELSTEIN PH
    Azithromycin Phenotypic versus Clinical Resistance.
    Antimicrob Agents Chemother. 2019;64.
    >> Share

  410. RICHTER WJ, Cohen KA
    No Amikacin, No Problem: a Successful Treatment Approach for Pediatric Otomastoiditis Due to Amikacin-Resistant Mycobacterium abscessus.
    Antimicrob Agents Chemother. 2019;64.
    >> Share

  411. VU TTT, Nguyen NTQ, Tran VG, Gras E, et al
    Protective Efficacy of Monoclonal Antibodies Neutralizing Alpha-Hemolysin and Bicomponent Leukocidins in Rabbit Model of Staphylococcus aureus Necrotizing Pneumonia.
    Antimicrob Agents Chemother. 2019 Dec 16. pii: AAC.02220.
    >> Share

  412. DELLIERE S, Verdurme L, Bigot J, Dannaoui E, et al
    Comparison of the MICs Obtained by Gradient Concentration Strip and EUCAST Methods for Four Azole Drugs and Amphotericin B Against azole-susceptible and -resistant Aspergillus section Fumigati clinical isolates.
    Antimicrob Agents Chemother. 2019 Dec 16. pii: AAC.01597.
    >> Share

  413. WIEDERHOLD NP, Najvar LK, Jaramillo R, Olivo M, et al
    The Novel Arylamidine T-2307 Demonstrates In vitro and In vivo Activity Against Candida auris.
    Antimicrob Agents Chemother. 2019 Dec 16. pii: AAC.02198.
    >> Share

  414. ROSE WE, Bienvenida AM, Xiong YQ, Chambers HF, et al
    Ability of Bicarbonate Supplementation to Sensitize Selected Methicillin-Resistant Staphylococcus aureus (MRSA) Strains to beta-Lactam Antibiotics in an Ex Vivo Simulated Endocardial Vegetation Model.
    Antimicrob Agents Chemother. 2019 Dec 16. pii: AAC.02072.
    >> Share

  415. ABDELWAHAB MT, Leisegang R, Dooley KE, Mathad JS, et al
    Population Pharmacokinetics of Isoniazid, Pyrazinamide, and Ethambutol in South African Pregnant Women with Tuberculosis and HIV.
    Antimicrob Agents Chemother. 2019 Dec 16. pii: AAC.01978.
    >> Share

  416. AGUILERA-ALONSO D, Escosa-Garcia L, Saavedra-Lozano J, Cercenado E, et al
    Carbapenem-Resistant Gram-Negative Infections in Children.
    Antimicrob Agents Chemother. 2019 Dec 16. pii: AAC.02183.
    >> Share

  417. TORRES SR, Pichowicz A, Torres-Velez F, Song R, et al
    Impact of Candida auris infection in a neutropenic murine model.
    Antimicrob Agents Chemother. 2019 Dec 9. pii: AAC.01625.
    >> Share

  418. ASEMPA TE, Abdelraouf K, Carabeo T, Schuch R, et al
    Synergistic Activity of Exebacase (CF-301) in Addition to Daptomycin against Staphylococcus aureus in the Neutropenic Murine Thigh Infection Model.
    Antimicrob Agents Chemother. 2019 Dec 9. pii: AAC.02176.
    >> Share

  419. TSOLAKI V, Mantzarlis K, Mpakalis A, Malli E, et al
    Ceftazidime-avibactam to treat life-threatening infections from carbapenem resistant pathogens in critically ill mechanically ventilated patients.
    Antimicrob Agents Chemother. 2019 Dec 9. pii: AAC.02320.
    >> Share

  420. WU Y, Totten M, Memon W, Ying C, et al
    In vitro antifungal susceptibility of miltefosine alone and in combination with amphotericin B against emerging multidrug resistant Candida auris.
    Antimicrob Agents Chemother. 2019 Dec 2. pii: AAC.02063.
    >> Share

    November 2019
  421. RECIO R, Mancheno M, Viedma E, Villa J, et al
    Predictors of Mortality in Bloodstream Infections Caused by Pseudomonas aeruginosa: Impact of Antimicrobial Resistance and Bacterial Virulence.
    Antimicrob Agents Chemother. 2019 Nov 25. pii: AAC.01759.
    >> Share

  422. ALBAC S, Labrousse D, Hayez D, Anzala N, et al
    Activity of different anti-staphylococcal therapies, alone or combined, in a rat model of methicillin-resistant Staphylococcus epidermidis osteitis without implant.
    Antimicrob Agents Chemother. 2019 Nov 18. pii: AAC.01865.
    >> Share

  423. FAN H, Chen Y, Duan L, Zhao J, et al
    Characterization of azole resistance in Aspergillus fumigatus from potting soil samples in a Chinese hospital:comparison of two typing methods.
    Antimicrob Agents Chemother. 2019 Nov 18. pii: AAC.01578.
    >> Share

  424. GHOSH D, Veeraraghavan B, Elangovan R, Vivekanandan P, et al
    Antibiotic resistance and epigenetics: more to it than meets the eye.
    Antimicrob Agents Chemother. 2019 Nov 18. pii: AAC.02225.
    >> Share

  425. FRAILE-RIBOT P, Zamorano L, Orellana R, Barrio-Tofino ED, et al
    Activity of imipenem/relebactam against a large collection of Pseudomonas aeruginosa clinical isolates and isogenic beta-lactam resistant mutants.
    Antimicrob Agents Chemother. 2019 Nov 18. pii: AAC.02165.
    >> Share

  426. MIZRAHI A, Marvaud JC, Pilmis B, Nguyen Van JC, et al
    Emergence of ceftriaxone resistance during a pneumococcal meningitis with fatal evolution.
    Antimicrob Agents Chemother. 2019 Nov 11. pii: AAC.01958.
    >> Share

  427. WATSON A, Sauve K, Cassino C, Schuch R, et al
    Exebacase demonstrates in vitro synergy with a broad range of antibiotics against both methicillin-resistant and methicillin-susceptible Staphylococcus aureus.
    Antimicrob Agents Chemother. 2019 Nov 11. pii: AAC.01885.
    >> Share

  428. LEPAK AJ, Zhao M, Marchillo K, VanHecker J, et al
    In Vivo Pharmacodynamic Evaluation of Omadacycline against Staphylococcus aureus in the Neutropenic Mouse Pneumonia Model.
    Antimicrob Agents Chemother. 2019 Nov 11. pii: AAC.02058.
    >> Share

  429. LOWES DJ, Hevener KE, Peters BM
    The second-generation anti-diabetic sulfonylureas inhibit Candida albicans and Candidalysin mediated activation of the NLRP3 inflammasome.
    Antimicrob Agents Chemother. 2019 Nov 11. pii: AAC.01777.
    >> Share

  430. SUNDELL J, Bienvenu E, Birgersson S, Abelo A, et al
    Population pharmacokinetics and pharmacogenetics of ethambutol in adult patients co-infected with tuberculosis and HIV.
    Antimicrob Agents Chemother. 2019 Nov 11. pii: AAC.01583.
    >> Share

  431. CASTANHEIRA M, Doyle TB, Kantro V, Mendes RE, et al
    Meropenem-Vaborbactam Activity against Carbapenem-Resistant Enterobacterales Isolates Collected in U.S. Hospitals During 2016-2018.
    Antimicrob Agents Chemother. 2019 Nov 11. pii: AAC.01951.
    >> Share

  432. GEBREMARIAM T, Alkhazraji S, Gu Y, Singh S, et al
    Galactomannan is a Biomarker of Fosmanogepix (APX001) Efficacy in Treating Experimental Invasive Pulmonary Aspergillosis.
    Antimicrob Agents Chemother. 2019 Nov 4. pii: AAC.01966.
    >> Share

  433. GONG J, Wu J, Ikeh M, Tao L, et al
    Antifungal Activity of Mammalian Serum amyloid A1 against Candida albicans.
    Antimicrob Agents Chemother. 2019 Nov 4. pii: AAC.01975.
    >> Share

  434. THALSO-MADSEN I, Torrubia FR, Xu L, Petersen A, et al
    The Sle1 Cell Wall Amidase is essential for beta-Lactam Resistance in Community Acquired Methicillin Resistant Staphylococcus aureus USA300.
    Antimicrob Agents Chemother. 2019 Nov 4. pii: AAC.01931.
    >> Share

  435. CHOUDHARY DK, Bhakt P, Kaur R
    Erratum for Choudhary et al., "Essential Role for the Phosphatidylinositol 3,5-Bisphosphate Synthesis Complex in Caspofungin Tolerance and Virulence in Candida glabrata".
    Antimicrob Agents Chemother. 2019;63.
    >> Share

  436. KAYE KS, Patel T, Drusano G
    Is Daptomycin plus Ceftaroline the Way To Go for Methicillin-Resistant Staphylococcus aureus Bacteremia?
    Antimicrob Agents Chemother. 2019;63.
    >> Share

  437. SAKOULAS G, Geriak M, Haddad F, Rose W, et al
    Reply to Kalil et al., "Is Daptomycin plus Ceftaroline Associated with Better Clinical Outcomes than Standard of Care Monotherapy for Staphylococcus aureus Bacteremia?"
    Antimicrob Agents Chemother. 2019;63.
    >> Share

  438. KALIL AC, Holubar M, Deresinski S, Chambers HF, et al
    Is Daptomycin plus Ceftaroline Associated with Better Clinical Outcomes than Standard of Care Monotherapy for Staphylococcus aureus Bacteremia?
    Antimicrob Agents Chemother. 2019;63.
    >> Share

    October 2019
  439. KHAN A, Shropshire WC, Hanson B, Dinh AQ, et al
    Simultaneous Infection with Enterobacteriaceae and Pseudomonas aeruginosa harboring Multiple Carbapenemases in a Returning Traveler colonized with Candida auris.
    Antimicrob Agents Chemother. 2019 Oct 28. pii: AAC.01466.
    >> Share

  440. KANG CK, Song KH, Kim SE, Kim ES, et al
    Durations of Staphylococcus aureus bacteremia according to different phenotypes and a new concept of persistent bacteremia: a prospective cohort study.
    Antimicrob Agents Chemother. 2019 Oct 21. pii: AAC.01656.
    >> Share

  441. VERDEROSA AD, Dhouib R, Fairfull-Smith KE, Totsika M, et al
    Nitroxide functionalized antibiotics are promising eradication agents against Staphylococcus aureus biofilms.
    Antimicrob Agents Chemother. 2019 Oct 21. pii: AAC.01685.
    >> Share

  442. IOVLEVA A, Mettus RT, McElheny CL, Griffifth MP, et al
    High-level carbapenem resistance triggered by ertapenem therapy in OXA-232-producing Raoultella ornithinolytica.
    Antimicrob Agents Chemother. 2019 Oct 21. pii: AAC.01335.
    >> Share

  443. YADAV R, Bergen PJ, Rogers KE, Kirkpatrick CMJ, et al
    Meropenem-tobramycin combination regimens combat carbapenem-resistant Pseudomonas aeruginosa in the hollow-fiber infection model simulating augmented renal clearance in critically ill patients.
    Antimicrob Agents Chemother. 2019 Oct 21. pii: AAC.01679.
    >> Share

  444. CEBALLOS S, Kim C, Qian Y, Mobashery S, et al
    Susceptibility of methicillin-resistant Staphylococcus aureus to five quinazolinone antibacterials.
    Antimicrob Agents Chemother. 2019 Oct 14. pii: AAC.01344.
    >> Share

  445. DONNELLAN S, Aljayyoussi G, Moyo E, Ardrey A, et al
    Intracellular pharmacodynamic modelling (PDi) is predictive of the clinical activity of fluoroquinolones against Tuberculosis.
    Antimicrob Agents Chemother. 2019 Oct 14. pii: AAC.00989.
    >> Share

  446. KAPOOR M, Moloney M, Soltow QA, Pillar CM, et al
    Evaluation of Resistance Development to the Gwt1 inhibitor Manogepix (APX001A) in Candida Species.
    Antimicrob Agents Chemother. 2019 Oct 14. pii: AAC.01387.
    >> Share

  447. KUIPERS S, Ruth MM, Mientjes M, de Sevaux RGL, et al
    Successful treatment of chronic relapsing urinary tract infection with bacteriophages in a renal transplant recipient - a Dutch case report.
    Antimicrob Agents Chemother. 2019 Oct 14. pii: AAC.01281.
    >> Share

  448. BIDAUD AL, Botterel F, Chowdhary A, Dannaoui E, et al
    In vitro antifungal combination of flucytosine with amphotericin B, voriconazole, or micafungin against Candida auris shows no antagonism.
    Antimicrob Agents Chemother. 2019 Oct 7. pii: AAC.01393.
    >> Share

  449. PETRAITIS V, Petraitiene R, Valdez JM, Pyrgos V, et al
    Amphotericin B Penetrates into the Central Nervous System Through Focal Disruption of the Blood Brain Barrier in Experimental Hematogenous Candida Meningoencephalitis.
    Antimicrob Agents Chemother. 2019 Oct 7. pii: AAC.01626.
    >> Share

  450. KEMPKER RR, Alghamdi WA, Al-Shaer MH, Burch G, et al
    A Pharmacology Perspective of Simultaneous Tuberculosis and Hepatitis C Treatment.
    Antimicrob Agents Chemother. 2019 Oct 7. pii: AAC.01215.
    >> Share

  451. CLARKE RS, Bruderer MS, Ha KP, Edwards AM, et al
    RexAB is essential for the mutagenic repair of Staphylococcus aureus DNA damage caused by co-trimoxazole.
    Antimicrob Agents Chemother. 2019 Oct 7. pii: AAC.00944.
    >> Share

  452. ALAMIRI F, Riesbeck K, Hakansson AP
    HAMLET, a protein complex from human milk has bactericidal activity and enhances the activity of antibiotics against pathogenic Streptococci.
    Antimicrob Agents Chemother. 2019 Oct 7. pii: AAC.01193.
    >> Share

  453. KORDALEWSKA M, Lee A, Zhao Y, Perlin DS, et al
    Detection of Candida auris antifungal drug resistance markers directly from clinical skin swabs.
    Antimicrob Agents Chemother. 2019 Oct 7. pii: AAC.01754.
    >> Share

  454. LURASCHI A, Richard S, Hauser PM
    Reply to Nevez and Le Gal, "Caspofungin and Pneumocystis Pneumonia: It Is Time To Go Ahead".
    Antimicrob Agents Chemother. 2019;63.
    >> Share

  455. NEVEZ G, Le Gal S
    Caspofungin and Pneumocystis Pneumonia: It Is Time To Go Ahead.
    Antimicrob Agents Chemother. 2019;63.
    >> Share

    September 2019
  456. LYONS MA
    Modeling and Simulation of Pretomanid Pharmacodynamics in Pulmonary Tuberculosis Patients.
    Antimicrob Agents Chemother. 2019 Sep 30. pii: AAC.00732.
    >> Share

  457. LOPES AA, Yoshii Y, Yamada S, Nagakura M, et al
    Roles of lytic transglycosylases in biofilm formation and beta-lactam resistance in methicillin-resistant Staphylococcus aureus.
    Antimicrob Agents Chemother. 2019 Sep 30. pii: AAC.01277.
    >> Share

  458. GHANNOUM M, Long L, Isham N, Hager C, et al
    Activity of a novel 1,3-beta-D-glucan Synthase Inhibitor, Ibrexafungerp (formerly SCY-078), Against Candida glabrata.
    Antimicrob Agents Chemother. 2019 Sep 30. pii: AAC.01510.
    >> Share

  459. CARRIGY NB, Larsen SE, Reese V, Pecor T, et al
    Prophylaxis of Mycobacterium tuberculosis H37Rv Infection in a Preclinical Mouse Model via Inhalation of Nebulized Bacteriophage D29.
    Antimicrob Agents Chemother. 2019 Sep 16. pii: AAC.00871.
    >> Share

  460. WATKINS RR, Holubar M, David MZ
    Antimicrobial resistance in methicillin-resistant Staphylococcus aureus to newer antimicrobial agents.
    Antimicrob Agents Chemother. 2019 Sep 16. pii: AAC.01216.
    >> Share

  461. RODRIGUES M, McBride SW, Hullahalli K, Palmer KL, et al
    Conjugative delivery of CRISPR-Cas9 for the selective depletion of antibiotic-resistant enterococci.
    Antimicrob Agents Chemother. 2019 Sep 16. pii: AAC.01454.
    >> Share

  462. SOMMER R, Cole ST
    Monitoring Tuberculosis Drug Activity in Live Animals by Near-Infrared Fluorescence Imaging.
    Antimicrob Agents Chemother. 2019 Sep 16. pii: AAC.01280.
    >> Share

  463. HENDON-DUNN CL, Pertinez H, Marriott AAN, Hatch K, et al
    Re-growth of Mycobacterium tuberculosis populations exposed to antibiotic combinations is due to the presence of isoniazid and not bacterial growth rate.
    Antimicrob Agents Chemother. 2019 Sep 16. pii: AAC.00570.
    >> Share

  464. JO KW, Kim M, Kim YJ, Lee HK, et al
    Early discontinuation of ethambutol in pulmonary tuberculosis treatment based on results of the GenoType MTBDRplus assay: A prospective, multicenter, non-inferiority randomized trial in South Korea.
    Antimicrob Agents Chemother. 2019 Sep 16. pii: AAC.00980.
    >> Share

  465. BRINK M, Glimaker M, Sjolin J, Naucler P, et al
    Meropenem versus cefotaxime and ampicillin as empirical antibiotic treatment in adult bacterial meningitis: A quality registry study 2008-2016.
    Antimicrob Agents Chemother. 2019 Sep 9. pii: AAC.00883.
    >> Share

  466. YADAV R, Saini A, Agarwal P, Kapoor P, et al
    A rare D94F change in gyrA gene of multi-drug resistant Mycobacterium tuberculosis possibly contributing to an unfavorable treatment outcome.
    Antimicrob Agents Chemother. 2019 Sep 9. pii: AAC.01312.
    >> Share

  467. KIM D, Hong JS, Yoon EJ, Lee H, et al
    Toxic shock syndrome toxin 1-producing methicillin-resistant Staphylococcus aureus of clonal complex 5, the New York/Japan epidemic clone, causing a high early mortality rate in patients with bloodstream infections.
    Antimicrob Agents Chemother. 2019 Sep 9. pii: AAC.01362.
    >> Share

  468. RICHARDS JP, Cai W, Zill NA, Zhang W, et al
    Adaptation of Mycobacterium tuberculosis to biofilm growth is genetically linked to drug tolerance.
    Antimicrob Agents Chemother. 2019 Sep 9. pii: AAC.01213.
    >> Share

  469. YUI ETO K, Firth N, Davis AM, Kwong SM, et al
    Evolution of a 72-kb cointegrant, conjugative multiresistance plasmid from early community-associated methicillin-resistant Staphylococcus aureus isolates.
    Antimicrob Agents Chemother. 2019 Sep 9. pii: AAC.01560.
    >> Share

  470. NUNNALLY NS, Etienne KA, Angulo D, Lockhart SR, et al
    In vitro activity of ibrexafungerp, a novel glucan synthase inhibitor against Candida glabrata isolates with FKS mutations.
    Antimicrob Agents Chemother. 2019 Sep 3. pii: AAC.01692.
    >> Share

  471. LAMOTH F, Kontoyiannis DP
    Therapeutic challenges of non-Aspergillus invasive mold infections in immunosuppressed patients.
    Antimicrob Agents Chemother. 2019 Sep 3. pii: AAC.01244.
    >> Share

  472. LEPAK AJ, Zhao M, Andes DR
    Determination of Pharmacodynamic Target Exposures for Rezafungin against Candida tropicalis and Candida dubliniensis in the Neutropenic Mouse Disseminated Candidiasis Model.
    Antimicrob Agents Chemother. 2019 Sep 3. pii: AAC.01556.
    >> Share

  473. MURASE LS, de Souza JVP, Meneguello JE, Seixas FAV, et al
    Possible binding of piperine in Mycobacterium tuberculosis RNA-polymerase and rifampicin synergism.
    Antimicrob Agents Chemother. 2019 Sep 3. pii: AAC.02520.
    >> Share

  474. DEMARCO VP, Ordonez AA, Klunk M, Prideaux B, et al
    Erratum for DeMarco et al., "Determination of [(11)C]Rifampin Pharmacokinetics within Mycobacterium tuberculosis-Infected Mice by Using Dynamic Positron Emission Tomography Bioimaging".
    Antimicrob Agents Chemother. 2019;63.
    >> Share

    August 2019
  475. SALINGER DH, Nedelman JR, Mendel C, Spigelman M, et al
    Daily Dosing for Bedaquiline in Patients with Tuberculosis.
    Antimicrob Agents Chemother. 2019 Aug 26. pii: AAC.00463.
    >> Share

  476. TALBOT JJ, Frisvad JC, Meis JF, Hagen F, et al
    Cyp51A mutations, Extrolite Profiles and Antifungal Susceptibility in Clinical and Environmental Isolates of the Aspergillus viridinutans Species Complex.
    Antimicrob Agents Chemother. 2019 Aug 26. pii: AAC.00632.
    >> Share

  477. ALBANO M, Karau MJ, Greenwood-Quaintance KE, Osmon DR, et al
    In vitro Activity of Rifampin, Rifabutin, Rifapentine and Rifaximin Against Planktonic and Biofilm States of Staphylococci Isolated from Periprosthetic Joint Infection.
    Antimicrob Agents Chemother. 2019 Aug 26. pii: AAC.00959.
    >> Share

  478. KISHIMOTO T, Ishida W, Fukuda K, Nakajima I, et al
    Therapeutic Effects of Intravitreously Administered Bacteriophage in a Mouse Model of Endophthalmitis Caused by Vancomycin-Sensitive or -Resistant Enterococcus faecalis.
    Antimicrob Agents Chemother. 2019 Aug 26. pii: AAC.01088.
    >> Share

  479. HAN JH, Lapp Z, Bushman F, Lautenbach E, et al
    Whole Genome Sequencing to Identify Drivers of Carbapenem-Resistant Klebsiella pneumoniae Transmission Within and Between Regional Long-Term Acute Care Hospitals.
    Antimicrob Agents Chemother. 2019 Aug 26. pii: AAC.01622.
    >> Share

  480. WIEDERHOLD NP, Najvar LK, Shaw KJ, Jaramillo R, et al
    Efficacy of Delayed Therapy with Fosmanogepix (APX001) in a Murine Model of Candida auris Invasive Candidiasis.
    Antimicrob Agents Chemother. 2019 Aug 19. pii: AAC.01120.
    >> Share

  481. TANNER L, Evans JC, Seldon R, Jordaan A, et al
    In vitro efficacies, ADME, and pharmacokinetic properties of phenoxazine derivatives active against Mycobacterium tuberculosis.
    Antimicrob Agents Chemother. 2019 Aug 19. pii: AAC.01010.
    >> Share

  482. XIAO S, Guo H, Weiner WS, Maddox C, et al
    Revisiting the beta-lactams for tuberculosis therapy: a compound-compound synthetic lethality approach.
    Antimicrob Agents Chemother. 2019 Aug 19. pii: AAC.01319.
    >> Share

  483. WILLEMS HME, Stultz JS, Coltrane ME, Fortwendel JP, et al
    Disparate Candida albicans biofilm formation in clinical lipid emulsions due to capric acid mediated inhibition.
    Antimicrob Agents Chemother. 2019 Aug 12. pii: AAC.01394.
    >> Share

  484. WANG Q, Modongo C, Allender C, Engelthaler DM, et al
    Utility of targeted, amplicon-based deep sequencing to detect resistance to first-line tuberculosis drugs in Botswana.
    Antimicrob Agents Chemother. 2019 Aug 12. pii: AAC.00982.
    >> Share

  485. NAKAMURA I, Ohsumi K, Takeda S, Katsumata K, et al
    ASP2397, a novel natural compound that exhibits rapid and potent fungicidal activity against Aspergillus species through a specific transporter.
    Antimicrob Agents Chemother. 2019 Aug 12. pii: AAC.02689.
    >> Share

  486. WIEDERHOLD NP, Najvar LK, Jaramillo R, Olivo M, et al
    Extended-Interval Dosing of Rezafungin against Azole-Resistant Aspergillus fumigatus.
    Antimicrob Agents Chemother. 2019 Aug 12. pii: AAC.01165.
    >> Share

  487. JIA X, Ren H, Nie X, Li Y, et al
    Antibiotic resistance and azithromycin resistance mechanism of Legionella pneumophila serogroup 1 in China.
    Antimicrob Agents Chemother. 2019 Aug 12. pii: AAC.00768.
    >> Share

  488. SALINGER DH, Subramoney V, Everitt D, Nedelman JR, et al
    Population Pharmacokinetics of Pretomanid.
    Antimicrob Agents Chemother. 2019 Aug 12. pii: AAC.00907.
    >> Share

  489. PARK Y, Ahn YM, Jonnala S, Oh S, et al
    Inhibition of CorA dependent Magnesium Homeostasis is cidal in Mycobacterium tuberculosis.
    Antimicrob Agents Chemother. 2019 Aug 5. pii: AAC.01006.
    >> Share

  490. TUCKER EW, Pieterse L, Zimmerman MD, Udwadia ZF, et al
    Delamanid Central Nervous System Pharmacokinetics in Tuberculous Meningitis in Rabbits and Humans.
    Antimicrob Agents Chemother. 2019 Aug 5. pii: AAC.00913.
    >> Share

  491. NISHIMOTO AT, Whaley SG, Wiederhold NP, Zhang Q, et al
    Impact of the major Candida glabrata triazole resistance determinants on the activity of the novel investigational tetrazoles VT-1598 and VT-1161.
    Antimicrob Agents Chemother. 2019 Aug 5. pii: AAC.01304.
    >> Share

  492. MARIMUTHU K, Ng OT, Cherng BPZ, Fong RKC, et al
    Antecedent Carbapenem Exposure as a Risk Factor for Non-Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae (NCPCRE) and Carbapenemase-Producing Enterobacteriaceae (CPE).
    Antimicrob Agents Chemother. 2019 Aug 5. pii: AAC.00845.
    >> Share

  493. VAZQUEZ-UCHA JC, Martinez-Guitian M, Maneiro M, Conde-Perez K, et al
    Therapeutic efficacy of LN-1-255 in combination with imipenem in severe infection caused by carbapenem-resistant Acinetobacter baumannii.
    Antimicrob Agents Chemother. 2019 Aug 5. pii: AAC.01092.
    >> Share

  494. WRIGHT WF, Bejou N, Shields RK, Marr K, et al
    Amphotericin B Induction with Voriconazole Consolidation as Salvage Therapy for FKS-Associated Echinocandin Resistance in Candida glabrata Septic Arthritis and Osteomyelitis.
    Antimicrob Agents Chemother. 2019;63.
    >> Share

    July 2019
  495. KARAU MJ, Schmidt-Malan SM, Yan Q, Greenwood-Quaintance KE, et al
    Exebacase in Addition to Daptomycin is More Active than Daptomycin or Exebacase Alone in Methicillin-Resistant Staphylococcus aureus Osteomyelitis in Rats.
    Antimicrob Agents Chemother. 2019 Jul 29. pii: AAC.01235.
    >> Share

  496. LI H, Salinger DH, Everitt D, Li M, et al
    Long-Term Effects on QT prolongation of Pretomanid, Alone and in Combinations, in Patients with Tuberculosis.
    Antimicrob Agents Chemother. 2019 Jul 29. pii: AAC.00445.
    >> Share

  497. SARATHY JP, Ragunathan P, Shin J, Cooper CB, et al
    TBAJ-876 retains Bedaquiline's activity against subunit c and of Mycobacterium tuberculosis F-ATP synthase.
    Antimicrob Agents Chemother. 2019 Jul 29. pii: AAC.01191.
    >> Share

  498. GONCALVES BV, Portela R, Lobo R, Figueiredo TA, et al
    The role of MurT C-terminal domain in the amidation of Staphylococcus aureus peptidoglycan.
    Antimicrob Agents Chemother. 2019 Jul 29. pii: AAC.00957.
    >> Share

  499. XU Q, Chen T, Yan B, Zhang L, et al
    Dual role of gnaA in antibiotic resistance and virulence in Acinetobacter baumannii.
    Antimicrob Agents Chemother. 2019 Jul 29. pii: AAC.00694.
    >> Share

  500. PRATER AG, Mehta HH, Kosgei AJ, Miller WR, et al
    Environment Shapes the Accessible Daptomycin Resistance Mechanisms in Enterococcus faecium.
    Antimicrob Agents Chemother. 2019 Jul 22. pii: AAC.00790.
    >> Share

  501. WATSON A, Oh JT, Sauve K, Bradford PA, et al
    Antimicrobial Activity of Exebacase (Lysin CF-301) Against the Most Common Causes of Infective Endocarditis.
    Antimicrob Agents Chemother. 2019 Jul 22. pii: AAC.01078.
    >> Share

  502. KORYCKA-MACHALA M, Viljoen A, Pawelczyk J, Borowka P, et al
    1H-benzo[d]imidazole derivatives affect MmpL3 in Mycobacterium tuberculosis.
    Antimicrob Agents Chemother. 2019 Jul 22. pii: AAC.00441.
    >> Share

  503. G C B, Sahukhal GS, Elasri MO
    Role of the msaABCR operon in cell wall biosynthesis, autolysis, integrity, and antibiotic resistance in Staphylococcus aureus.
    Antimicrob Agents Chemother. 2019 Jul 15. pii: AAC.00680.
    >> Share

  504. BELLOUARD R, Deschanvres C, Deslandes G, Dailly E, et al
    Cefazolin dosage adaptation in bacteremia and infective endocarditis based on a nomogram: a population pharmacokinetic study.
    Antimicrob Agents Chemother. 2019 Jul 15. pii: AAC.00806.
    >> Share

  505. YOUSFI H, Cassagne C, Ranque S, Rolain JM, et al
    Repurposing of ribavirin as an adjunct therapy against invasive Candida strains: In vitro study.
    Antimicrob Agents Chemother. 2019 Jul 15. pii: AAC.00263.
    >> Share

  506. DONG N, Sun Q, Huang Y, Shu L, et al
    Evolution of carbapenem-resistant serotype K1 hypervirulent Klebsiella pneumoniae by acquisition of bla VIM-1-bearing plasmid.
    Antimicrob Agents Chemother. 2019 Jul 15. pii: AAC.01056.
    >> Share

  507. RIVERO-MENENDEZ O, Soto-Debran JC, Medina N, Lucio J, et al
    Molecular identification, antifungal susceptibility testing and mechanisms of azole resistance in Aspergillus spp. received within a surveillance program on antifungal resistance in Spain.
    Antimicrob Agents Chemother. 2019 Jul 8. pii: AAC.00865.
    >> Share

  508. VATANSHENASSAN M, Arastehfar A, Boekhout T, Berman J, et al
    Rapid antifungal susceptibility testing of Candida glabrata isolates against anidulafungin from positive blood culture by MBT ASTRA.
    Antimicrob Agents Chemother. 2019 Jul 8. pii: AAC.00554.
    >> Share

  509. KIDWAI S, Bouzeyen R, Chakraborti S, Khare N, et al
    NU-6027 inhibits growth of Mycobacterium tuberculosis by targeting Protein Kinase D and Protein Kinase G.
    Antimicrob Agents Chemother. 2019 Jul 8. pii: AAC.00996.
    >> Share

  510. DAHESH S, Wong B, Nizet V, Sakoulas G, et al
    Treatment of Multidrug-Resistant Vancomycin-Resistant Enterococcus faecium Hardware-Associated Vertebral Osteomyelitis with Oritavancin plus Ampicillin.
    Antimicrob Agents Chemother. 2019;63.
    >> Share

  511. GHODOUSI A, Rizvi AH, Baloch AQ, Ghafoor A, et al
    Acquisition of cross-resistance to Bedaquiline and Clofazimine following treatment for Tuberculosis in Pakistan.
    Antimicrob Agents Chemother. 2019 Jul 1. pii: AAC.00915.
    >> Share

  512. LI Q, Cheng J, Wu Y, Wang Z, et al
    Effects of Delayed Antibiotic Therapy on Outcomes in Children with Streptococcus pneumoniae Sepsis.
    Antimicrob Agents Chemother. 2019 Jul 1. pii: AAC.00623.
    >> Share

  513. CANVER MC, Satlin MJ, Westblade LF, Kreiswirth BN, et al
    Activity of imipenem-relebactam and comparator agents against genetically characterized isolates of carbapenem-resistant Enterobacteriaceae.
    Antimicrob Agents Chemother. 2019 Jul 1. pii: AAC.00672.
    >> Share

    June 2019
  514. GREGOIRE M, Dailly E, Turnier PL, Garot D, et al
    High-dose ceftriaxone for bacterial meningitis: optimization of administration scheme based on nomogram.
    Antimicrob Agents Chemother. 2019 Jun 24. pii: AAC.00634.
    >> Share

  515. YAMASHITA Y, Nagaoka K, Kimura H, Suzuki M, et al
    Efficacy of azithromycin in a mouse pneumonia model against hospital-acquired methicillin-resistant Staphylococcus aureus.
    Antimicrob Agents Chemother. 2019 Jun 24. pii: AAC.00149.
    >> Share

  516. NAKANO S, Fujisawa T, Ito Y, Chang B, et al
    Penicillin-binding protein typing, antibiotic resistance gene identification and molecular phylogenetic analysis of meropenem-resistant Streptococcus pneumoniae serotype 19A-CC3111 strains in Japan.
    Antimicrob Agents Chemother. 2019 Jun 24. pii: AAC.00711.
    >> Share

  517. SEWELL TR, Zhang Y, Brackin AP, Shelton JMG, et al
    Elevated prevalence of azole resistant Aspergillus fumigatus in urban versus rural environments in the United Kingdom.
    Antimicrob Agents Chemother. 2019 Jun 24. pii: AAC.00548.
    >> Share

  518. PAULSHUS E, Thorell K, Guzman-Otazo J, Joffre E, et al
    Repeated isolation of ESBL positive Escherichia coli ST648 and ST131 from community wastewater - are sewage systems important sources of emerging clones of antibiotic resistant bacteria?
    Antimicrob Agents Chemother. 2019 Jun 24. pii: AAC.00823.
    >> Share

  519. LAM SW, Athans V
    Clinical and Microbiological Outcomes in Obese Patients Receiving Colistin for Carbapenem-Resistant Gram-negative Bloodstream Infection.
    Antimicrob Agents Chemother. 2019 Jun 24. pii: AAC.00531.
    >> Share

  520. REHBERG N, Omeje E, Ebada SS, van Geelen L, et al
    3-O-Methyl-alkylgallates inhibit fatty acid desaturation in Mycobacterium tuberculosis.
    Antimicrob Agents Chemother. 2019 Jun 17. pii: AAC.00136.
    >> Share

  521. RODRIGUEZ LOPEZ AL, Lee MR, Wang NB, Dunn KK, et al
    Small-molecule morphogenesis modulators enhance the ability of 14-helical beta-peptides to prevent Candida albicans biofilm formation.
    Antimicrob Agents Chemother. 2019 Jun 17. pii: AAC.02653.
    >> Share

  522. LI D, Li XY, Schwarz S, Yang M, et al
    Tn6674, a Novel Enterococcal optrA-Carrying Multiresistance Transposon of the Tn554 Family.
    Antimicrob Agents Chemother. 2019 Jun 17. pii: AAC.00809.
    >> Share

  523. LEE H, Boyle-Vavra S, Ren J, Jarusiewicz J, et al
    Identification of small molecules exhibiting oxacillin synergy through a novel assay for inhibition of vraTSR expression in methicillin resistant Staphylococcus aureus.
    Antimicrob Agents Chemother. 2019 Jun 17. pii: AAC.02593.
    >> Share

  524. BHAGWAT SS, Periasamy H, Takalkar SS, Chavan R, et al
    In vivo pharmacokinetic/pharmacodynamic targets of levonadifloxacin against Staphylococcus aureus in a neutropenic murine lung infection model.
    Antimicrob Agents Chemother. 2019 Jun 17. pii: AAC.00909.
    >> Share

  525. PERICAS JM, Nathavitharana R, Garcia-de-la-Maria C, Falces C, et al
    Endocarditis Caused by Highly Penicillin-Resistant Viridans Group Streptococci: Still Room for Vancomycin-Based Regimens.
    Antimicrob Agents Chemother. 2019 Jun 10. pii: AAC.00516.
    >> Share

  526. OKUSANYA OO, Forrest A, Bhavnani SM, Fernandes P, et al
    Pharmacokinetic/Pharmacodynamic Evaluation of Solithromycin Against Streptococcus pneumoniae Using Data from a Neutropenic Murine-Lung Infection Model.
    Antimicrob Agents Chemother. 2019 Jun 10. pii: AAC.02606.
    >> Share

  527. TENERO D, Derimanov G, Carlton A, Tonkyn J, et al
    First time in human (FTIH) study and prediction of early bactericidal activity for GSK3036656, a potent Leucyl - tRNA synthetase inhibitor for tuberculosis treatment.
    Antimicrob Agents Chemother. 2019 Jun 10. pii: AAC.00240.
    >> Share

  528. KIM DH, Jhun BW, Moon SM, Kim SY, et al
    In Vitro Activity of Bedaquiline and Delamanid Against Nontuberculous Mycobacteria Including Macrolide-Resistant Clinical Isolates.
    Antimicrob Agents Chemother. 2019 Jun 10. pii: AAC.00665.
    >> Share

  529. MCNEIL MB, Cook GM
    Utilization of CRISPR interference to validate MmpL3 as a drug target in Mycobacterium tuberculosis.
    Antimicrob Agents Chemother. 2019 Jun 3. pii: AAC.00629.
    >> Share

  530. KOHLHOFF S, Huerta N, Hammerschlag MR
    In Vitro Activity of Levonadifloxacin (WCK 771) against Chlamydia pneumoniae.
    Antimicrob Agents Chemother. 2019 Jun 3. pii: AAC.01048.
    >> Share

  531. GARCIA MT, Valenzuela MV, Ferrandiz MJ, de la Campa AG, et al
    Reactive Oxygen Species Production is a Major Factor Directing the Post-antibiotic Effect of Fluoroquinolones in Streptococcus pneumoniae.
    Antimicrob Agents Chemother. 2019 Jun 3. pii: AAC.00737.
    >> Share

  532. LE HN, Tran VG, Vu TTT, Gras E, et al
    Treatment Efficacy of MEDI3902 in Pseudomonas aeruginosa blood stream infection and acute pneumonia rabbit models.
    Antimicrob Agents Chemother. 2019 Jun 3. pii: AAC.00710.
    >> Share

  533. O'DONNELL MR, Larsen MH, Brown TS, Jain P, et al
    Erratum for O'Donnell et al., "Early Detection of Emergent Extensively Drug-Resistant Tuberculosis by Flow Cytometry-Based Phenotyping and Whole-Genome Sequencing".
    Antimicrob Agents Chemother. 2019;63.
    >> Share

  534. MACDONALD D, Thomson DD, Johns A, Valenzuela AC, et al
    Correction for Macdonald et al., "Inducible Cell Fusion Permits Use of Competitive Fitness Profiling in the Human Pathogenic Fungus Aspergillus fumigatus".
    Antimicrob Agents Chemother. 2019;63.
    >> Share

    May 2019
  535. YU X, Gao X, Li C, Luo J, et al
    In Vitro Activity of bedaquiline and delamanid against Non-tuberculous Mycobacteria isolated in Beijing, China.
    Antimicrob Agents Chemother. 2019 May 28. pii: AAC.00031.
    >> Share

  536. CHOUDHARY DK, Bhakt P, Kaur R
    An essential role for the PI(3,5)P2 synthesis complex in caspofungin tolerance and virulence in Candida glabrata.
    Antimicrob Agents Chemother. 2019 May 28. pii: AAC.00886.
    >> Share

  537. ORTINES RV, Wang Y, Liu H, Dikeman DA, et al
    Efficacy of a multimechanistic monoclonal antibody combination against Staphylococcus aureus surgical site infections in mice.
    Antimicrob Agents Chemother. 2019 May 28. pii: AAC.00346.
    >> Share

  538. ARUANNO M, Glampedakis E, Lamoth F
    Echinocandins for the treatment of invasive aspergillosis: from laboratory to bedside.
    Antimicrob Agents Chemother. 2019 May 28. pii: AAC.00399.
    >> Share

  539. TOHYA M, Tada T, Watanabe S, Kuwahara-Arai K, et al
    Emergence of carbapenem-resistant Pseudomonas asiatica producing NDM-1 and VIM-2 metallo-beta-lactamases in Myanmar.
    Antimicrob Agents Chemother. 2019 May 28. pii: AAC.00475.
    >> Share

  540. TAMMA PD, Kazmi A, Bergman Y, Goodman KE, et al
    The Likelihood of Developing a Carbapenem-Resistant Enterobacteriaceae Infection during the Hospital Stay.
    Antimicrob Agents Chemother. 2019 May 28. pii: AAC.00757.
    >> Share

  541. SUVICHAPANICH S, Wattanapokayakit S, Mushiroda T, Yanai H, et al
    Genome-Wide Association Study Confirming the Association of NAT2 with Susceptibility to Anti-tuberculosis Drug-Induced Liver Injury in Thai Patients.
    Antimicrob Agents Chemother. 2019 May 20. pii: AAC.02692.
    >> Share

  542. SEIFERT M, Capparelli E, Catanzaro DG, Rodwell TC, et al
    Using Mycobacterium tuberculosis single nucleotide polymorphisms to predict fluoroquinolone treatment response.
    Antimicrob Agents Chemother. 2019 May 13. pii: AAC.00076.
    >> Share

  543. ARUANNO M, Bachmann D, Sanglard D, Lamoth F, et al
    Link between heat shock protein 90 (Hsp90) and the mitochondrial respiratory chain in the caspofungin stress response of Aspergillus fumigatus.
    Antimicrob Agents Chemother. 2019 May 6. pii: AAC.00208.
    >> Share

  544. SANGUINETTI M, Canton E, Torelli R, Tumietto F, et al
    In Vitro Activity of Fenticonazole against Candida and Bacterial Vaginitis Isolates Determined by Mono- or Dual-Species Testing Assays.
    Antimicrob Agents Chemother. 2019 May 6. pii: AAC.02693.
    >> Share

  545. PEREZ-CANTERO A, Lopez-Fernandez L, Guarro J, Capilla J, et al
    New insights into the Cyp51 contribution to azole resistance in Aspergillus section Nigri.
    Antimicrob Agents Chemother. 2019 May 6. pii: AAC.00543.
    >> Share

  546. MURI L, Perny M, Zemp J, Grandgirard D, et al
    Combining Ceftriaxone with Doxycycline and Daptomycin Reduces Mortality, Neuroinflammation, Brain Damage and Hearing Loss in Infant Rat Pneumococcal Meningitis.
    Antimicrob Agents Chemother. 2019 May 6. pii: AAC.00220.
    >> Share

  547. ZHANG Y, Zhu H, Fu L, Wang B, et al
    Identifying regimens containing a new drug candidate TBI-166 against Mycobacterium tuberculosis in vitro and in vivo.
    Antimicrob Agents Chemother. 2019 May 6. pii: AAC.02496.
    >> Share

  548. AL-SHAER MH, Alghamdi WA, Alsultan A, An G, et al
    Fluoroquinolones in drug-resistant tuberculosis: culture conversion and pharmacokinetic/pharmacodynamic target attainment to guide dose selection.
    Antimicrob Agents Chemother. 2019 May 6. pii: AAC.00279.
    >> Share

    April 2019
  549. LEPAK AJ, Zhao M, Marchillo K, VanHecker J, et al
    In vivo Pharmacodynamics of Omadacycline against Staphylococcus aureus in the Neutropenic Murine Thigh Infection Model.
    Antimicrob Agents Chemother. 2019 Apr 29. pii: AAC.00624.
    >> Share

  550. VARGAS-CRUZ N, Reitzel RA, Rosenblatt J, Chaftari AM, et al
    Nitroglycerin-Citrate-Ethanol (NiCE) Catheter Lock Solution is Highly Effective for in vitro Eradication of Candida auris Biofilm.
    Antimicrob Agents Chemother. 2019 Apr 29. pii: AAC.00299.
    >> Share

  551. KASPAR JR, Godwin MJ, Velsko IM, Richards VP, et al
    Spontaneously Arising Streptococcus mutans Variants With Reduced Susceptibility to Chlorhexidine Display Genetic Defects and Diminished Fitness.
    Antimicrob Agents Chemother. 2019 Apr 29. pii: AAC.00161.
    >> Share

  552. DIAZ IGLESIAS Y, Wilms T, Vanbever R, Van Bambeke F, et al
    Activity of antibiotics against Staphylococcus aureus in an in vitro model of biofilms in the context of cystic fibrosis: influence of the culture medium.
    Antimicrob Agents Chemother. 2019 Apr 29. pii: AAC.00602.
    >> Share

  553. VAN DEN ELSEN SHJ, Sturkenboom MGG, Akkerman OW, Manika K, et al
    Limited sampling strategies using linear regression and the Bayesian approach for therapeutic drug monitoring of moxifloxacin in tuberculosis patients.
    Antimicrob Agents Chemother. 2019 Apr 22. pii: AAC.00384.
    >> Share

  554. GHODOUSI A, Tagliani E, Karunaratne E, Niemann S, et al
    Isoniazid resistance in Mycobacterium tuberculosis is a heterogeneous phenotype comprised of overlapping MIC distributions with different underlying resistance mechanisms.
    Antimicrob Agents Chemother. 2019 Apr 22. pii: AAC.00092.
    >> Share

  555. IACOBINO A, Giannoni F, Pardini M, Piccaro G, et al
    The combination rifampin-nitazoxanide, but not rifampin-isoniazid-pyrazinamide-ethambutol, kills dormant Mycobacterium tuberculosis in hypoxia at neutral pH.
    Antimicrob Agents Chemother. 2019 Apr 22. pii: AAC.00273.
    >> Share

  556. LUN S, Tasneen R, Chaira T, Stec J, et al
    Advancing the therapeutic potential of indoleamides for tuberculosis.
    Antimicrob Agents Chemother. 2019 Apr 22. pii: AAC.00343.
    >> Share

  557. ERSOY SC, Abdelhady W, Li L, Chambers HF, et al
    Bicarbonate Resensitization of Methicillin-Resistant Staphylococcus aureus to beta-Lactam Antibiotics.
    Antimicrob Agents Chemother. 2019 Apr 22. pii: AAC.00496.
    >> Share

  558. KIM D, Lee H, Yoon EJ, Hong JS, et al
    Clinical prognoses of patients with a bloodstream infection caused by ampicillin-susceptible but penicillin-resistant Enterococcus faecalis: prospective observational study.
    Antimicrob Agents Chemother. 2019 Apr 22. pii: AAC.00291.
    >> Share

  559. ADDETIA A, Greninger AL, Adler A, Yuan S, et al
    A novel, widespread qacA allele results in reduced chlorhexidine susceptibility in Staphylococcus epidermidis.
    Antimicrob Agents Chemother. 2019 Apr 15. pii: AAC.02607.
    >> Share

  560. LEE A, Prideaux B, Lee MH, Zimmerman M, et al
    Tissue distribution and penetration of isavuconazole at the site of infection in Experimental Invasive Aspergillosis in Mice with underlying Chronic Granulomatous Disease.
    Antimicrob Agents Chemother. 2019 Apr 15. pii: AAC.00524.
    >> Share

  561. LOISEAU C, Brites D, Moser I, Coll F, et al
    Revised interpretation of the Hain Lifescience GenoType MTBC to differentiate Mycobacterium canettii and members of the M. tuberculosis complex.
    Antimicrob Agents Chemother. 2019 Apr 8. pii: AAC.00159.
    >> Share

  562. KEBRIAEI R, Rice SA, Stamper KC, Seepersaud R, et al
    Daptomycin Dose-Ranging Evaluation with Single vs. Multi-Dose Ceftriaxone Combinations against Streptococcus mitis-oralis in an Ex Vivo Simulated Endocarditis Vegetation Model.
    Antimicrob Agents Chemother. 2019 Apr 8. pii: AAC.00386.
    >> Share

  563. BERUBE BJ, Russell D, Castro L, Choi SR, et al
    Novel MenA inhibitors are bactericidal against Mycobacterium tuberculosis and synergize with electron-transport chain inhibitors.
    Antimicrob Agents Chemother. 2019 Apr 8. pii: AAC.02661.
    >> Share

  564. RANJAN R, Srivastava A, Bharti R, Roy T, et al
    Preclinical development of inhalable D-cycloserine and ethionamide to overcome pharmacokinetic interaction and enhance efficacy against Mycobacterium tuberculosis.
    Antimicrob Agents Chemother. 2019 Apr 8. pii: AAC.00099.
    >> Share

  565. SIOPI M, Mouton J, Pournaras S, Meletiadis J, et al
    In vitro and in vivo exposure-effect relationship of liposomal amphotericin B against Aspergillus fumigatus.
    Antimicrob Agents Chemother. 2019 Apr 8. pii: AAC.02673.
    >> Share

  566. HUANG Y, Alumasa JN, Callaghan LT, Baugh RS, et al
    A Small-Molecule Inhibitor of trans-Translation Synergistically Interacts with Cathelicidin Antimicrobial Peptides To Impair Survival of Staphylococcus aureus.
    Antimicrob Agents Chemother. 2019;63.
    >> Share

  567. TETZ G, Collins M, Vikina D, Tetz V, et al
    In Vitro Activity of a Novel Antifungal Compound, MYC-053, against Clinically Significant Antifungal-Resistant Strains of Candida glabrata, Candida auris, Cryptococcus neoformans, and Pneumocystis spp.
    Antimicrob Agents Chemother. 2019;63.
    >> Share

  568. LI Y, Liu G, Zhai Z, Liu L, et al
    Erratum for Li et al., "Antibacterial Properties of Magnesium In Vitro and in an In Vivo Model of Implant-Associated Methicillin-Resistant Staphylococcus aureus Infection".
    Antimicrob Agents Chemother. 2019;63.
    >> Share

  569. ARASTEHFAR A, Daneshnia F, Zomorodian K, Najafzadeh MJ, et al
    Low level of antifungal resistance in Iranian isolates of Candida glabrata recovered from blood samples from multicenter (2015-2018): Potential prognostic values of genotyping and sequencing of PDR1.
    Antimicrob Agents Chemother. 2019 Apr 1. pii: AAC.02503.
    >> Share

  570. OH JT, Cassino C, Schuch R
    Postantibiotic and Sub-MIC Effects of Exebacase (Lysin CF-301) Enhance Antimicrobial Activity Against Staphylococcus aureus.
    Antimicrob Agents Chemother. 2019 Apr 1. pii: AAC.02616.
    >> Share

  571. AIGNER M, Wanner M, Kreidl P, Lass-Florl C, et al
    Candida in the respiratory tract potentially triggers galactomannan-positivity in non-haematological patients.
    Antimicrob Agents Chemother. 2019 Apr 1. pii: AAC.00138.
    >> Share

  572. SAINI V, Ammerman NC, Chang YS, Tasneen R, et al
    Treatment-shortening effect of a novel regimen combining high-dose rifapentine and clofazimine in pathologically distinct mouse models of tuberculosis.
    Antimicrob Agents Chemother. 2019 Apr 1. pii: AAC.00388.
    >> Share

    March 2019
  573. NISHIMOTO AT, Wiederhold NP, Flowers SA, Zhang Q, et al
    In vitro activities of the novel investigational tetrazoles VT-1161 and VT-1598 compared to the triazole antifungals against azole-resistant strains and clinical isolates of Candida albicans.
    Antimicrob Agents Chemother. 2019 Mar 25. pii: AAC.00341.
    >> Share

  574. PECK M, Rothenberg ME, Deng R, Lewin-Koh N, et al
    A phase 1, randomized, single ascending-dose study to investigate the safety, tolerability, and pharmacokinetics of DSTA4637S, an anti-Staphylococcus aureus THIOMAB antibody-antibiotic conjugate, in healthy volunteers.
    Antimicrob Agents Chemother. 2019 Mar 25. pii: AAC.02588.
    >> Share

  575. SEKAGGYA-WILTSHIRE C, Chirehwa M, Musaazi J, von Braun A, et al
    Low anti-tuberculosis drug concentrations in HIV-Tuberculosis co-infected adults with low body weight; is it time to update dosing guidelines?
    Antimicrob Agents Chemother. 2019 Mar 25. pii: AAC.02174.
    >> Share

  576. SEYEDMOUSAVI S, Chang Y, Law D, Birch M, et al
    Efficacy of olorofim (F901318) against Aspergillus fumigatus, A. nidulans, and A. tanneri in murine models of profound neutropenia and chronic granulomatous disease.
    Antimicrob Agents Chemother. 2019 Mar 18. pii: AAC.00129.
    >> Share

  577. SINGH KV, Murray BE
    Loss of a Major Enterococcal Polysaccharide Antigen (Epa) by Enterococcus faecalis is Associated with Increased Resistance to Ceftriaxone and Carbapenems.
    Antimicrob Agents Chemother. 2019 Mar 11. pii: AAC.00481.
    >> Share

  578. SHI W, Cui P, Niu H, Zhang S, et al
    Introducing RpsA Point Mutations Delta438A and D123A into the Chromosome of M. tuberculosis Confirms their Role in Causing Resistance to Pyrazinamide.
    Antimicrob Agents Chemother. 2019 Mar 11. pii: AAC.02681.
    >> Share

  579. ALGHAMDI WA, Alsultan A, Al-Shaer MH, An G, et al
    Cycloserine Population Pharmacokinetics and Pharmacodynamics in Patients with Tuberculosis.
    Antimicrob Agents Chemother. 2019 Mar 11. pii: AAC.00055.
    >> Share

  580. BUTTS A, Reitler P, Nishimoto AT, DeJarnette C, et al
    A systematic screen reveals a diverse collection of medications induce antifungal resistance in Candida species.
    Antimicrob Agents Chemother. 2019 Mar 11. pii: AAC.00054.
    >> Share

  581. GERIAK M, Haddad F, Rizvi K, Rose W, et al
    Clinical Data on Daptomycin Plus Ceftaroline Versus Standard of Care Monotherapy in the Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia.
    Antimicrob Agents Chemother. 2019 Mar 11. pii: AAC.02483.
    >> Share

  582. JANARDHANAN J, Bouley R, Martinez-Caballero S, Peng Z, et al
    The quinazolinone allosteric inhibitor of PBP2a synergizes with piperacillin and tazobactam against methicillin-resistant Staphylococcus aureus.
    Antimicrob Agents Chemother. 2019 Mar 11. pii: AAC.02637.
    >> Share

  583. XU J, Li SY, Almeida DV, Tasneen R, et al
    Contribution of pretomanid to novel regimens containing bedaquiline with either linezolid or moxifloxacin and pyrazinamide in murine models of tuberculosis.
    Antimicrob Agents Chemother. 2019 Mar 4. pii: AAC.00021.
    >> Share

  584. NISHIMOTO AT, Zhang Q, Hazlett B, Morschhauser J, et al
    The contribution of clinically-derived mutations in the gene encoding the zinc cluster transcription factor Mrr2 to fluconazole antifungal resistance and CDR1 expression in Candida albicans.
    Antimicrob Agents Chemother. 2019 Mar 4. pii: AAC.00078.
    >> Share

    February 2019
  585. NAKANO S, Fujisawa T, Ito Y, Chang B, et al
    Whole-genome sequencing analysis of multidrug-resistant serotype 15A Streptococcus pneumoniae in Japan and the emergence of a highly resistant serotype 15A-ST9084 clone.
    Antimicrob Agents Chemother. 2019 Feb 25. pii: AAC.02579.
    >> Share

  586. SARATHY J, Blanc L, Alvarez-Cabrera N, O'Brien P, et al
    Fluoroquinolone efficacy against tuberculosis is driven by penetration into lesions and activity against resident bacterial populations.
    Antimicrob Agents Chemother. 2019 Feb 25. pii: AAC.02516.
    >> Share

  587. BAINES SL, Jensen SO, Firth N, Goncalves da Silva A, et al
    Remodelling of pSK1 Family Plasmids and Enhanced Chlorhexidine Tolerance in a Dominant Hospital Lineage of Methicillin-Resistant Staphylococcus aureus.
    Antimicrob Agents Chemother. 2019 Feb 19. pii: AAC.02356.
    >> Share

  588. WARRILOW AG, Nishimoto AT, Parker JE, Price CL, et al
    The Evolution of Azole Resistance in Candida albicans Sterol 14alpha-Demethylase (CYP51) through Incremental Amino Acid Substitutions.
    Antimicrob Agents Chemother. 2019 Feb 19. pii: AAC.02586.
    >> Share

  589. GINGRAS H, Patron K, Bhattacharya A, Leprohon P, et al
    Gain and loss of function screens coupled to next generation sequencing for antibiotic mode of action and resistance studies in Streptococcus pneumoniae.
    Antimicrob Agents Chemother. 2019 Feb 19. pii: AAC.02381.
    >> Share

  590. DENEGA I, d'Enfert C, Bachellier-Bassi S
    Candida albicans biofilms are generally devoid of persister cells.
    Antimicrob Agents Chemother. 2019 Feb 19. pii: AAC.01979.
    >> Share

  591. XU J, Wang B, Fu L, Zhu H, et al
    In vitro and in vivo activities of the riminophenazine TBI-166 against Mycobacterium tuberculosis.
    Antimicrob Agents Chemother. 2019 Feb 19. pii: AAC.02155.
    >> Share

  592. LIESE J, Schule L, Oberhettinger P, Tschorner L, et al
    Expansion of Vancomycin-resistant Enterococcus faecium in an academic tertiary hospital in Southwest Germany: a large-scale whole genome-based outbreak investigation.
    Antimicrob Agents Chemother. 2019 Feb 19. pii: AAC.01978.
    >> Share

  593. VERREAULT D, Ennis J, Whaley K, Killeen SZ, et al
    Effective Treatment of Staphylococcal Enterotoxin B (SEB) Aerosol Intoxication in Rhesus Macaques using two parentally-administered High Affinity Monoclonal Antibodies.
    Antimicrob Agents Chemother. 2019 Feb 19. pii: AAC.02049.
    >> Share

  594. ROBERTSON GT, Ektnitphong VA, Scherman MS, McNeil MB, et al
    Efficacy and improved resistance potential of a cofactor-independent InhA inhibitor of Mycobacterium tuberculosis in a C3HeB/FeJ mouse model.
    Antimicrob Agents Chemother. 2019 Feb 11. pii: AAC.02071.
    >> Share

  595. KAUSHIK A, Ammerman NC, Tyagi S, Saini V, et al
    Activity of a long-acting injectable bedaquiline formulation in a paucibacillary mouse model of latent tuberculosis infection.
    Antimicrob Agents Chemother. 2019 Feb 11. pii: AAC.00007.
    >> Share

  596. GYGLI SM, Keller PM, Ballif M, Blochliger N, et al
    Whole genome sequencing for drug resistance profile prediction in Mycobacterium tuberculosis.
    Antimicrob Agents Chemother. 2019 Feb 4. pii: AAC.02175.
    >> Share

  597. ZHANG H, Liu S, Yue J, Sun S, et al
    In vitro antimicrobial activity of diacerein on 76 gram-positive cocci isolates from bacterial keratitis patients and an in vivo study of diacerein eye drops on Staphylococcus aureus keratitis in mice.
    Antimicrob Agents Chemother. 2019 Feb 4. pii: AAC.01874.
    >> Share

  598. PEE CJE, Pader V, Ledger EVK, Edwards AM, et al
    A FASII inhibitor prevents staphylococcal evasion of daptomycin by inhibiting phospholipid decoy production.
    Antimicrob Agents Chemother. 2019 Feb 4. pii: AAC.02105.
    >> Share

  599. HONG SI, Lee YM, Park KH, Ryu BH, et al
    Clinical and Molecular Characteristics of qacA/B-Positive Methicillin-resistant Staphylococcus aureus Causing Bloodstream Infections.
    Antimicrob Agents Chemother. 2019 Feb 4. pii: AAC.02157.
    >> Share

  600. PURI S, Kumar R, Rojas IG, Salvatori O, et al
    Iron Chelator Deferasirox Reduces Candida albicans Invasion of Oral Epithelial Cells and Infection Levels in Murine Oropharyngeal Candidiasis.
    Antimicrob Agents Chemother. 2019 Feb 4. pii: AAC.02152.
    >> Share

  601. RYBAK JM, Doorley LA, Nishimoto AT, Barker KS, et al
    Abrogation of triazole resistance upon deletion of CDR1 in a clinical isolate of Candida auris.
    Antimicrob Agents Chemother. 2019 Feb 4. pii: AAC.00057.
    >> Share

  602. KINNEAR CL, Patel TS, Young CL, Marshall V, et al
    Impact of an antimicrobial stewardship intervention on within and between patient daptomycin resistance evolution in vancomycin-resistant Enterococcus faecium.
    Antimicrob Agents Chemother. 2019 Feb 4. pii: AAC.01800.
    >> Share

  603. SAVAGE KA, Parquet MDC, Allan DS, Davidson RJ, et al
    Erratum for Savage et al., "Iron Restriction to Clinical Isolates of Candida albicans by the Novel Chelator DIBI Inhibits Growth and Increases Sensitivity to Azoles In Vitro and In Vivo in a Murine Model of Experimental Vaginitis".
    Antimicrob Agents Chemother. 2019;63.
    >> Share

    January 2019
  604. MENG L, Zhao H, Zhao S, Sun X, et al
    Inhibition of yeast-to-hypha transition and virulence of Candida albicans by 2-alkylaminoquinoline derivatives.
    Antimicrob Agents Chemother. 2019 Jan 22. pii: AAC.01891.
    >> Share

  605. KEBRIAEI R, Rice SA, Stamper KC, Rybak MJ, et al
    Dalbavancin Alone and in Combination with Ceftaroline against Four Different Phenotypes of Staphylococcus aureus in a PK/PD Model.
    Antimicrob Agents Chemother. 2019 Jan 22. pii: AAC.01743.
    >> Share

  606. SINGH KV, Arias CA, Murray BE
    Efficacy of Tedizolid Against Enterococci and Staphylococci, including cfr+ strains, in a Mouse Peritonitis Model.
    Antimicrob Agents Chemother. 2019 Jan 22. pii: AAC.02627.
    >> Share

  607. INDIANI C, Sauve K, Raz A, Abdelhady W, et al
    The Anti-Staphylococcal Lysin, CF-301, Activates Key Host Factors in Human Blood to Potentiate MRSA Bacteriolysis.
    Antimicrob Agents Chemother. 2019 Jan 22. pii: AAC.02291.
    >> Share

  608. ZHAO M, Lepak AJ, Marchillo K, Vanhecker J, et al
    APX001 Pharmacokinetic/Pharmacodynamic Target Determination against Aspergillus fumigatus in an in vivo Model of Invasive Pulmonary Aspergillosis.
    Antimicrob Agents Chemother. 2019 Jan 22. pii: AAC.02372.
    >> Share

  609. O'DONNELL MR, Larsen MH, Brown TS, Jain P, et al
    Early detection of emergent extensively drug resistant tuberculosis (XDR-TB) by flow cytometry-based phenotyping and whole genome sequencing.
    Antimicrob Agents Chemother. 2019 Jan 22. pii: AAC.01834.
    >> Share

  610. GARCIA-PRATS AJ, Purchase SE, Osman M, Draper HR, et al
    Pharmacokinetics, safety, and dosing of novel pediatric levofloxacin dispersible tablets in children with multidrug-resistant tuberculosis exposure.
    Antimicrob Agents Chemother. 2019 Jan 22. pii: AAC.01865.
    >> Share

  611. BAE JY, Jun KI, Kang CK, Song KH, et al
    The Efficacy of Intranasal Administration of the Recombinant Endolysin, SAL200, in a Lethal Murine Staphylococcus aureus Pneumonia Model.
    Antimicrob Agents Chemother. 2019 Jan 22. pii: AAC.02009.
    >> Share

  612. RUIZ P, Causse M, Vaquero M, Casal M, et al
    In vitro activity of Tedizolid against Mycobacterium tuberculosis.
    Antimicrob Agents Chemother. 2019 Jan 22. pii: AAC.01939.
    >> Share

  613. MARSHALL AC, Kidd SE, Lamont-Friedrich SJ, Arentz G, et al
    Aspergillus fumigatus thioredoxin reductase: structure, mechanism, and inhibition.
    Antimicrob Agents Chemother. 2019 Jan 14. pii: AAC.02281.
    >> Share

  614. JIANG JH, Dexter C, Cameron DR, Monk IR, et al
    Evolution of daptomycin resistance in coagulase negative staphylococci involves mutations of the essential two component regulator WalKR.
    Antimicrob Agents Chemother. 2019 Jan 7. pii: AAC.01926.
    >> Share

  615. DILWORTH TJ, Casapao AM, Ibrahim OM, Jacobs DM, et al
    Adjuvant beta-lactam therapy combined with vancomycin for methicillin-resistant Staphylococcus aureus (MRSA) bacteremia: Does beta-lactam class matter?
    Antimicrob Agents Chemother. 2019 Jan 7. pii: AAC.02211.
    >> Share

  616. WASSERMAN S, Denti P, Brust JCM, Tareq M, et al
    Linezolid pharmacokinetics in South African patients with drug resistant tuberculosis and a high prevalence of HIV co-infection.
    Antimicrob Agents Chemother. 2019 Jan 7. pii: AAC.02164.
    >> Share

  617. GHAJAVAND H, Kargarpour Kamakoli M, Khanipour S, Pourazar Dizaji S, et al
    High Prevalence of Bedaquiline Resistance in Treatment-naive Tuberculosis Patients and Verapamil Effectiveness.
    Antimicrob Agents Chemother. 2019 Jan 2. pii: AAC.02530.
    >> Share

  618. CHOULES MP, Wolf NM, Lee H, Anderson JR, et al
    Rufomycin Targets ClpC1 Proteolysis in Mycobacterium tuberculosis and M. abscessus.
    Antimicrob Agents Chemother. 2019 Jan 2. pii: AAC.02204.
    >> Share

  619. KHALIL ZG, Hill TA, De Leon Rodriguez LM, Lohman RJ, et al
    Structure-activity relationships of wollamide cyclic hexapeptides with activity against drug-resistant and intracellular Mycobacterium tuberculosis.
    Antimicrob Agents Chemother. 2019 Jan 2. pii: AAC.01773.
    >> Share

    December 2018
  620. BORDALLO-CARDONA MA, Sanchez-Carrillo C, Bouza E, Munoz P, et al
    Detection of echinocandin-resistant Candida glabrata in blood cultures spiked with different percentages of FKS2 mutants.
    Antimicrob Agents Chemother. 2018 Dec 17. pii: AAC.02004.
    >> Share

  621. MENETREY A, Janin A, Pullman J, Overcash JS, et al
    Bone and Joint Tissues Penetration of the Staphylococcus-Selective Antibiotic Afabicin in Patients Undergoing Elective Hip Replacement Surgery.
    Antimicrob Agents Chemother. 2018 Dec 17. pii: AAC.01669.
    >> Share

  622. HEIDARI A, Quinlan M, Benjamin DJ, Laurence B, et al
    Isavuconazole in the Treatment of Coccidioidal Meningitis.
    Antimicrob Agents Chemother. 2018 Dec 17. pii: AAC.02232.
    >> Share

  623. WIEDERHOLD NP, Lockhart SR, Najvar LK, Berkow EL, et al
    The Fungal Cyp51 Specific Inhibitor VT-1598 Demonstrates In vitro and In vivo Activity against Candida auris.
    Antimicrob Agents Chemother. 2018 Dec 10. pii: AAC.02233.
    >> Share

  624. ANDREONI F, Toyofuku M, Menzi C, Kalawong R, et al
    Antibiotics stimulate vesicles formation in Staphylococcus aureus in a phage-dependent and independent fashion and via different routes.
    Antimicrob Agents Chemother. 2018 Dec 3. pii: AAC.01439.
    >> Share

  625. KOHLHOFF SA, Huerta N, Hammerschlag MR
    In vitro activity of Omadacycline against Chlamydia pneumoniae.
    Antimicrob Agents Chemother. 2018 Dec 3. pii: AAC.01907.
    >> Share

  626. MATSUO M, Hiramatsu M, Singh M, Sasaki T, et al
    Genetic and transcriptomic analyses of ciprofloxacin-tolerant Staphylococcus aureus isolated by the Replica Plating Tolerance Isolation System (REPTIS).
    Antimicrob Agents Chemother. 2018 Dec 3. pii: AAC.02019.
    >> Share

  627. STOTT KE, Beardsley J, Kolamunnage-Dona R, Castelazo AS, et al
    Correction for Stott et al., "Population Pharmacokinetics and Cerebrospinal Fluid Penetration of Fluconazole in Adults with Cryptococcal Meningitis".
    Antimicrob Agents Chemother. 2018;62.
    >> Share

  628. STOTT KE, Beardsley J, Whalley S, Mukasa Kibengo F, et al
    Correction for Stott et al., "Population Pharmacokinetic Model and Meta-analysis of Outcomes of Amphotericin B Deoxycholate Use in Adults with Cryptococcal Meningitis".
    Antimicrob Agents Chemother. 2018;62.
    >> Share

    November 2018
  629. BARBER AE, Weber M, Kaerger K, Linde J, et al
    Comparative genomics of serial Candida glabrata isolates and the rapid acquisition of echinocandin resistance during therapy.
    Antimicrob Agents Chemother. 2018 Nov 26. pii: AAC.01628.
    >> Share

  630. AHMAD S, Joseph L, Parker JE, Asadzadeh M, et al
    ERG6 and ERG2 are major targets conferring reduced susceptibility to amphotericin B in clinical Candida glabrata isolates in Kuwait.
    Antimicrob Agents Chemother. 2018 Nov 19. pii: AAC.01900.
    >> Share

  631. WURSTER S, Lewis RE, Albert ND, Kontoyiannis DP, et al
    Pre-Exposure to Isavuconazole Increases the Virulence of Mucorales but not Aspergillus fumigatus in a Drosophila melanogaster Infection Model.
    Antimicrob Agents Chemother. 2018 Nov 19. pii: AAC.01896.
    >> Share

  632. SCHMIDT S, Schubert R, Tramsen L, Lehrnbecher T, et al
    Impact of Antifungal Compounds on Viability and Anti-Aspergillus Activity of Human Natural Killer Cells.
    Antimicrob Agents Chemother. 2018 Nov 19. pii: AAC.01993.
    >> Share

  633. GEBREMARIAM T, Alkhazraji S, Alqarihi A, Jeon HH, et al
    APX001 is Effective in the Treatment of Murine Invasive Pulmonary Aspergillosis.
    Antimicrob Agents Chemother. 2018 Nov 19. pii: AAC.01713.
    >> Share

  634. DEKKERS BGJ, Akkerman OW, Alffenaar JWC
    The role of therapeutic drug monitoring in treatment optimization in tuberculosis and diabetes mellitus co-morbidity.
    Antimicrob Agents Chemother. 2018 Nov 19. pii: AAC.02074.
    >> Share

  635. VAN RIJN SP, Zuur MA, Anthony R, Wilffert B, et al
    Evaluation of carbapenems for multi/extensive-drug resistant Mycobacterium tuberculosis treatment.
    Antimicrob Agents Chemother. 2018 Nov 19. pii: AAC.01489.
    >> Share

  636. MATSUO M, Yamamoto N, Hishinuma T, Hiramatsu K, et al
    Identification of a novel gene associated with high-level beta-lactam resistance in heterogeneous vancomycin-intermediate Staphylococcus aureus strain Mu3 and methicillin-resistant S. aureus strain N315.
    Antimicrob Agents Chemother. 2018 Nov 19. pii: AAC.00712.
    >> Share

  637. ZIMMERLI W, Sendi P
    The Role of Rifampin against Staphylococcal Biofilm Infections in Vitro, in Animal Models, and in Orthopedic Device-Related Infections.
    Antimicrob Agents Chemother. 2018 Nov 19. pii: AAC.01746.
    >> Share

  638. ANDRES S, Groschel MI, Hillemann D, Merker M, et al
    A diagnostic algorithm to investigate pyrazinamide and ethambutol resistance in rifampicin resistant Mycobacterium tuberculosis isolates in a low incidence setting.
    Antimicrob Agents Chemother. 2018 Nov 19. pii: AAC.01798.
    >> Share

  639. PERSYN A, Rogiers O, Brock M, Vande Velde G, et al
    Monitoring of fluconazole and caspofungin activity against in vivo Candida glabrata biofilms by bioluminescence imaging.
    Antimicrob Agents Chemother. 2018 Nov 12. pii: AAC.01555.
    >> Share

  640. CHOJNACKI M, Philbrick A, Wucher B, Reed JN, et al
    Development of a broad-spectrum antimicrobial combination for the treatment of Staphylococcus aureus and Pseudomonas aeruginosa corneal infections.
    Antimicrob Agents Chemother. 2018 Nov 12. pii: AAC.01929.
    >> Share

  641. GREGOIRE M, Gaborit B, Deschanvres C, Lecomte R, et al
    High-dosage cefazolin achieves sufficient cerebrospinal diffusion to treat an external ventricular drainage-related Staphylococcus aureus ventriculitis.
    Antimicrob Agents Chemother. 2018 Nov 12. pii: AAC.01844.
    >> Share

  642. MEIKLE V, Mossberg AK, Mitra A, Hakansson AP, et al
    A protein complex from human milk enhances the activity of antibiotics and drugs against Mycobacterium tuberculosis.
    Antimicrob Agents Chemother. 2018 Nov 12. pii: AAC.01846.
    >> Share

  643. MACDONALD D, Thomson DD, Johns A, Contreras Valenzuela A, et al
    Inducible cell fusion permits use of competitive fitness profiling in the human pathogenic fungus Aspergillus fumigatus.
    Antimicrob Agents Chemother. 2018 Nov 5. pii: AAC.01615.
    >> Share

  644. BORDALLO-CARDONA MA, Agnelli C, Gomez-Nunez A, Sanchez-Carrillo C, et al
    MSH2 gene point mutations are not antifungal resistance markers in Candida glabrata.
    Antimicrob Agents Chemother. 2018 Nov 5. pii: AAC.01876.
    >> Share

  645. CHOI MJ, Won EJ, Joo MY, Park YJ, et al
    Emergence of Voriconazole-resistant Aspergillus flavus Isolates in Korean Hospitals: Microsatellite Typing and Resistance Mechanism Analysis.
    Antimicrob Agents Chemother. 2018 Nov 5. pii: AAC.01610.
    >> Share

  646. DE MIRANDA SILVA C, Hajihosseini A, Myrick J, Nole J, et al
    Effect of Moxifloxacin plus Pretomanid against Mycobacterium tuberculosis in Log-phase, Acid-phase and Non-Replicating-Persister (NRP)-phase in an in vitro Assay.
    Antimicrob Agents Chemother. 2018 Nov 5. pii: AAC.01695.
    >> Share

  647. BARROS EM, Martin MJ, Selleck EM, Lebreton F, et al
    Daptomycin resistance and tolerance due to loss-of-function in Staphylococcus aureus dsp1 and asp23.
    Antimicrob Agents Chemother. 2018 Nov 5. pii: AAC.01542.
    >> Share

  648. HOU X, Lee A, Jimenez-Ortigosa C, Kordalewska M, et al
    Rapid Detection of ERG11-Associated Azole Resistance and FKS-Associated Echinocandin Resistance in Candida auris.
    Antimicrob Agents Chemother. 2018 Nov 5. pii: AAC.01811.
    >> Share

  649. PICCINELLI G, Fernandes P, Bonfanti C, Caccuri F, et al
    Erratum for Piccinelli et al., "In Vitro Activity of Solithromycin against Erythromycin-Resistant Streptococcus agalactiae".
    Antimicrob Agents Chemother. 2018;62.
    >> Share

  650. GOMEZ-SANZ E, Schwendener S, Thomann A, Gobeli Brawand S, et al
    Correction for Gomez-Sanz et al., "First Staphylococcal Cassette Chromosome mec Containing a mecB-Carrying Gene Complex Independent of Transposon Tn6045 in a Macrococcus caseolyticus Isolate from a Canine Infection".
    Antimicrob Agents Chemother. 2018;62.
    >> Share

  651. VILCHEZE C, Jacobs WR Jr
    Reply to Yew et al., "Vitamin C and Mycobacterium tuberculosis Persisters".
    Antimicrob Agents Chemother. 2018;62.
    >> Share

  652. YEW WW, Chang KC, Leung CC, Chan DP, et al
    Vitamin C and Mycobacterium tuberculosis Persisters.
    Antimicrob Agents Chemother. 2018;62.
    >> Share

    October 2018
  653. RAFFAI T, Burian K, Janovak L, Bogdanov A, et al
    Vaginal gel component hydroxyethyl cellulose significantly enhances the infectivity of Chlamydia trachomatis serovars D and E.
    Antimicrob Agents Chemother. 2018 Oct 29. pii: AAC.02034.
    >> Share

  654. VAN DEN ELSEN SHJ, Sturkenboom MGG, van 't Boveneind-Vrubleuskaya N, Skrahina A, et al
    Population pharmacokinetic model and limited sampling strategies for personalized dosing of levofloxacin in tuberculosis patients.
    Antimicrob Agents Chemother. 2018 Oct 29. pii: AAC.01092.
    >> Share

  655. SHIELDS RK, Kline EG, Healey KR, Kordalewska M, et al
    Spontaneous mutational frequency and FKS mutation rates vary by echinocandin agent against Candida glabrata.
    Antimicrob Agents Chemother. 2018 Oct 29. pii: AAC.01692.
    >> Share

  656. ANDES DR, Ghannoum MA, Mukherjee PK, Kovanda LL, et al
    Outcomes by Minimum Inhibitory Concentrations for Patients Treated with Isavuconazole or Voriconazole for Invasive Aspergillosis in the Phase 3 SECURE and VITAL Trials.
    Antimicrob Agents Chemother. 2018 Oct 29. pii: AAC.01634.
    >> Share

  657. CAVALHEIRO M, Costa C, Silva-Dias A, Miranda IM, et al
    Unveiling the mechanisms of in vitro evolution towards fluconazole resistance of a Candida glabrata clinical isolate: a transcriptomics approach.
    Antimicrob Agents Chemother. 2018 Oct 22. pii: AAC.00995.
    >> Share

  658. TANABE K, Bonus M, Tomiyama S, Miyoshi K, et al
    FK506 resistance of Saccharomyces cerevisiae Pdr5 and Candida albicans Cdr1 involves mutations in the transmembrane domains and extracellular loops.
    Antimicrob Agents Chemother. 2018 Oct 22. pii: AAC.01146.
    >> Share

  659. LUNA-TAPIA A, Butts A, Palmer GE
    Loss of C-5 sterol desaturase activity in Candida albicans - azole resistance or merely trailing growth?
    Antimicrob Agents Chemother. 2018 Oct 15. pii: AAC.01337.
    >> Share

  660. MELIEF E, Bonnett SA, Zuniga ES, Parish T, et al
    Activation of 2,4-diaminoquinazoline in Mycobacterium tuberculosis by Rv3161c, a putative dioxygenase.
    Antimicrob Agents Chemother. 2018 Oct 15. pii: AAC.01505.
    >> Share

  661. RYBNIKER J, Andreas Kohl T, Barilar I, Niemann S, et al
    No evidence for acquired mutations associated with cytochrome bc 1-inhibitor resistance in 13,559 clinical Mycobacterium tuberculosis complex isolates.
    Antimicrob Agents Chemother. 2018 Oct 15. pii: AAC.01317.
    >> Share

  662. ESPINEL-INGROFF A, Turnidge J, Alastruey-Izquierdo A, Botterel F, et al
    Method-dependent epidemiological cutoff values (ECVs) for detection of triazole resistance in Candida and Aspergillus species for the SYO colorimetric broth and Etest agar diffusion methods.
    Antimicrob Agents Chemother. 2018 Oct 15. pii: AAC.01651.
    >> Share

  663. GLAMPEDAKIS E, Coste AT, Aruanno M, Bachmann D, et al
    Efficacy of antifungal monotherapies and combinations against Aspergillus calidoustus.
    Antimicrob Agents Chemother. 2018 Oct 15. pii: AAC.01137.
    >> Share

  664. ROUARD C, Garnier F, Leraut J, Lepainteur M, et al
    Emergence and within-host genetic evolution of methicillin-resistant Staphylococcus aureus resistant to linezolid in a cystic fibrosis patient.
    Antimicrob Agents Chemother. 2018 Oct 1. pii: AAC.00720.
    >> Share

    September 2018
  665. DOAN TN, Cao P, Emeto TI, McCaw JM, et al
    Predicting the Outcomes of New Short-Course Regimens for Multi-Drug Resistant Tuberculosis Using Intrahost and Pharmacokinetic-Pharmacodynamic Modelling.
    Antimicrob Agents Chemother. 2018 Sep 24. pii: AAC.01487.
    >> Share

  666. LOUIE A, Duncanson B, Myrick J, Maynard M, et al
    The Activity of Moxifloxacin against Acid-Phase and Non-Replicative Persister Phenotype Phase Mycobacterium tuberculosis in a Hollow Fiber Infection Model.
    Antimicrob Agents Chemother. 2018 Sep 24. pii: AAC.01470.
    >> Share

  667. SAMPAIO ADG, Gontijo AVL, Araujo HM, Koga-Ito CY, et al
    In vivo efficacy of ellagic acid against Candida albicans in a Drosophila melanogaster infection model.
    Antimicrob Agents Chemother. 2018 Sep 24. pii: AAC.01716.
    >> Share

  668. PADILLA E, Oms L, Espejo E, Gomez L, et al
    Rifampin resistance in staphylococci after rifaximin intake for surgical prophylaxis in elective colorectal surgery.
    Antimicrob Agents Chemother. 2018 Sep 24. pii: AAC.01353.
    >> Share

  669. RAMIREZ-ZAVALA B, Manz H, Englert F, Rogers PD, et al
    A hyperactive form of the zinc cluster transcription factor Stb5 causes YOR1 overexpression and beauvericin resistance in Candida albicans.
    Antimicrob Agents Chemother. 2018 Sep 24. pii: AAC.01655.
    >> Share

  670. TAN D, Htun HL, Koh J, Kanagasabai K, et al
    Comparative epidemiology of vancomycin-resistant enterococci colonization in an acute care hospital and its affiliated intermediate- and long-term care facilities in Singapore.
    Antimicrob Agents Chemother. 2018 Sep 17. pii: AAC.01507.
    >> Share

  671. DIAN S, Yunivita V, Ganiem AR, Pramaesya T, et al
    A double-blinded randomised placebo-controlled phase II trial to evaluate high dose rifampicin for tuberculous meningitis: a dose finding study.
    Antimicrob Agents Chemother. 2018 Sep 17. pii: AAC.01014.
    >> Share

  672. AURITI C, Ronchetti MP, Bersani I, Gennari F, et al
    Intrahepatic Administration of Amphotericin B Liposomal (Ambisome(R)) for the Management of a Liver Abscess from Candida albicans in a preterm infant.
    Antimicrob Agents Chemother. 2018 Sep 17. pii: AAC.01239.
    >> Share

  673. GUEST JM, Singh PK, Revankar SG, Chandrasekar PH, et al
    Isavuconazole for treatment of experimental fungal endophthalmitis caused by Aspergillus fumigatus.
    Antimicrob Agents Chemother. 2018 Sep 10. pii: AAC.01537.
    >> Share

  674. LEPAK AJ, Zhao M, Andes DR
    Pharmacodynamic Evaluation of Rezafungin (CD101) Against Candida auris in the Neutropenic Mouse Invasive Candidiasis Model.
    Antimicrob Agents Chemother. 2018 Sep 4. pii: AAC.01572.
    >> Share

  675. DOMON H, Maekawa T, Yonezawa D, Nagai K, et al
    Mechanism of macrolide-induced inhibition of pneumolysin release involves impairment of autolysin release in macrolide-resistant Streptococcus pneumoniae.
    Antimicrob Agents Chemother. 2018 Sep 4. pii: AAC.00161.
    >> Share

    August 2018
  676. CARTER GP, Ussher JE, Goncalves Da Silva A, Baines SL, et al
    Genomic analysis of multi-resistant Staphylococcus capitis associated with neonatal sepsis.
    Antimicrob Agents Chemother. 2018 Aug 27. pii: AAC.00898.
    >> Share

  677. MILLER WR, Singh KV, Arias CA, Murray BE, et al
    Adjunctive Clavulanic Acid Abolishes the Cefazolin Inoculum Effect in an Experimental Rat Model of Methicillin-Sensitive Staphylococcus aureus Endocarditis.
    Antimicrob Agents Chemother. 2018 Aug 27. pii: AAC.01158.
    >> Share

  678. ROUARD C, Doucet-Populaire F, Guillet-Caruba C, Villet M, et al
    Deletion of one 23S rDNA (rrl) copy contributes to the development of resistance to linezolid in Staphylococcus warneri.
    Antimicrob Agents Chemother. 2018 Aug 20. pii: AAC.01139.
    >> Share

  679. KENIYA MV, Sabherwal M, Wilson RK, Woods MA, et al
    Crystal structures of full-length lanosterol 14alpha-demethylases of prominent fungal pathogens Candida albicans and Candida glabrata provide tools for antifungal discovery.
    Antimicrob Agents Chemother. 2018 Aug 20. pii: AAC.01134.
    >> Share

  680. UKAI Y, Kuroiwa M, Kurihara N, Naruse H, et al
    Contributions of yap1 mutation and subsequent atrF upregulation to voriconazole resistance in Aspergillus flavus.
    Antimicrob Agents Chemother. 2018 Aug 20. pii: AAC.01216.
    >> Share

  681. KENIYA MV, Ruma YN, Tyndall JDA, Monk BC, et al
    Heterologous expression of full-length lanosterol 14alpha-demethylases of prominent fungal pathogens Candida albicans and Candida glabrata provides tools for antifungal discovery.
    Antimicrob Agents Chemother. 2018 Aug 20. pii: AAC.01131.
    >> Share

  682. CAO R, Teskey G, Islamoglu H, Abrahem R, et al
    Characterizing the Effects of Glutathione as an Immunoadjuvant in the Treatment of Tuberculosis.
    Antimicrob Agents Chemother. 2018 Aug 20. pii: AAC.01132.
    >> Share

  683. PAUL RA, Rudramurthy SM, Dhaliwal M, Singh P, et al
    Voriconazole resistance in clinical and environmental isolates of Aspergillus flavus - frequency and investigation into the role of multidrug efflux pumps.
    Antimicrob Agents Chemother. 2018 Aug 20. pii: AAC.01022.
    >> Share

  684. ALFARISI O, Mave V, Gaikwad S, Sahasrabudhe T, et al
    The effect of diabetes mellitus on the pharmacokinetics and pharmacodynamics of tuberculosis treatment.
    Antimicrob Agents Chemother. 2018 Aug 20. pii: AAC.01383.
    >> Share

  685. LUPIEN A, Vocat A, Foo CS, Blattes E, et al
    An optimized background regimen for treatment of active tuberculosis with the next-generation benzothiazinone Macozinone (PBTZ169).
    Antimicrob Agents Chemother. 2018 Aug 20. pii: AAC.00840.
    >> Share

  686. WIEDERHOLD NP, Xu X, Wang A, Najvar LK, et al
    In Vivo Efficacy of VT-1129 against Experimental Cryptococcal Meningitis with the Use of a Loading Dose-Maintenance Dose Administration Strategy.
    Antimicrob Agents Chemother. 2018 Aug 13. pii: AAC.01315.
    >> Share

  687. WALL G, Chaturvedi AK, Wormley FL Jr, Wiederhold NP, et al
    Screening a Repurposing Library for Inhibitors of Multi-Drug Resistant Candida auris Identifies Ebselen as a Repositionable Candidate for Antifungal Drug Development.
    Antimicrob Agents Chemother. 2018 Aug 13. pii: AAC.01084.
    >> Share

  688. HO K, Huo W, Pas S, Dao R, et al
    Loss of function mutations in epaR confer resistance to phage NPV1 infection in Enterococcus faecalis OG1RF.
    Antimicrob Agents Chemother. 2018 Aug 13. pii: AAC.00758.
    >> Share

  689. KANDLER JL, Mercante AD, Dalton TL, Ezewudo MN, et al
    Validation of novel Mycobacterium tuberculosis isoniazid resistance mutations not detectable by common molecular tests.
    Antimicrob Agents Chemother. 2018 Aug 6. pii: AAC.00974.
    >> Share

  690. ISLA G, Leonardelli F, Tiraboschi IN, Refojo N, et al
    First clinical isolation of an azole-resistant Aspergillus fumigatus harboring a TR46/Y121F/T289A mutation in South America.
    Antimicrob Agents Chemother. 2018 Aug 6. pii: AAC.00872.
    >> Share

  691. HEALEY KR, Kordalewska M, Jimenez Ortigosa C, Singh A, et al
    Limited ERG11 mutations identified in isolates of Candida auris directly contribute to reduced azole susceptibility.
    Antimicrob Agents Chemother. 2018 Aug 6. pii: AAC.01427.
    >> Share

  692. KOSER CU, Heyckendorf J, Andres S, Olaru ID, et al
    Reply to Dookie et al., "Whole-Genome Sequencing To Guide the Selection of Treatment for Drug-Resistant Tuberculosis".
    Antimicrob Agents Chemother. 2018;62.
    >> Share

  693. DOOKIE N, Naidoo K, Padayatchi N
    Whole-Genome Sequencing To Guide the Selection of Treatment for Drug-Resistant Tuberculosis.
    Antimicrob Agents Chemother. 2018;62.
    >> Share

    July 2018
  694. JAGIELSKI T, Bakula Z, Brzostek A, Minias A, et al
    Characterization of mutations conferring resistance to rifampicin in Mycobacterium tuberculosis clinical strains.
    Antimicrob Agents Chemother. 2018 Jul 30. pii: AAC.01093.
    >> Share

  695. WEIKUM J, Ritzmann N, Jelden N, Klockner A, et al
    Sulfide protects Staphylococcus aureus from aminoglycoside antibiotics but cannot be regarded as a general defense mechanism against antibiotics.
    Antimicrob Agents Chemother. 2018 Jul 30. pii: AAC.00602.
    >> Share

  696. KIM NH, Park WB, Cho JE, Choi YJ, et al
    Effects of phage endolysin SAL200 combined with antibiotics on Staphylococcus aureus infection.
    Antimicrob Agents Chemother. 2018 Jul 23. pii: AAC.00731.
    >> Share

  697. RAZ A, Serrano A, Thaker M, Alston T, et al
    Lysostaphin lysibody leads to effective opsonization and killing of methicillin resistant Staphylococcus aureus in a murine model.
    Antimicrob Agents Chemother. 2018 Jul 23. pii: AAC.01056.
    >> Share

  698. WHALEY SG, Zhang Q, Caudle KE, Rogers PD, et al
    Relative Contribution of the ABC Transporters Cdr1, Pdh1, and Snq2 to Azole Resistance in Candida glabrata.
    Antimicrob Agents Chemother. 2018 Jul 23. pii: AAC.01070.
    >> Share

  699. PELOQUIN CA, Phillips PPJ, Mitnick CD, Eisenach K, et al
    Increased Doses Lead to Higher Drug Exposures of Levofloxacin for the Treatment of Tuberculosis.
    Antimicrob Agents Chemother. 2018 Jul 16. pii: AAC.00770.
    >> Share

  700. ZHAO Y, Lee MH, Paderu P, Lee A, et al
    Significantly improved pharmacokinetics enhances in vivo efficacy of APX001 against echinocandin and multidrug resistant Candida isolates in a mouse model of invasive candidiasis.
    Antimicrob Agents Chemother. 2018 Jul 16. pii: AAC.00425.
    >> Share

  701. YAN Q, Karau MJ, Raval YS, Patel R, et al
    Evaluation of Oritavancin in Combination with Rifampin, Gentamicin or Linezolid Against Prosthetic Joint Infection-Associated Methicillin-Resistant Staphylococcus aureus Biofilms by Time-Kill Assays.
    Antimicrob Agents Chemother. 2018 Jul 16. pii: AAC.00943.
    >> Share

  702. KANWAR A, Cadnum JL, Jencson AL, Donskey CJ, et al
    Impact of Antibiotic Treatment on the Burden of Nasal Staphylococcus aureus Among Hospitalized Patients.
    Antimicrob Agents Chemother. 2018 Jul 16. pii: AAC.00609.
    >> Share

  703. KIDD JM, Abdelraouf K, Asempa TE, Humphries RM, et al
    Pharmacodynamics of Daptomycin Against Enterococcus faecium and Enterococcus faecalis in the Murine Thigh Infection Model.
    Antimicrob Agents Chemother. 2018 Jul 16. pii: AAC.00506.
    >> Share

  704. PITON J, Vocat A, Lupien A, Foo C, et al
    Structure-based drug design and characterization of sulfonyl-piperazine benzothiazinone inhibitors of DprE1 from Mycobacterium tuberculosis.
    Antimicrob Agents Chemother. 2018 Jul 16. pii: AAC.00681.
    >> Share

  705. PIETERMAN ED, Te Brake LHM, de Knegt GJ, van der Meijden A, et al
    Assessment of the additional value of verapamil to a moxifloxacin and linezolid combination regimen in a murine tuberculosis model.
    Antimicrob Agents Chemother. 2018 Jul 9. pii: AAC.01354.
    >> Share

  706. WIEDERHOLD NP, Najvar LK, Garvey EP, Brand SR, et al
    The Fungal Cyp-51 Inhibitor VT-1129 is Efficacious in an Experimental Model of Cryptococcal Meningitis.
    Antimicrob Agents Chemother. 2018 Jul 9. pii: AAC.01071.
    >> Share

  707. HOYER AR, Johnson CJ, Hoyer MR, Kernien JF, et al
    Echinocandin treatment of Candida albicans biofilms enhances neutrophil extracellular trap (NET) formation.
    Antimicrob Agents Chemother. 2018 Jul 9. pii: AAC.00797.
    >> Share

  708. AGUILAR-PEREZ C, Gracia B, Rodrigues L, Vitoria A, et al
    Synergy between circular bacteriocin AS-48 and ethambutol against Mycobacterium tuberculosis.
    Antimicrob Agents Chemother. 2018 Jul 9. pii: AAC.00359.
    >> Share

  709. DANION F, Jullien V, Rouzaud C, Abdel Fattah M, et al
    Is it time for systematic voriconazole pharmacogenomic investigation for central nervous system aspergillosis?
    Antimicrob Agents Chemother. 2018 Jul 2. pii: AAC.00705.
    >> Share

  710. PARDOS DE LA GANDARA M, Borges V, Chung M, Milheirico C, et al
    Correction for Pardos de la Gandara et al., "Genetic Determinants of High-Level Oxacillin Resistance in Methicillin-Resistant Staphylococcus aureus".
    Antimicrob Agents Chemother. 2018;62.
    >> Share

    June 2018
  711. TAJ-ALDEEN SJ, Salah H, Perez WB, Almaslamani M, et al
    Molecular analysis of resistance and detection of non-wild type strains using ECV values of Etest for amphotericin B and echinocandins for bloodstream Candida infections from a tertiary hospital in Qatar.
    Antimicrob Agents Chemother. 2018 Jun 25. pii: AAC.00214.
    >> Share

  712. CAMPEAU SA, Schuetz AN, Kohner P, Arias CA, et al
    Variability of daptomycin minimum inhibitory concentrations for Enterococcus faecium when measured by reference broth microdilution and gradient diffusion tests.
    Antimicrob Agents Chemother. 2018 Jun 25. pii: AAC.00745.
    >> Share

  713. LEE H, Yoon EJ, Kim D, Kim JW, et al
    Ceftaroline resistance by clone-specific polymorphism in penicillin-binding protein 2a of methicillin-resistant Staphylococcus aureus.
    Antimicrob Agents Chemother. 2018 Jun 25. pii: AAC.00485.
    >> Share

  714. RANCOITA PMV, Cugnata F, Gibertoni Cruz AL, Borroni E, et al
    Validating a 14-drug microtitre plate containing bedaquiline and delamanid for large-scale research susceptibility testing of Mycobacterium tuberculosis.
    Antimicrob Agents Chemother. 2018 Jun 25. pii: AAC.00344.
    >> Share

  715. HORITA Y, Alsultan A, Kwara A, Antwi S, et al
    Evaluation of the Adequacy of WHO revised Dosages of the First-Line Anti-Tuberculosis Drugs in Children with Tuberculosis using Population Pharmacokinetic Modeling and Simulations.
    Antimicrob Agents Chemother. 2018 Jun 18. pii: AAC.00008.
    >> Share

  716. UMEYAMA T, Hayashi Y, Shimosaka H, Inukai T, et al
    Cas9/CRISPR genome editing to demonstrate the contribution of Cyp51A Gly138Ser to azole resistance in Aspergillus fumigatus.
    Antimicrob Agents Chemother. 2018 Jun 18. pii: AAC.00894.
    >> Share

  717. STOTT KE, Beardsley J, Kolamunnage-Dona R, Santoyo Castelazo A, et al
    Population pharmacokinetics and cerebrospinal fluid penetration of fluconazole in adults with cryptococcal meningitis.
    Antimicrob Agents Chemother. 2018 Jun 18. pii: AAC.00885.
    >> Share

  718. TRUONG-BOLDUC QC, Wang Y, Hooper DC
    Tet38 Efflux Pump Contributes to Fosfomycin Resistance in Staphylococcus aureus.
    Antimicrob Agents Chemother. 2018 Jun 11. pii: AAC.00927.
    >> Share

  719. WANG SK, Gilchrist A, Loukitcheva A, Plotkin BJ, et al
    The Prevalence of a Cefazolin Inoculum Effect Associated with blaZ Gene Types Among Methicillin-Susceptible Staphylococcus aureus Isolates from Four Major Medical Centers in Chicago.
    Antimicrob Agents Chemother. 2018 Jun 11. pii: AAC.00382.
    >> Share

  720. DABAS Y, Xess I, Bakshi S, Mahapatra M, et al
    "Emergence of azole resistant Aspergillus fumigatus from immunocompromised hosts in India".
    Antimicrob Agents Chemother. 2018 Jun 11. pii: AAC.02264.
    >> Share

  721. DU PRE S, Beckmann N, Almeida MC, Sibley GEM, et al
    The effect of the novel antifungal drug F901318 (Olorofim) on the growth and viability of Aspergillus fumigatus.
    Antimicrob Agents Chemother. 2018 Jun 11. pii: AAC.00231.
    >> Share

  722. SIMITSOPOULOU M, Chlichlia K, Kyrpitzi D, Walsh TJ, et al
    Pharmacodynamic and immunomodulatory effects of micafungin on host responses against biofilms of Candida parapsilosis in comparison to those of Candida albicans.
    Antimicrob Agents Chemother. 2018 Jun 4. pii: AAC.00478.
    >> Share

  723. DE MIRANDA SILVA C, Hajihosseini A, Myrick J, Nole J, et al
    Effect of Linezolid plus Bedaquiline against Mycobacterium tuberculosis in Log-Phase, Acid-Phase and Non-Replicating-Persister (NRP)-Phase in an In vitro Assay.
    Antimicrob Agents Chemother. 2018 Jun 4. pii: AAC.00856.
    >> Share

  724. CEBALLOS S, Kim C, Ding D, Mobashery S, et al
    Activities of oxadiazole antibacterials against Staphylococcus aureus and other Gram-positive bacteria.
    Antimicrob Agents Chemother. 2018 Jun 4. pii: AAC.00453.
    >> Share

  725. DRUSANO GL, Myrick J, Maynard M, Nole J, et al
    Linezolid Kills Acid Phase and Non-replicative Persister Phase Mycobacterium tuberculosis in a Hollow Fiber Infection Model.
    Antimicrob Agents Chemother. 2018 Jun 4. pii: AAC.00221.
    >> Share

    May 2018
  726. SAVAGE KA, Parquet MDC, Allan DS, Davidson RJ, et al
    Iron restriction to clinical isolates of Candida albicans by the novel chelator DIBI inhibits growth and increases sensitivity to azoles in vitro and in vivo in a murine model of experimental vaginitis.
    Antimicrob Agents Chemother. 2018 May 29. pii: AAC.02576.
    >> Share

  727. ZONG Z, Jing W, Shi J, Wen S, et al
    Comparison of in vitro activity and MIC distributions between the novel oxazolidinone delpazolid and linezolid against multidrug-resistant and extensively drug-resistant Mycobacterium tuberculosis in China.
    Antimicrob Agents Chemother. 2018 May 29. pii: AAC.00165.
    >> Share

  728. JAHANBAKHSH S, Singh NB, Yim J, Rose WE, et al
    Evaluation of Telavancin Alone and Combined with Ceftaroline or Rifampin against Methicillin-Resistant Staphylococcus aureus (MRSA) in an in vitro Biofilm Model.
    Antimicrob Agents Chemother. 2018 May 21. pii: AAC.00567.
    >> Share

  729. SHOEN C, DeStefano M, Hafkin B, Cynamon M, et al
    In vitro and in vivo activity of contezolid (MRX-I) against Mycobacterium tuberculosis.
    Antimicrob Agents Chemother. 2018 May 21. pii: AAC.00493.
    >> Share

  730. GOEMAERE B, Lagrou K, Spriet I, Hendrickx M, et al
    Clonal spread in Candida glabrata bloodstream isolates and fluconazole resistance affected by prolonged exposure: a 12-year single-center study in Belgium.
    Antimicrob Agents Chemother. 2018 May 21. pii: AAC.00591.
    >> Share

  731. BROWN GANDT A, Griffith EC, Lister IM, Billings LL, et al
    In vivo and in vitro effects of a ClpP activating antibiotic against vancomycin resistant enterococci.
    Antimicrob Agents Chemother. 2018 May 21. pii: AAC.00424.
    >> Share

  732. KEBRIAEI R, Rice SA, Singh KV, Stamper KC, et al
    Efficacy of Daptomycin Monotherapy and In Combination with beta-lactams for Daptomycin-Susceptible Enterococcus faecium Harboring LiaSR Substitutions: Influence of The Inoculum Effect.
    Antimicrob Agents Chemother. 2018 May 14. pii: AAC.00315.
    >> Share

  733. POELMANS J, Himmelreich U, Vanherp L, Zhai L, et al
    A multimodal imaging approach enables in vivo assessment of antifungal treatment in a mouse model of invasive pulmonary aspergillosis.
    Antimicrob Agents Chemother. 2018 May 14. pii: AAC.00240.
    >> Share

  734. LUO J, Yu X, Jiang G, Fu Y, et al
    In Vitro Activity of Clofazimine against Non-tuberculous Mycobacteriaisolated in Beijing, China.
    Antimicrob Agents Chemother. 2018 May 14. pii: AAC.00072.
    >> Share

  735. LOPEZ-SANCHEZ A, Perez-Cantero A, Torrado-Salmeron C, Martin-Vicente A, et al
    Experimental Amphotericin B-Deoxycholate formulations for pulmonary aspergillosis: efficacy, biodistribution and nephrotoxicity.
    Antimicrob Agents Chemother. 2018 May 14. pii: AAC.00489.
    >> Share

  736. STOTT KE, Beardsley J, Whalley S, Kibengo FM, et al
    Amphotericin B Deoxycholate in adults with Cryptococcal Meningitis; a Population Pharmacokinetic Model and Meta-Analysis of Outcomes.
    Antimicrob Agents Chemother. 2018 May 7. pii: AAC.02526.
    >> Share

  737. BOUDJEMAA R, Cabriel C, Dubois-Brissonnet F, Bourg N, et al
    Failure of daptomycin to kill Staphylococcus aureus: impact of bacterial membrane fatty acid composition.
    Antimicrob Agents Chemother. 2018 May 7. pii: AAC.00023.
    >> Share

  738. GUO H, Zhou L, He Y, Gao C, et al
    Natamycin and Azithromycin are Synergistic in vitro against Ocular Pathogenic Aspergillus flavus species complex and Fusarium solani species complex Isolates.
    Antimicrob Agents Chemother. 2018 May 7. pii: AAC.00077.
    >> Share

  739. AMMERMAN NC, Swanson RV, Bautista EM, Almeida DV, et al
    Impact of Clofazimine Dosing on Treatment-Shortening of the First-Line Regimen in a Mouse Model of Tuberculosis.
    Antimicrob Agents Chemother. 2018 May 7. pii: AAC.00636.
    >> Share

  740. TIWARI KB, Gatto C, Walker S, Wilkinson BJ, et al
    Targocil-exposure of Staphylococcus aureus Blocks Translocation of the Major Autolysin Atl Across the Membrane Resulting in a Significant Decrease in Autolysis.
    Antimicrob Agents Chemother. 2018 May 7. pii: AAC.00323.
    >> Share

  741. KASPAR U, de Haro Sautto JA, Molinaro S, Peters G, et al
    The novel phage-derived antimicrobial agent HY-133 is active against livestock-associated methicillin-resistant Staphylococcus aureus (LA-MRSA).
    Antimicrob Agents Chemother. 2018 May 7. pii: AAC.00385.
    >> Share

  742. KAUFMANN SHE
    Indole Propionic Acid: a Small Molecule Links between Gut Microbiota and Tuberculosis.
    Antimicrob Agents Chemother. 2018;62.
    >> Share

    April 2018
  743. BUTTS A, Reitler P, Ge W, Fortwendel JR, et al
    Commonly used oncology drugs decrease antifungal effectiveness against Candida and Aspergillus species.
    Antimicrob Agents Chemother. 2018 Apr 30. pii: AAC.00504.
    >> Share

  744. BORDALLO-CARDONA MA, Marcos-Zambrano LJ, Sanchez-Carrillo C, Bouza E, et al
    Resistance to echinocandins in Candida can be detected by performing the Etest directly on blood culture samples.
    Antimicrob Agents Chemother. 2018 Apr 30. pii: AAC.00162.
    >> Share

  745. SIALA W, Rodriguez-Villalobos H, Fernandes P, Tulkens PM, et al
    Activity of combinations of antistaphylococcal antibiotics with fusidic acid against staphylococcal biofilms in in vitro static and dynamic models.
    Antimicrob Agents Chemother. 2018 Apr 30. pii: AAC.00598.
    >> Share

  746. SHI W, Chen J, Zhang S, Zhang W, et al
    Identification of novel mutations in LprG (rv1411c), rv0521,rv3630, rv0010c, ppsC,cyp128 associated with pyrazinoic acid/pyrazinamide resistance in Mycobacterium tuberculosis.
    Antimicrob Agents Chemother. 2018 Apr 23. pii: AAC.00430.
    >> Share

  747. BUTLER-LAPORTE G, Lee TC, Cheng MP
    Increasing Rates of Penicillin Sensitivity in Staphylococcus aureus.
    Antimicrob Agents Chemother. 2018 Apr 23. pii: AAC.00680.
    >> Share

  748. BOOT M, Commandeur S, Subudhi AK, Bahira M, et al
    Accelerating early anti-tuberculosis drug discovery by creating mycobacterial indicator strains that predict mode of action.
    Antimicrob Agents Chemother. 2018 Apr 16. pii: AAC.00083.
    >> Share

  749. ZHENG H, Williams JT, Coulson GB, Haiderer ER, et al
    HC2091 kills Mycobacterium tuberculosis by targeting the MmpL3 mycolic acid transporter.
    Antimicrob Agents Chemother. 2018 Apr 16. pii: AAC.02459.
    >> Share

  750. BEN-SHMUEL A, Glinert I, Sittner A, Bar-David E, et al
    Treating Anthrax-Induced Meningitis in Rabbits.
    Antimicrob Agents Chemother. 2018 Apr 16. pii: AAC.00298.
    >> Share

  751. LIU Y, Pertinez H, Davies GR, Gillespie SH, et al
    Moxifloxacin replacement in contemporary tuberculosis drug regimens is ineffective against persistent Mycobacterium tuberculosis: Novel insights from the Cornell mouse model.
    Antimicrob Agents Chemother. 2018 Apr 16. pii: AAC.00190.
    >> Share

  752. LYONS MA
    Modeling and Simulation of Pretomanid Pharmacokinetics in Pulmonary Tuberculosis Patients.
    Antimicrob Agents Chemother. 2018 Apr 16. pii: AAC.02359.
    >> Share

  753. STEFAN MA, Ugur FS, Garcia GA
    SOURCE OF THE FITNESS DEFECT IN RIFAMYCIN-RESISTANT M. TUBERCULOSIS RNA POLYMERASE AND THE MECHANISM OF COMPENSATION BY MUTATIONS IN THE beta'-SUBUNIT.
    Antimicrob Agents Chemother. 2018 Apr 16. pii: AAC.00164.
    >> Share

  754. KORDALEWSKA M, Lee A, Park S, Berrio I, et al
    Understanding echinocandin resistance in the emerging pathogen Candida auris.
    Antimicrob Agents Chemother. 2018 Apr 9. pii: AAC.00238.
    >> Share

  755. GARCIA-RUBIO R, Alcazar-Fuoli L, Monteiro MC, Monzon S, et al
    Aspergillus fumigatus cyp51A polymorphisms, an insight on their significance.
    Antimicrob Agents Chemother. 2018 Apr 9. pii: AAC.00241.
    >> Share

  756. LASKARIS P, Vicentefranqueira R, Helynck O, Jouvion G, et al
    A novel polyaminocarboxylate compound to treat murine pulmonary aspergillosis by interfering with zinc metabolism.
    Antimicrob Agents Chemother. 2018 Apr 9. pii: AAC.02510.
    >> Share

  757. GHANNOUM M, Long L, Larkin EL, Isham N, et al
    SCY-078, a Novel Oral Glucan Synthase Inhibitor, for the Treatment of Invasive Aspergillosis: Evaluation of Antifungal Activity Singly and in Combination.
    Antimicrob Agents Chemother. 2018 Apr 2. pii: AAC.00244.
    >> Share

  758. LI JL, Yang N, Huang L, Chen D, et al
    Pyocyanin Inhibits Chlamydia Infection by Disabling Infectivity of the Elementary Body and Disrupting Intracellular Growth.
    Antimicrob Agents Chemother. 2018 Apr 2. pii: AAC.02260.
    >> Share

  759. BARMAN TK, Kumar M, Mathur T, Namba E, et al
    In vitro and in vivo activities of DS-2969b, a novel GyrB inhibitor, and its water-soluble prodrug, DS11960558, against methicillin-resistant Staphylococcus aureus.
    Antimicrob Agents Chemother. 2018 Apr 2. pii: AAC.02556.
    >> Share

  760. LAMONTAGNE BOULET M, Isabelle C, Guay I, Brouillette E, et al
    Tomatidine, a lead antibiotic molecule that targets Staphylococcus aureus ATP synthase subunit C.
    Antimicrob Agents Chemother. 2018 Apr 2. pii: AAC.02197.
    >> Share

  761. LI FJ, Palmer KL
    EfrEF and the transcription regulator ChlR are required for chlorhexidine stress response in Enterococcus faecalis V583.
    Antimicrob Agents Chemother. 2018 Apr 2. pii: AAC.00267.
    >> Share

  762. SINGH A, Healey KR, Yadav P, Upadhyaya G, et al
    Absence of azole or echinocandin resistance in Candida glabrata isolates in India despite background prevalence of strains with defects in DNA mismatch repair pathway.
    Antimicrob Agents Chemother. 2018 Apr 2. pii: AAC.00195.
    >> Share

  763. GSALLER F, Furukawa T, Carr PD, Rash B, et al
    The mechanistic basis of pH-dependent 5-flucytosine resistance in Aspergillus fumigatus.
    Antimicrob Agents Chemother. 2018 Apr 2. pii: AAC.02593.
    >> Share

  764. BASSO V, Garcia A, Tran DQ, Schaal JB, et al
    Fungicidal potency and mechanisms of theta-defensins against multi-drug resistant Candida species.
    Antimicrob Agents Chemother. 2018 Apr 2. pii: AAC.00111.
    >> Share

  765. GARCIA-DE-LA-MARIA C, Gasch O, Garcia-Gonzalez J, Soy D, et al
    The Combination of Daptomycin plus Fosfomycin has Synergistic, Potent and Rapid Bactericidal Activity against Methicillin-Resistant Staphylococcus aureus (MRSA) in a Rabbit Model of Experimental Endocarditis (EE).
    Antimicrob Agents Chemother. 2018 Apr 2. pii: AAC.02633.
    >> Share

  766. YANG F, Zhang L, Wakabayashi H, Myers J, et al
    Correction for Yang et al., "Tolerance to Caspofungin in Candida albicans Is Associated with at Least Three Distinctive Mechanisms That Govern Expression of FKS Genes and Cell Wall Remodeling".
    Antimicrob Agents Chemother. 2018;62.
    >> Share

  767. CHEN Y, Mallick J, Maqnas A, Sun Y, et al
    Erratum for Chen et al., "Chemogenomic Profiling of the Fungal Pathogen Candida albicans".
    Antimicrob Agents Chemother. 2018;62.
    >> Share

    March 2018
  768. CHEN CL, Cheng MH, Kuo CF, Cheng YL, et al
    Dextromethorphan Attenuates NADPH Oxidase-regulated GSK-3beta and NF-kappaB Activation and Reduces Nitric Oxide Production in Group A Streptococcal Infection.
    Antimicrob Agents Chemother. 2018 Mar 26. pii: AAC.02045.
    >> Share

  769. HIRAYAMA T, Miyazaki T, Yamagishi Y, Mikamo H, et al
    Clinical and Microbiological Characteristics of Candida guilliermondii and Candida fermentati.
    Antimicrob Agents Chemother. 2018 Mar 26. pii: AAC.02528.
    >> Share

  770. ESCHENAUER GA, Carver PL, Patel TS, Lin SW, et al
    Survival in Patients with Candida glabrata Bloodstream Infections is Associated with Fluconazole Dose.
    Antimicrob Agents Chemother. 2018 Mar 26. pii: AAC.02566.
    >> Share

  771. HOU X, Xiao M, Wang H, Yu SY, et al
    Profiling of PDR1 and MSH2 in Candida glabrata Bloodstream Isolates from a Multi-Center Study in China.
    Antimicrob Agents Chemother. 2018 Mar 26. pii: AAC.00153.
    >> Share

  772. BADER JC, Lakota EA, Flanagan S, Ong V, et al
    Overcoming the Resistance Hurdle: PK-PD Target Attainment Analyses of Rezafungin (CD101) for Candida albicans and Candida glabrata.
    Antimicrob Agents Chemother. 2018 Mar 19. pii: AAC.02614.
    >> Share

  773. LUTHER MK, Parente DM, Caffrey AR, Daffinee K, et al
    Clinical and genetic risk factors for biofilm-forming Staphylococcus aureus.
    Antimicrob Agents Chemother. 2018 Mar 12. pii: AAC.02252.
    >> Share

  774. TOMAS ME, Mana TSC, Wilson BM, Nerandzic MM, et al
    Tapering Courses of Oral Vancomycin Induce Persistent Disruption of the Microbiota that Provide Colonization Resistance to Clostridium difficile and Vancomycin-Resistant Enterococci in Mice.
    Antimicrob Agents Chemother. 2018 Mar 12. pii: AAC.02237.
    >> Share

  775. KOK EY, Vallejo JG, Sommer LM, Rosas L, et al
    Association of Vancomycin MIC and Molecular Characteristics With Clinical Outcomes in Methicillin-Susceptible Staphylococcus aureus Acute Hematogenous Osteoarticular Infections in Children.
    Antimicrob Agents Chemother. 2018 Mar 12. pii: AAC.00084.
    >> Share

  776. SMITH JR, Yim J, Rice S, Stamper K, et al
    The combination of tedizolid and daptomycin against methicillin-resistant Staphylococcus aureus in an in vitro model of simulated endocardial vegetations.
    Antimicrob Agents Chemother. 2018 Mar 12. pii: AAC.00101.
    >> Share

  777. CHEN Y, Li Z, Han X, Tian S, et al
    Elevated MIC values to imidazole drugs among Aspergillus fumigatus isolates with TR34/L98H/S297T/F495I mutation.
    Antimicrob Agents Chemother. 2018 Mar 5. pii: AAC.01549.
    >> Share

  778. MERCER DK, Katvars LK, Hewitt F, Smith DW, et al
    Correction for Mercer et al., "NP108, an Antimicrobial Polymer with Activity against Methicillin- and Mupirocin-Resistant Staphylococcus aureus".
    Antimicrob Agents Chemother. 2018;62.
    >> Share

  779. ARIAS CA, Reyes J, Carvajal LP, Rincon S, et al
    Erratum for Arias et al., "A Prospective Cohort Multicenter Study of Molecular Epidemiology and Phylogenomics of Staphylococcus aureus Bacteremia in Nine Latin American Countries".
    Antimicrob Agents Chemother. 2018;62.
    >> Share

    February 2018
  780. GUIRAO-ABAD JP, Sanchez-Fresneda R, Machado F, Arguelles JC, et al
    MICAFUNGIN ENHANCES THE HUMAN MACROPHAGE RESPONSE TO Candida albicans THROUGH beta-GLUCAN EXPOSURE.
    Antimicrob Agents Chemother. 2018 Feb 26. pii: AAC.02161.
    >> Share

  781. LU Z, Jia X, Chen Y, Han X, et al
    Identification and Characterization of Key Charged Residues in the Cofilin Protein Involved in Azole Susceptibility, Apoptosis, and Virulence of Aspergillus fumigatus.
    Antimicrob Agents Chemother. 2018 Feb 26. pii: AAC.01659.
    >> Share

  782. GUPTA R, Felix CR, Akerman MP, Akerman KJ, et al
    Gold(III) macrocycles and chelates targeting Mycobacterium tuberculosis and Mycobacterium abscessus: evidence for inhibition of topoisomerase 1A.
    Antimicrob Agents Chemother. 2018 Feb 26. pii: AAC.01696.
    >> Share

  783. BERKOW EL, Nunnally NS, Bandea A, Kuykendall R, et al
    Detection of TR34/L98H Cyp51A mutation through passive surveillance for azole-resistant Aspergillus fumigatus in the US, 2015-2017.
    Antimicrob Agents Chemother. 2018 Feb 20. pii: AAC.02240.
    >> Share

  784. CHEN C, Gardete S, Jansen RS, Shetty A, et al
    Verapamil targets membrane energetics in Mycobacterium tuberculosis.
    Antimicrob Agents Chemother. 2018 Feb 20. pii: AAC.02107.
    >> Share

  785. HEMANTH KUMAR AK, Kumar A, Kannan T, Bhatia R, et al
    Pharmacokinetics of second-line anti-tuberculosis drugs in children with multidrug-resistant tuberculosis in India.
    Antimicrob Agents Chemother. 2018 Feb 20. pii: AAC.02410.
    >> Share

  786. MELETIADIS J, Siopi M, Tsakris A, Mouton JW, et al
    A new marker of echinocandins activity in an in vitro PK/PD model correlates with an animal model of Aspergillus fumigatus infection.
    Antimicrob Agents Chemother. 2018 Feb 20. pii: AAC.02322.
    >> Share

  787. WEINER M, Gelfond J, Johnson-Pais TL, Engle M, et al
    Elevated Plasma Moxifloxacin Concentrations and SLCO1B1 g.-11187G>A Polymorphism in Adults with Pulmonary Tuberculosis.
    Antimicrob Agents Chemother. 2018 Feb 20. pii: AAC.01802.
    >> Share

  788. ZUUR MA, Ghimire S, Bolhuis MS, Wessels AMA, et al
    The Pharmacokinetics of 2000 mg Ertapenem in Tuberculosis Patients.
    Antimicrob Agents Chemother. 2018 Feb 12. pii: AAC.02250.